https://www.moreblossom.com/papers/5-methoxy-n-n-dimethyltryptamine-5-meo-dmt-for-alcohol-use-disorder-an-open-label-phase-2-proof 2026-05-05T15:00:52Z monthly 0.7 https://www.moreblossom.com/papers/preliminary-evidence-that-serum-interleukin-6-is-a-candidate-biomarker-of-response-to-esketamine 2026-04-28T13:30:50Z monthly 0.7 https://www.moreblossom.com/papers/negative-affective-bias-depression-treatment-psilocybin-escitalopram-secondary-analysis 2026-05-12T23:37:15Z monthly 0.7 https://www.moreblossom.com/papers/cognitive-behavioral-therapy-following-esketamine-for-major-depression-and-suicidal-ideation-for 2026-05-12T10:34:50Z monthly 0.7 https://www.moreblossom.com/papers/trip-sitting-or-just-sitting-session-facilitators-substantially-influence-psychedelic 2026-05-05T14:59:39Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-therapy-vs-antidepressants-for-the-treatment-of-depression-under-equal-unblinding 2026-04-10T13:44:53Z monthly 0.7 https://www.moreblossom.com/papers/measuring-and-appraising-placebo-effects-in-clinical-trials-contemporary-challenges-and 2026-05-05T14:59:08Z monthly 0.7 https://www.moreblossom.com/papers/a-randomized-clinical-trial-of-repeated-doses-of-psilocybin-for-the-treatment-of-obsessive 2026-05-13T09:00:06Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-like-context-and-relational-support-during-psychedelic-use-moderate-links-among 2026-04-06T10:40:06Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-medicine-mechanisms-evidence-and-translation-to-practice 2026-03-27T10:45:16Z monthly 0.7 https://www.moreblossom.com/papers/single-dose-iv-ketamine-for-adolescent-suicidal-ideation-in-the-emergency-department-a-pilot 2026-05-19T10:29:52Z monthly 0.7 https://www.moreblossom.com/papers/r-mddma-is-a-safer-analogue-of-mdma-with-therapeutic-potential 2026-05-05T14:59:33Z monthly 0.7 https://www.moreblossom.com/papers/intranasal-5-meo-dmt-concomitant-with-ssri-for-treatment-resistant-depression-a-proof-of-concept 2026-05-05T15:00:17Z monthly 0.7 https://www.moreblossom.com/papers/protocol-and-pilot-results-for-a-double-blind-randomized-placebo-controlled-trial-of-ketamine 2026-05-19T09:31:45Z monthly 0.7 https://www.moreblossom.com/papers/an-international-mega-analysis-of-psychedelic-drug-effects-on-brain-circuit-function 2026-05-05T14:58:51Z monthly 0.7 https://www.moreblossom.com/papers/role-of-concomitant-benzodiazepines-lithium-and-lamotrigine-in-modulating-the-antidepressant 2026-04-06T09:47:05Z monthly 0.7 https://www.moreblossom.com/papers/synergies-in-psychedelic-assisted-therapy-a-qualitative-interview-study-of-psychotherapeutic 2026-04-13T14:02:09Z monthly 0.7 https://www.moreblossom.com/papers/investigational-psilocybin-treatment-for-ptsd-qualitative-study-participant-experience 2026-05-11T17:06:35Z monthly 0.7 https://www.moreblossom.com/papers/mixed-methods-analysis-on-psychedelic-augmented-meditation-experiences-from-a-randomized 2026-04-27T11:55:37Z monthly 0.7 https://www.moreblossom.com/papers/increased-cortical-thickness-and-decreased-brain-age-among-special-operations-veterans-with 2026-05-13T13:44:38Z monthly 0.7 https://www.moreblossom.com/papers/the-therapeutic-potential-of-psychedelics-for-treatment-resistant-depression-reality-or 2026-04-16T09:51:15Z monthly 0.7 https://www.moreblossom.com/papers/low-dose-buprenorphine-following-ketamine-treatment-for-suicidal-ideation-in-major-depressive 2026-05-20T10:48:50Z monthly 0.7 https://www.moreblossom.com/papers/inhaled-dmt-diminishes-connectivity-ventral-tegmental-area-nucleus-accumbens 2026-04-16T10:48:30Z monthly 0.7 https://www.moreblossom.com/papers/age-moderates-the-relationship-between-psychedelics-use-and-mental-health-in-naturalistic 2026-04-01T20:51:05Z monthly 0.7 https://www.moreblossom.com/papers/a-living-systematic-review-meta-analysis-and-open-data-resource-of-randomized-controlled-trials 2026-05-05T15:00:30Z monthly 0.7 https://www.moreblossom.com/papers/characterizing-resting-state-brain-dynamics-with-frequency-resolved-eeg-microstates-parallel 2026-05-11T13:16:41Z monthly 0.7 https://www.moreblossom.com/papers/evaluating-the-evidence-for-repressed-memory-recovery-in-psychedelic-contexts 2026-05-05T14:58:56Z monthly 0.7 https://www.moreblossom.com/papers/an-open-label-pilot-study-of-psilocybin-assisted-therapy-for-binge-eating-disorder 2026-05-13T06:42:27Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-reshapes-cortical-inhibition-through-selective-interneuron-recruitment 2026-05-05T15:00:48Z monthly 0.7 https://www.moreblossom.com/papers/blinding-integrity-in-psychedelic-randomized-clinical-trials-a-systematic-review 2026-05-05T14:59:02Z monthly 0.7 https://www.moreblossom.com/papers/predicting-and-exploring-ayahuasca-effects-perception-mind-wandering-and-eeg-oscillations 2026-05-05T14:59:21Z monthly 0.7 https://www.moreblossom.com/papers/inflammatory-biomarker-outcomes-associated-with-mdma-assisted-therapy-an-open-label-exploratory 2026-05-19T13:53:35Z monthly 0.7 https://www.moreblossom.com/papers/case-report-repeated-low-doses-of-psilocybin-reduce-perceived-symptom-severity-but-fail-to 2026-05-12T10:34:52Z monthly 0.7 https://www.moreblossom.com/papers/large-scale-and-local-functional-connectivity-changes-following-psilocybin-administration-in 2026-04-28T13:29:45Z monthly 0.7 https://www.moreblossom.com/papers/post-traumatic-stress-disorder-symptoms-following-psychedelic-use-a-naturalistic-survey-study 2026-04-01T19:27:51Z monthly 0.7 https://www.moreblossom.com/papers/the-role-of-therapeutic-alliance-in-psilocybin-treatment-for-treatment-resistant-depression-a 2026-05-19T09:31:50Z monthly 0.7 https://www.moreblossom.com/papers/gh001-vs-placebo-in-patients-with-treatment-resistant-depression-a-randomized-clinical-trial 2026-05-05T15:00:19Z monthly 0.7 https://www.moreblossom.com/papers/5-ht1a-receptor-blockade-potentiates-the-subjective-effects-of-dmt 2026-05-11T13:50:10Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-psilocybin-in-treatment-resistant-major-depression-the-episode-randomized 2026-05-19T09:31:39Z monthly 0.7 https://www.moreblossom.com/papers/a-living-systematic-review-meta-analysis-and-open-data-resource-of-trials-of-mdma-assisted 2026-05-05T14:59:15Z monthly 0.7 https://www.moreblossom.com/papers/group-retreat-psilocybin-therapy-for-people-with-metastatic-cancer-with-anxiety-and-depression-a 2026-05-11T17:06:36Z monthly 0.7 https://www.moreblossom.com/papers/participant-experiences-microdosed-lsd-6-week-randomised-controlled-trial 2026-05-05T15:00:13Z monthly 0.7 https://www.moreblossom.com/papers/subjective-and-neurocognitive-profiling-of-clinical-doses-of-3-4-methylenedioxymethamphetamine 2026-04-13T13:45:27Z monthly 0.7 https://www.moreblossom.com/papers/dissociating-the-hallucinogenic-and-neuroplastic-effects-of-psilocybin 2026-04-29T08:17:17Z monthly 0.7 https://www.moreblossom.com/papers/mystical-experience-induced-by-esketamine-treatment-a-real-world-observational-study 2026-04-13T13:16:42Z monthly 0.7 https://www.moreblossom.com/papers/intranasal-esketamine-real-world-clinical-practice-in-treatment-resistant-depression-and-factors 2026-05-05T13:31:24Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-lsd-and-psilocybin-on-heart-rate-in-patients-receiving-psychedelic-treatment-for 2026-04-11T10:48:55Z monthly 0.7 https://www.moreblossom.com/papers/general-anesthesia-and-discrete-components-of-ketamine-neurophysiology 2026-05-05T14:59:11Z monthly 0.7 https://www.moreblossom.com/papers/intranasal-esketamine-in-treatment-resistant-depression-long-term-dosing-patterns-and-clinical 2026-05-05T15:00:32Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-in-nhs-services-exploring-a-model-for-real-world-implementation-of-psilocybin 2026-03-31T10:00:26Z monthly 0.7 https://www.moreblossom.com/papers/pilot-study-of-psilocybin-in-patients-with-post-treatment-lyme-disease 2026-05-12T21:36:11Z monthly 0.7 https://www.moreblossom.com/papers/a-phase-2-uncontrolled-open-label-study-of-intranasal-bpl-003-5-methoxy-n-n-dimethyltryptamine 2026-05-05T15:00:54Z monthly 0.7 https://www.moreblossom.com/papers/it-s-all-about-the-relationship-the-caregiver-experience-of-supporting-a-person-with-advanced 2026-05-11T17:07:35Z monthly 0.7 https://www.moreblossom.com/papers/a-phase-1-study-of-a-second-experience-with-group-retreat-psilocybin-therapy-for-partial 2026-05-13T09:08:58Z monthly 0.7 https://www.moreblossom.com/papers/the-dynamics-of-ampa-receptors-underlies-the-efficacy-of-ketamine-in-treatment-resistant 2026-04-27T18:59:57Z monthly 0.7 https://www.moreblossom.com/papers/intranasal-ketamine-for-existential-distress-in-advanced-cancer 2026-05-19T10:29:42Z monthly 0.7 https://www.moreblossom.com/papers/brain-body-integromics-of-the-ayahuasca-experience 2026-05-05T14:58:57Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-or-nicotine-patch-for-smoking-cessation-a-pilot-randomized-clinical-trial 2026-05-12T17:09:03Z monthly 0.7 https://www.moreblossom.com/papers/long-term-treatment-with-esketamine-nasal-spray-in-patients-with-treatment-resistant-depression 2026-05-19T14:14:21Z monthly 0.7 https://www.moreblossom.com/papers/extended-difficulties-after-psychedelic-experiences-prevalence-and-associations-in-a-global 2026-05-05T14:59:43Z monthly 0.7 https://www.moreblossom.com/papers/do-psychedelics-mimic-psychosis-perspectives-on-similarities-and-differences-from-individuals 2026-04-16T10:48:32Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-psilocybin-on-time-perception-in-humans-a-comparative-analysis-of-subjective-and 2026-05-05T14:59:28Z monthly 0.7 https://www.moreblossom.com/papers/lsd-microdosing-for-major-depressive-disorder-mood-and-pharmacokinetic-outcomes-from-a-phase-2a 2026-05-19T10:29:44Z monthly 0.7 https://www.moreblossom.com/papers/what-is-it-like-to-microdose-lsd-for-depression-a-thematic-analysis-of-participant-interviews 2026-05-11T17:07:35Z monthly 0.7 https://www.moreblossom.com/papers/the-relationship-between-participant-pretreatment-clinical-presentation-and-the-quality-of 2026-05-11T17:06:36Z monthly 0.7 https://www.moreblossom.com/papers/dose-dependent-pharmacokinetics-and-acute-effects-of-intravenous-bolus-n-n-dimethyltryptamine 2026-05-05T14:59:40Z monthly 0.7 https://www.moreblossom.com/papers/symmetrical-global-mental-health-sym-gmh-ayahuasca-and-shipibo-traditional-medicine-for-lasting 2026-05-19T11:22:28Z monthly 0.7 https://www.moreblossom.com/papers/detecting-neuroplastic-effects-induced-by-ketamine-in-healthy-human-subjects-a-multimodal 2026-05-05T14:59:30Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-as-a-potential-treatment-for-borderline-personality-disorder-a-narrative-review 2026-05-05T14:59:09Z monthly 0.7 https://www.moreblossom.com/papers/group-retreat-psilocybin-therapy-for-people-with-metastatic-cancer-with-symptoms-of-anxiety-and 2026-05-19T09:31:42Z monthly 0.7 https://www.moreblossom.com/papers/mystical-dynamics-renewal-luminous-light-and-ego-disintegration-as-key-features-associated-with 2026-05-05T14:59:25Z monthly 0.7 https://www.moreblossom.com/papers/the-combination-of-exercise-and-psychedelics-for-the-treatment-of-major-depressive-disorder 2026-04-16T10:48:34Z monthly 0.7 https://www.moreblossom.com/papers/cognitive-outcomes-psilocybin-assisted-therapy-treatment-resistant-depression-post-hoc 2026-05-12T23:56:30Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-therapy-and-postpartum-depression-priorities-and-prospects 2026-03-27T11:41:01Z monthly 0.7 https://www.moreblossom.com/papers/acute-experiences-persisting-psychological-effects-encapsulated-dmt-harmala-alkaloid 2026-05-05T14:59:52Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-psychedelic-use-on-authoritarian-attitudes-revisited 2026-05-11T13:21:21Z monthly 0.7 https://www.moreblossom.com/papers/dmt-induced-shifts-criticality-correlate-self-dissolution 2026-05-05T14:58:59Z monthly 0.7 https://www.moreblossom.com/papers/acute-dose-dependent-effects-of-4-bromo-2-5-dimethoxyphenethylamine-2c-b-compared-with-3-4 2026-05-05T14:58:52Z monthly 0.7 https://www.moreblossom.com/papers/blood-biomarker-changes-and-relationships-after-low-dose-oral-ketamine-treatment-for-post 2026-05-12T05:41:11Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-in-the-treatment-of-cocaine-use-disorder-a-randomized-clinical-trial 2026-05-12T21:09:33Z monthly 0.7 https://www.moreblossom.com/papers/mystical-experiences-magnesium-ibogaine-associated-improvements-ptsd-symptoms-veterans 2026-05-19T10:29:46Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-induced-changes-in-accumbal-glutamate-and-their-association-with-altered-states-of 2026-05-19T11:23:39Z monthly 0.7 https://www.moreblossom.com/papers/comparing-single-and-repeat-dose-psilocybin-with-active-placebo-for-migraine-prevention-in-an 2026-05-19T12:40:14Z monthly 0.7 https://www.moreblossom.com/papers/mapping-phenomenology-intranasal-5-meo-dmt-psychedelic-naive-healthy-adults 2026-04-13T18:59:35Z monthly 0.7 https://www.moreblossom.com/papers/neuroplastic-white-matter-changes-in-patients-with-major-depression-following-lysergic-acid 2026-05-19T11:24:01Z monthly 0.7 https://www.moreblossom.com/papers/faster-and-greater-antidepressant-response-to-intravenous-ketamine-in-bipolar-compared-with 2026-05-05T17:17:06Z monthly 0.7 https://www.moreblossom.com/papers/real-world-psilocybin-therapy-for-treatment-resistant-depression-a-retrospective-observational 2026-05-05T14:59:14Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-the-pathway-to-implementation-in-the-european-healthcare-systems 2026-05-05T15:00:16Z monthly 0.7 https://www.moreblossom.com/papers/serotonergic-polypharmacology-of-2-halogenated-tryptamines 2026-05-05T13:31:05Z monthly 0.7 https://www.moreblossom.com/papers/intact-neurophysiological-markers-death-denial-long-term-ayahuasca-users 2026-04-16T10:48:36Z monthly 0.7 https://www.moreblossom.com/papers/oxa-noribogaine-reduces-alcohol-drinking-through-aversion-learning-and-by-altering-glutamatergic 2026-05-05T15:00:56Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-shapes-the-slow-global-propagation-of-brain-activity-over-the-cortical-layout-of 2026-04-13T10:32:17Z monthly 0.7 https://www.moreblossom.com/papers/single-low-dose-esketamine-improves-postpartum-depression-symptoms-and-recovery-quality-in 2026-05-11T20:28:17Z monthly 0.7 https://www.moreblossom.com/papers/esketamine-in-treatment-resistant-depression-with-and-without-comorbid-borderline-personality 2026-05-05T15:00:50Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-addiction-following-a-single-sub-anaesthetic-ketamine-treatment-for-acute-suicidality 2026-05-05T14:59:37Z monthly 0.7 https://www.moreblossom.com/papers/an-open-label-study-of-single-dose-psilocybin-for-borderline-personality-disorder-with-co 2026-05-13T06:45:57Z monthly 0.7 https://www.moreblossom.com/papers/lsd-persistently-disrupts-affective-pain-processing 2026-05-12T12:43:38Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-are-associated-with-changes-in-spiritual-beliefs-and-orientations-in-us-veterans 2026-04-13T18:54:10Z monthly 0.7 https://www.moreblossom.com/papers/virtual-clinical-trial-psychedelics-treat-patients-disorders-of-consciousness 2026-05-05T14:58:55Z monthly 0.7 https://www.moreblossom.com/papers/evaluation-of-a-facilitator-training-program-in-a-randomized-controlled-trial-of-psilocybin 2026-05-11T17:06:40Z monthly 0.7 https://www.moreblossom.com/papers/repeated-intranasal-esketamine-augmentation-in-treatment-resistant-obsessive-compulsive-disorder 2026-04-29T08:18:52Z monthly 0.7 https://www.moreblossom.com/papers/trip-killers-addressing-a-critical-knowledge-gap-in-psychedelic-research 2026-03-31T10:46:58Z monthly 0.7 https://www.moreblossom.com/papers/ibogaine-for-the-treatment-of-parkinson-s-disease-a-case-report 2026-04-07T15:05:09Z monthly 0.7 https://www.moreblossom.com/papers/a-qualitative-analysis-of-participant-expectations-and-experiences-of-psilocybin-assisted 2026-05-13T08:41:41Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-the-neuroplastogen-tsnd-201-for-the-treatment-of-ptsd-a-randomized 2026-05-13T13:53:57Z monthly 0.7 https://www.moreblossom.com/papers/magnitude-of-response-in-treatment-and-control-groups-within-psychedelic-trials-for-psychiatric 2026-04-13T18:59:28Z monthly 0.7 https://www.moreblossom.com/papers/oral-ketamine-for-chronic-pain-towards-an-evidence-based-dosing-regimen 2026-03-31T10:17:44Z monthly 0.7 https://www.moreblossom.com/papers/roland-r-griffiths-psychopharmacology-pioneer-abuse-liability-alcohol-nicotine-caffeine 2026-03-24T15:21:56Z monthly 0.7 https://www.moreblossom.com/papers/epidemiology-of-hallucinogen-microdosing-among-young-adults-in-the-united-states-a-national 2026-04-06T10:47:05Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-therapy-major-depressive-disorder-seven-month-follow-up-proof-of-principle 2026-05-19T15:57:27Z monthly 0.7 https://www.moreblossom.com/papers/effectiveness-and-factors-associated-with-esketamine-response-during-the-4-week-induction-period 2026-05-19T13:23:14Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-produce-enduring-behavioral-effects-functional-plasticity-independent-structural 2026-04-13T18:59:34Z monthly 0.7 https://www.moreblossom.com/papers/acute-and-post-dosing-effects-of-single-dose-psilocybin-for-obsessive-compulsive-disorder-in-a 2026-05-11T17:06:36Z monthly 0.7 https://www.moreblossom.com/papers/when-therapy-falls-short-a-qualitative-study-of-psychotherapy-after-challenging-psychedelic-expe 2026-05-19T11:22:27Z monthly 0.7 https://www.moreblossom.com/papers/short-term-and-late-term-effects-of-psilocybin-on-symptoms-in-major-depression-a-randomized-clin 2026-05-19T09:31:48Z monthly 0.7 https://www.moreblossom.com/papers/perceptions-of-australasian-palliative-care-physicians-regarding-the-safety-and-efficacy-of-psyc 2026-05-19T18:17:26Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-a-single-dose-of-psilocybin-for-chronic-suicidal-ideation-an-open-label-t 2026-05-19T11:22:30Z monthly 0.7 https://www.moreblossom.com/papers/association-between-lifetime-hallucinogen-use-and-valvular-heart-disease-findings-from-the-all-o 2026-05-20T10:50:37Z monthly 0.7 https://www.moreblossom.com/papers/m-dasc-measuring-subjective-effects-of-very-low-doses-of-psychedelic-drugs 2026-05-19T11:22:25Z monthly 0.7 https://www.moreblossom.com/papers/34-methylenedioxymethamphetamine-assisted-psychotherapy-for-treatment-of-chronic 2026-05-19T13:11:57Z monthly 0.7 https://www.moreblossom.com/papers/34-methylenedioxymethamphetamine-facilitates-fear-extinction-learning 2026-04-16T10:48:43Z monthly 0.7 https://www.moreblossom.com/papers/34-methylenedioxymethamphetamine-mdma-assisted-psychotherapy-for-post-traumatic- 2026-05-19T09:31:36Z monthly 0.7 https://www.moreblossom.com/papers/34-methylenedioxymethamphetamine-mdma-assisted-psychotherapy-for-victims-of-sexu 2026-05-18T19:12:33Z monthly 0.7 https://www.moreblossom.com/papers/4-bromo-25-dimethoxyphenethylamine-2c-b-and-structurally-related-phenylethylamin 2026-04-16T09:51:27Z monthly 0.7 https://www.moreblossom.com/papers/5-ht2a-agonists-a-novel-therapy-for-functional-neurological-disorders 2026-04-16T09:51:29Z monthly 0.7 https://www.moreblossom.com/papers/5-ht2ars-mediate-therapeutic-behavioral-effects-of-psychedelic-tryptamines 2026-04-16T10:48:45Z monthly 0.7 https://www.moreblossom.com/papers/5-ht2cr-is-as-important-as-5-ht2ar-in-inducing-hallucinogenic-effects-in-seroton 2026-04-16T09:51:32Z monthly 0.7 https://www.moreblossom.com/papers/5-meo-dmt-an-atypical-psychedelic-with-unique-pharmacology-phenomenology-risk 2026-04-16T10:48:46Z monthly 0.7 https://www.moreblossom.com/papers/5-meo-dmt-for-post-traumatic-stress-disorder-a-real-world-longitudinal-case-stud 2026-03-25T10:58:49Z monthly 0.7 https://www.moreblossom.com/papers/5-methoxy-2-aminoindane-reverses-diet-induced-obesity-and-improves-metabolic-par 2026-04-16T09:51:35Z monthly 0.7 https://www.moreblossom.com/papers/5-methoxy-nn-dimethyltryptamine-5-meo-dmt-used-in-a-naturalistic-group-setting-i 2026-04-16T09:51:37Z monthly 0.7 https://www.moreblossom.com/papers/a-bayesian-reanalysis-of-a-trial-of-psilocybin-versus-escitalopram-for-depressio 2026-05-19T09:31:37Z monthly 0.7 https://www.moreblossom.com/papers/a-brief-survey-of-drug-use-and-other-activities-preceding-mystical-religious-exp 2026-04-16T09:51:39Z monthly 0.7 https://www.moreblossom.com/papers/a-case-report-spect-study-and-theoretical-rationale-for-the-sequential-administr 2026-04-16T09:51:40Z monthly 0.7 https://www.moreblossom.com/papers/a-clinical-study-of-lsd-treatment-in-alcoholism 2026-05-19T10:29:37Z monthly 0.7 https://www.moreblossom.com/papers/a-comparison-between-psilocybin-and-esketamine-in-treatment-resistant-depression 2026-04-16T09:51:42Z monthly 0.7 https://www.moreblossom.com/papers/a-comparison-of-mdma-assisted-psychotherapy-to-non-assisted-psychotherapy-in-tre 2026-04-16T09:51:44Z monthly 0.7 https://www.moreblossom.com/papers/a-comparison-of-the-antianhedonic-effects-of-repeated-ketamine-infusions-in-mela 2026-05-19T10:29:38Z monthly 0.7 https://www.moreblossom.com/papers/a-complex-systems-perspective-on-psychedelic-brain-action 2026-04-16T09:51:46Z monthly 0.7 https://www.moreblossom.com/papers/a-consensus-statement-on-the-use-of-ketamine-in-the-treatment-of-mood-disorders 2026-04-16T09:51:48Z monthly 0.7 https://www.moreblossom.com/papers/a-continuum-hypothesis-of-psychotomimetic-rapid-antidepressants 2026-04-16T09:52:13Z monthly 0.7 https://www.moreblossom.com/papers/a-critical-review-of-reports-of-endogenous-psychedelic-n-n-dimethyltryptamines-i 2026-04-16T09:52:15Z monthly 0.7 https://www.moreblossom.com/papers/a-dendrite-focused-framework-for-understanding-the-actions-of-ketamine-and-psych 2026-04-16T09:52:17Z monthly 0.7 https://www.moreblossom.com/papers/a-dose-of-creativity-an-integrative-review-of-the-effects-of-serotonergic-psyche 2026-04-16T09:52:19Z monthly 0.7 https://www.moreblossom.com/papers/a-double-blind-randomized-placebo-controlled-dose-frequency-study-of-intravenous 2026-05-11T21:35:30Z monthly 0.7 https://www.moreblossom.com/papers/a-double-blinded-randomized-placebo-controlled-sub-dissociative-dose-ketamine-pi 2026-04-14T09:08:39Z monthly 0.7 https://www.moreblossom.com/papers/a-draft-reference-assembly-of-the-psilocybe-cubensis-genome 2026-04-16T09:52:21Z monthly 0.7 https://www.moreblossom.com/papers/a-dual-receptor-model-of-serotonergic-psychedelics-therapeutic-insights-from-sim 2026-04-16T09:52:22Z monthly 0.7 https://www.moreblossom.com/papers/a-dynamic-and-multilocus-metabolic-regulation-strategy-using-quorum-sensing-cont 2026-04-16T09:52:24Z monthly 0.7 https://www.moreblossom.com/papers/a-feasibility-study-of-low-dose-ketamine-for-acute-management-of-suicidal-ideati 2026-05-11T17:08:41Z monthly 0.7 https://www.moreblossom.com/papers/a-gratuitous-grace-the-influence-of-religious-set-and-intent-on-the-psychedelic- 2026-04-16T09:52:28Z monthly 0.7 https://www.moreblossom.com/papers/a-long-trip-into-the-universe-psychedelics-and-space-travel 2026-04-16T09:52:52Z monthly 0.7 https://www.moreblossom.com/papers/a-low-dose-of-lysergic-acid-diethylamide-decreases-pain-perception-in-healthy-vo 2026-04-16T09:52:54Z monthly 0.7 https://www.moreblossom.com/papers/a-meta-analysis-of-placebo-controlled-trials-of-psychedelic-assisted-therapy-2 2026-04-16T09:52:55Z monthly 0.7 https://www.moreblossom.com/papers/a-mixed-method-analysis-of-persisting-effects-associated-with-positive-outcomes- 2026-04-16T09:52:57Z monthly 0.7 https://www.moreblossom.com/papers/a-model-for-the-application-of-target-controlled-intravenous-infusion-for-a-prol 2026-04-16T09:53:19Z monthly 0.7 https://www.moreblossom.com/papers/a-multi-institutional-investigation-of-psilocybins-effects-on-mouse-behavior 2026-04-16T09:53:21Z monthly 0.7 https://www.moreblossom.com/papers/a-multidisciplinary-hypothesis-about-serotonergic-psychedelics-is-it-possible-th 2026-04-16T09:53:24Z monthly 0.7 https://www.moreblossom.com/papers/a-narrative-synthesis-of-research-with-5-meo-dmt 2026-04-16T09:53:25Z monthly 0.7 https://www.moreblossom.com/papers/a-nationwide-study-comparing-mental-health-professionals-willingness-to-try-hall 2026-04-16T09:53:27Z monthly 0.7 https://www.moreblossom.com/papers/a-network-model-of-the-modulation-of-gamma-oscillations-by-nmda-receptors-in-cer 2026-04-16T09:53:28Z monthly 0.7 https://www.moreblossom.com/papers/a-neurophenomenological-approach-to-non-ordinary-states-of-consciousness-hypnosi 2026-04-16T09:53:30Z monthly 0.7 https://www.moreblossom.com/papers/a-non-hallucinogenic-lsd-analog-with-therapeutic-potential-for-mood-disorders 2026-04-16T09:53:32Z monthly 0.7 https://www.moreblossom.com/papers/a-non-hallucinogenic-psychedelic-analogue-with-therapeutic-potential 2026-04-16T10:48:48Z monthly 0.7 https://www.moreblossom.com/papers/a-novel-brief-fully-automated-intervention-to-extend-the-antidepressant-effect-o 2026-05-12T13:30:04Z monthly 0.7 https://www.moreblossom.com/papers/a-novel-psychedelic-5-ht2a-receptor-agonist-gm-2505-the-pharmacokinetic-safety-a 2026-04-27T12:03:19Z monthly 0.7 https://www.moreblossom.com/papers/a-phase-1-2-trial-to-assess-safety-and-efficacy-of-a-vaporized-5-methoxy-nn-dime 2026-04-27T11:58:56Z monthly 0.7 https://www.moreblossom.com/papers/a-phase-1-assessment-of-the-safety-tolerability-pharmacokinetics-and-pharmacodyn 2026-04-16T09:53:41Z monthly 0.7 https://www.moreblossom.com/papers/a-phase-1-dose-ranging-study-to-assess-safety-and-psychoactive-effects-of-a-vapo 2026-04-27T12:03:25Z monthly 0.7 https://www.moreblossom.com/papers/a-phase-1-single-ascending-dose-study-of-pure-oral-harmine-in-healthy-volunteers 2026-04-16T09:54:10Z monthly 0.7 https://www.moreblossom.com/papers/a-phase-2-trial-of-inhaled-nitrous-oxide-for-treatment-resistant-major-depressio 2026-04-27T12:03:28Z monthly 0.7 https://www.moreblossom.com/papers/a-phase-i-trial-to-inform-clinical-protocols-for-the-safe-administration-of-psil 2026-04-16T09:54:14Z monthly 0.7 https://www.moreblossom.com/papers/a-phase-ii-open-label-clinical-trial-of-intranasal-ketamine-for-depression-in-pa 2026-04-27T12:03:30Z monthly 0.7 https://www.moreblossom.com/papers/a-phenomenological-analysis-of-fellinis-films-to-understand-the-effect-of-lsd-th 2026-04-16T09:54:17Z monthly 0.7 https://www.moreblossom.com/papers/a-phenomenological-analysis-of-the-subjective-experience-elicited-by-ibogaine-in 2026-04-16T09:54:19Z monthly 0.7 https://www.moreblossom.com/papers/a-phenomenological-investigation-into-the-lived-experience-of-ibogaine-and-its-p 2026-04-16T09:54:20Z monthly 0.7 https://www.moreblossom.com/papers/a-physicians-attempt-to-self-medicate-bipolar-depression-with-nn-dimethyltryptam 2026-04-16T09:54:22Z monthly 0.7 https://www.moreblossom.com/papers/a-pilot-randomized-controlled-trial-of-ketamine-in-borderline-personality-disord 2026-04-27T11:59:14Z monthly 0.7 https://www.moreblossom.com/papers/a-pilot-study-of-ketamine-infusion-after-suicide-attempt-new-frontiers-in-treati 2026-05-12T12:27:12Z monthly 0.7 https://www.moreblossom.com/papers/a-placebo-controlled-investigation-of-synaesthesia-like-experiences-under-lsd 2026-04-16T09:54:28Z monthly 0.7 https://www.moreblossom.com/papers/a-placebo-controlled-study-of-the-effects-of-ayahuasca-set-and-setting-on-mental 2026-04-16T10:48:52Z monthly 0.7 https://www.moreblossom.com/papers/a-possibly-sigma-1-receptor-mediated-role-of-dimethyltryptamine-in-tissue-protec 2026-04-16T10:48:53Z monthly 0.7 https://www.moreblossom.com/papers/a-potential-role-for-psilocybin-in-the-treatment-of-obsessive-compulsive-disorde 2026-04-16T09:54:34Z monthly 0.7 https://www.moreblossom.com/papers/a-prehistoric-mural-in-spain-depicting-neurotropic-psilocybe-mushrooms 2026-04-16T10:48:54Z monthly 0.7 https://www.moreblossom.com/papers/a-proof-of-principle-study-of-the-short-term-effects-of-34-methylenedioxymethamp 2026-05-19T08:55:36Z monthly 0.7 https://www.moreblossom.com/papers/a-proposed-mechanism-for-the-mdma-mediated-extinction-of-traumatic-memories-in-p 2026-04-16T09:55:00Z monthly 0.7 https://www.moreblossom.com/papers/a-psychoanalytic-perspective-on-psychedelic-experience 2026-04-16T09:55:02Z monthly 0.7 https://www.moreblossom.com/papers/a-public-health-based-vision-for-the-management-and-regulation-of-psychedelics 2026-04-16T09:55:03Z monthly 0.7 https://www.moreblossom.com/papers/a-qualitative-analysis-of-the-psychedelic-mushroom-come-up-and-come-down 2026-04-16T10:48:56Z monthly 0.7 https://www.moreblossom.com/papers/a-qualitative-and-quantitative-account-of-patients-experiences-of-ketamine-and-i 2026-05-12T14:30:38Z monthly 0.7 https://www.moreblossom.com/papers/a-qualitative-descriptive-analysis-of-effects-of-psychedelic-phenethylamines-and 2026-04-16T09:55:09Z monthly 0.7 https://www.moreblossom.com/papers/a-qualitative-exploration-of-relational-ethical-challenges-and-practices-in-psyc 2026-04-16T09:55:10Z monthly 0.7 https://www.moreblossom.com/papers/a-qualitative-report-on-the-subjective-experience-of-intravenous-psilocybin-admi 2026-04-16T09:55:13Z monthly 0.7 https://www.moreblossom.com/papers/a-qualitative-study-of-intention-and-impact-of-ayahuasca-use-by-westerners 2026-04-16T09:55:15Z monthly 0.7 https://www.moreblossom.com/papers/a-quantitative-exploration-of-the-relationships-between-regular-yoga-practice-mi 2026-04-16T09:55:16Z monthly 0.7 https://www.moreblossom.com/papers/a-quantitative-textual-analysis-of-the-subjective-effects-of-ayahuasca-in-naive- 2026-04-16T10:48:57Z monthly 0.7 https://www.moreblossom.com/papers/a-randomised-placebo-controlled-study-of-the-effects-of-lysergic-acid-diethylami 2026-04-27T12:03:36Z monthly 0.7 https://www.moreblossom.com/papers/a-randomized-add-on-trial-of-an-n-methyl-d-aspartate-antagonist-in-treatment-res 2026-05-11T17:08:17Z monthly 0.7 https://www.moreblossom.com/papers/a-randomized-controlled-pilot-study-of-mdma-34-methylenedioxymethamphetamine-ass 2026-05-19T10:29:38Z monthly 0.7 https://www.moreblossom.com/papers/a-randomized-controlled-trial-of-34-methylenedioxymethamphetamine-mdma-and-fear- 2026-04-27T12:03:42Z monthly 0.7 https://www.moreblossom.com/papers/a-randomized-controlled-trial-of-repeated-ketamine-administration-for-chronic-po 2026-05-08T16:34:59Z monthly 0.7 https://www.moreblossom.com/papers/a-randomized-double-blind-active-placebo-controlled-study-of-efficacy-safety-and 2026-05-12T09:13:21Z monthly 0.7 https://www.moreblossom.com/papers/a-randomized-double-blind-midazolam-controlled-trial-of-low-dose-ketamine-infusi 2026-05-12T06:53:42Z monthly 0.7 https://www.moreblossom.com/papers/a-rapid-positive-influence-of-s-ketamine-on-the-anxiety-of-patients-in-palliativ 2026-04-16T10:49:00Z monthly 0.7 https://www.moreblossom.com/papers/a-rapid-scoping-review-of-harm-reduction-strategies-for-ecstasy-mdma-users-in-re 2026-04-16T09:55:28Z monthly 0.7 https://www.moreblossom.com/papers/a-retrospective-analysis-of-ketamine-intravenous-therapy-for-depression-in-real- 2026-04-16T09:55:30Z monthly 0.7 https://www.moreblossom.com/papers/a-retrospective-analysis-of-the-neverending-trip-after-administration-of-a-poten 2026-04-16T09:55:32Z monthly 0.7 https://www.moreblossom.com/papers/a-retrospective-study-of-ketamine-administration-and-the-development-of-acute-or 2026-04-16T09:55:33Z monthly 0.7 https://www.moreblossom.com/papers/a-retrospective-study-to-determine-the-impact-of-psychedelic-therapy-qualitative 2026-04-16T09:55:35Z monthly 0.7 https://www.moreblossom.com/papers/a-retrospective-study-to-determine-the-impact-of-psychedelic-therapy-quantitative 2026-04-16T09:55:37Z monthly 0.7 https://www.moreblossom.com/papers/a-review-of-emerging-therapeutic-potential-of-psychedelic-drugs-in-the-treatment 2026-04-16T09:55:38Z monthly 0.7 https://www.moreblossom.com/papers/a-review-of-lysergic-acid-diethylamide-lsd-in-the-treatment-of-addictions-histor 2026-04-16T09:55:41Z monthly 0.7 https://www.moreblossom.com/papers/a-review-of-psychedelics-trials-completed-in-depression-informed-by-european-reg 2026-04-16T09:55:43Z monthly 0.7 https://www.moreblossom.com/papers/a-review-of-the-clinical-effects-of-psychotomimetic-agents 2026-04-16T09:55:44Z monthly 0.7 https://www.moreblossom.com/papers/a-semantic-scale-network-analysis-of-the-revised-mystical-experiences-questionna 2026-04-16T09:55:46Z monthly 0.7 https://www.moreblossom.com/papers/a-sense-of-the-bigger-picture-a-qualitative-analysis-of-follow-up-interviews-wit 2026-04-16T09:55:48Z monthly 0.7 https://www.moreblossom.com/papers/a-single-administration-of-the-atypical-psychedelic-ibogaine-or-its-metabolite-n 2026-04-16T09:55:50Z monthly 0.7 https://www.moreblossom.com/papers/a-single-belief-changing-psychedelic-experience-is-associated-with-increased-att 2026-04-16T09:55:57Z monthly 0.7 https://www.moreblossom.com/papers/a-single-dose-of-5-meo-dmt-stimulates-cell-proliferation-neuronal-survivability- 2026-04-16T09:56:04Z monthly 0.7 https://www.moreblossom.com/papers/a-single-dose-of-ayahuasca-modulates-salivary-cortisol-in-treatment-resistant-de 2026-04-27T11:56:06Z monthly 0.7 https://www.moreblossom.com/papers/a-single-dose-of-lsd-does-not-alter-gene-expression-of-the-serotonin-2a-receptor 2026-04-27T12:03:51Z monthly 0.7 https://www.moreblossom.com/papers/a-single-infusion-of-ketamine-improves-depression-scores-in-patients-with-anxiou 2026-05-11T17:08:19Z monthly 0.7 https://www.moreblossom.com/papers/a-single-inhalation-of-vapor-from-dried-toad-secretion-containing-5-methoxy-nn-d 2026-04-16T10:49:01Z monthly 0.7 https://www.moreblossom.com/papers/a-single-intravenous-administration-of-a-sub-anesthetic-ketamine-dose-during-the 2026-04-16T09:56:15Z monthly 0.7 https://www.moreblossom.com/papers/a-single-ketamine-infusion-combined-with-mindfulness-based-behavioral-modificati 2026-05-12T12:09:49Z monthly 0.7 https://www.moreblossom.com/papers/a-single-ketamine-infusion-combined-with-motivational-enhancement-therapy-for-al 2026-05-12T12:18:24Z monthly 0.7 https://www.moreblossom.com/papers/a-single-psilocybin-dose-is-associated-with-long-term-increased-mindfulness-prec 2026-04-16T09:56:20Z monthly 0.7 https://www.moreblossom.com/papers/a-spectrum-of-selves-reinforced-in-multilevel-coherence-a-contextual-behavioural 2026-04-16T09:56:28Z monthly 0.7 https://www.moreblossom.com/papers/a-sub-set-of-psychoactive-effects-may-be-critical-to-the-behavioral-impact-of-ke 2026-05-19T10:29:39Z monthly 0.7 https://www.moreblossom.com/papers/a-suite-of-engineered-mice-for-interrogating-psychedelic-drug-actions 2026-04-16T09:56:30Z monthly 0.7 https://www.moreblossom.com/papers/a-survey-of-american-psychiatrists-attitudes-toward-classic-hallucinogens 2026-04-16T09:56:33Z monthly 0.7 https://www.moreblossom.com/papers/a-systematic-literature-review-of-clinical-trials-and-therapeutic-applications-o 2026-04-16T09:56:35Z monthly 0.7 https://www.moreblossom.com/papers/a-systematic-review-of-neurocognitive-effects-of-subanesthetic-doses-of-intraven 2026-04-16T10:49:03Z monthly 0.7 https://www.moreblossom.com/papers/a-systematic-review-of-reporting-practices-in-psychedelic-clinical-trials-psycho 2026-04-16T09:56:39Z monthly 0.7 https://www.moreblossom.com/papers/a-systematic-review-of-the-effects-of-novel-psychoactive-substances-legal-highs- 2026-04-16T09:56:40Z monthly 0.7 https://www.moreblossom.com/papers/a-systematic-review-of-the-mdma-model-to-address-social-impairment-in-autism 2026-04-16T09:56:43Z monthly 0.7 https://www.moreblossom.com/papers/a-systematic-study-of-microdosing-psychedelics 2026-04-16T09:56:45Z monthly 0.7 https://www.moreblossom.com/papers/a-transdiagnostic-systematic-review-and-meta-analysis-of-ketamines-anxiolytic-ef 2026-04-16T09:56:47Z monthly 0.7 https://www.moreblossom.com/papers/a-transformative-trip-experiences-of-psychedelic-use 2026-04-16T10:49:04Z monthly 0.7 https://www.moreblossom.com/papers/a-unified-model-of-ketamines-dissociative-and-psychedelic-properties 2026-04-16T09:56:50Z monthly 0.7 https://www.moreblossom.com/papers/a-unique-natural-selective-kappa-opioid-receptor-agonist-salvinorin-a-and-its-ro 2026-04-16T09:56:52Z monthly 0.7 https://www.moreblossom.com/papers/a-whole-brain-model-of-the-neural-entropy-increase-elicited-by-psychedelic-drugs 2026-04-16T10:49:06Z monthly 0.7 https://www.moreblossom.com/papers/a-window-into-the-intoxicated-mind-speech-as-an-index-of-psychoactive-drug-effec 2026-04-16T10:49:07Z monthly 0.7 https://www.moreblossom.com/papers/a1-adrenergic-receptors-contribute-to-the-acute-effects-of-34-methylenedioxymeth 2026-04-27T12:04:07Z monthly 0.7 https://www.moreblossom.com/papers/abnormal-visual-experiences-in-individuals-with-histories-of-hallucinogen-use-a- 2026-04-16T09:57:00Z monthly 0.7 https://www.moreblossom.com/papers/absence-of-long-term-analgesic-effect-from-a-short-term-s-ketamine-infusion-on-f 2026-05-11T18:28:35Z monthly 0.7 https://www.moreblossom.com/papers/absolute-oral-bioavailability-and-bioequivalence-of-lsd-base-and-tartrate-in-a-d 2026-04-27T12:04:12Z monthly 0.7 https://www.moreblossom.com/papers/acceptability-of-psilocybin-assisted-group-therapy-in-patients-with-cancer-and-m 2026-05-11T17:06:19Z monthly 0.7 https://www.moreblossom.com/papers/acceptance-as-a-possible-link-between-past-psychedelic-experiences-and-psycholog 2026-04-16T10:49:09Z monthly 0.7 https://www.moreblossom.com/papers/access-and-real-world-use-patterns-of-esketamine-nasal-spray-among-patients-with 2026-04-16T09:57:09Z monthly 0.7 https://www.moreblossom.com/papers/accounting-for-microdosing-classic-psychedelics 2026-04-16T09:57:12Z monthly 0.7 https://www.moreblossom.com/papers/activities-of-extract-and-constituents-of-banisteriopsis-caapi-relevant-to-parki 2026-04-16T09:57:14Z monthly 0.7 https://www.moreblossom.com/papers/acute-and-enduring-effects-of-naturalistic-psychedelic-use-among-indigenous-peop 2026-04-16T09:57:17Z monthly 0.7 https://www.moreblossom.com/papers/acute-and-long-term-effects-of-psilocybin-on-energy-balance-and-feeding-behavior 2026-04-16T10:49:10Z monthly 0.7 https://www.moreblossom.com/papers/acute-and-longer-term-outcomes-using-ketamine-as-a-clinical-treatment-at-the-yal 2026-04-16T09:57:24Z monthly 0.7 https://www.moreblossom.com/papers/acute-and-subacute-psychoactive-effects-of-kambo-the-secretion-of-the-amazonian- 2026-04-16T10:49:11Z monthly 0.7 https://www.moreblossom.com/papers/acute-and-sustained-reductions-in-loss-of-meaning-and-suicidal-ideation-followin 2026-05-12T19:28:04Z monthly 0.7 https://www.moreblossom.com/papers/acute-biphasic-effects-of-ayahuasca 2026-04-16T09:57:31Z monthly 0.7 https://www.moreblossom.com/papers/acute-cognitive-effects-of-single-dose-intravenous-ketamine-in-major-depressive- 2026-05-19T10:29:39Z monthly 0.7 https://www.moreblossom.com/papers/acute-dose-dependent-effects-and-self-guided-titration-of-continuous-nn-dimethyl 2026-04-27T12:04:47Z monthly 0.7 https://www.moreblossom.com/papers/acute-dose-dependent-effects-of-lysergic-acid-diethylamide-in-a-double-blind-pla 2026-04-16T10:49:14Z monthly 0.7 https://www.moreblossom.com/papers/acute-dose-dependent-effects-of-mescaline-in-a-double-blind-placebo-controlled-s 2026-04-27T12:04:55Z monthly 0.7 https://www.moreblossom.com/papers/acute-dose-of-mdma-75-mg-impairs-spatial-memory-for-location-but-leaves-contextu 2026-04-27T12:04:57Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-and-pharmacokinetics-of-lsd-after-paroxetine-or-placebo-pre-admini 2026-04-27T12:05:02Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-3-4-methylenedioxymethamphetamine-mdma-on-behavioral-measures-o 2026-04-16T10:49:19Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-ayahuasca-in-a-juvenile-non-human-primate-model-of-depression 2026-04-16T09:57:49Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-ayahuasca-on-neuropsychological-performance-differences-in-exec 2026-04-16T10:49:20Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-hallucinogens-on-functional-connectivity-psilocybin-and-salvino 2026-04-16T09:57:53Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-intravenous-dmt-in-a-randomized-placebo-controlled-study-in-hea 2026-05-05T14:59:46Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-ketamine-and-esketamine-on-cognition-in-healthy-subjects-a-meta 2026-04-16T09:57:57Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-lsd-on-amygdala-activity-during-processing-of-fearful-stimuli-i 2026-04-16T10:49:23Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-lysergic-acid-diethylamide-in-healthy-subjects 2026-04-16T09:58:01Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-lysergic-acid-diethylamide-lsd-on-resting-brain-function 2026-04-16T09:58:03Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-lysergic-acid-diethylamide-on-circulating-steroid-levels-in-hea 2026-04-16T09:58:04Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-mdma-and-lsd-co-administration-in-a-double-blind-placebo-contro 2026-04-27T12:05:06Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-mdma-mda-lysine-mdma-and-lysine-mda-in-a-randomized-double-blin 2026-04-27T12:05:08Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-methylphenidate-modafinil-and-mdma-on-negative-emotion-processi 2026-04-27T12:05:15Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-psilocybin-after-escitalopram-or-placebo-pretreatment-in-a-rand 2026-04-27T12:05:22Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-psilocybin-on-glutamate-concentration-levels-functional-connect 2026-04-16T09:58:16Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-psilocybin-on-the-dynamics-of-gaze-fixations-during-visual-aest 2026-04-16T10:49:27Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-r-mdma-s-mdma-and-racemic-mdma-in-a-randomized-double-blind-cro 2026-04-16T10:49:28Z monthly 0.7 https://www.moreblossom.com/papers/acute-effects-of-the-novel-psychoactive-drug-2c-b-on-emotions 2026-03-25T05:29:20Z monthly 0.7 https://www.moreblossom.com/papers/acute-ketamine-challenge-increases-resting-state-prefrontal-hippocampal-connecti 2026-04-16T10:49:29Z monthly 0.7 https://www.moreblossom.com/papers/acute-lsd-effects-on-response-inhibition-neural-networks 2026-04-27T12:03:54Z monthly 0.7 https://www.moreblossom.com/papers/acute-mood-elevating-properties-of-microdosed-lsd-in-healthy-volunteers-a-home-a 2026-04-27T12:05:24Z monthly 0.7 https://www.moreblossom.com/papers/acute-pharmacological-effects-of-2c-b-in-humans-an-observational-study 2026-04-05T19:07:11Z monthly 0.7 https://www.moreblossom.com/papers/acute-psilocybin-and-ketanserin-effects-on-cerebral-blood-flow-5-ht2ar-neuromodu 2026-04-16T09:58:28Z monthly 0.7 https://www.moreblossom.com/papers/acute-psychedelic-reactions-post-acute-changes-in-dysfunctional-attitudes-and-ps 2026-04-16T09:58:30Z monthly 0.7 https://www.moreblossom.com/papers/acute-psychoactive-effects-of-intravenous-ketamine-during-treatment-of-mood-diso 2026-04-16T09:58:32Z monthly 0.7 https://www.moreblossom.com/papers/acute-psychological-adverse-reactions-in-first-time-ritual-ayahuasca-users 2026-04-16T09:58:34Z monthly 0.7 https://www.moreblossom.com/papers/acute-psychological-and-physiological-effects-of-psilocybin-in-healthy-humans-a- 2026-04-16T10:49:31Z monthly 0.7 https://www.moreblossom.com/papers/acute-psychological-effects-of-3-4-methylenedioxymethamphetamine-mdmaecstasy-are 2026-05-12T10:36:07Z monthly 0.7 https://www.moreblossom.com/papers/acute-psychotropic-autonomic-and-endocrine-effects-of-56-methylenedioxy-2-aminoi 2026-04-16T09:58:41Z monthly 0.7 https://www.moreblossom.com/papers/acute-subacute-and-long-term-subjective-effects-of-psilocybin-in-healthy-humans- 2026-04-16T09:58:42Z monthly 0.7 https://www.moreblossom.com/papers/acute-subjective-and-behavioral-effects-of-microdoses-of-lysergic-acid-diethylam 2026-04-27T12:05:36Z monthly 0.7 https://www.moreblossom.com/papers/acute-subjective-effects-in-lsd-and-mdma-assisted-psychotherapy 2026-04-16T09:58:46Z monthly 0.7 https://www.moreblossom.com/papers/additive-effects-of-34-methylenedioxymethamphetamine-mdma-and-compassionate-imag 2026-04-16T10:49:34Z monthly 0.7 https://www.moreblossom.com/papers/adjunctive-ketamine-with-relapse-prevention-based-psychological-therapy-in-the-t 2026-05-19T09:31:37Z monthly 0.7 https://www.moreblossom.com/papers/administration-of-ketamine-for-unipolar-and-bipolar-depression 2026-04-16T09:58:51Z monthly 0.7 https://www.moreblossom.com/papers/administration-of-nn-dimethyltryptamine-dmt-in-psychedelic-therapeutics-and-rese 2026-04-16T10:49:35Z monthly 0.7 https://www.moreblossom.com/papers/adolescent-psychedelic-use-and-psychotic-or-manic-symptoms 2026-04-16T09:58:55Z monthly 0.7 https://www.moreblossom.com/papers/adults-who-microdose-psychedelics-report-health-related-motivations-and-lower-le 2026-04-16T10:49:37Z monthly 0.7 https://www.moreblossom.com/papers/adverse-effects-of-ayahuasca-results-from-the-global-ayahuasca-survey 2026-04-16T09:58:59Z monthly 0.7 https://www.moreblossom.com/papers/adverse-effects-of-psychedelics-from-anecdotes-and-misinformation-to-systematic- 2026-04-16T09:59:00Z monthly 0.7 https://www.moreblossom.com/papers/adverse-events-and-measurement-of-dissociation-after-the-first-dose-of-esketamin 2026-04-27T12:05:47Z monthly 0.7 https://www.moreblossom.com/papers/adverse-events-in-clinical-treatments-with-serotonergic-psychedelics-and-mdma-a- 2026-04-16T09:59:03Z monthly 0.7 https://www.moreblossom.com/papers/adverse-events-in-studies-of-classic-psychedelics-a-systematic-review-and-meta-a 2026-04-16T09:59:05Z monthly 0.7 https://www.moreblossom.com/papers/adverse-experiences-resulting-in-emergency-medical-treatment-seeking-following-t 2026-04-16T09:59:07Z monthly 0.7 https://www.moreblossom.com/papers/adverse-reactions-to-psychedelic-drugs-a-review-of-the-literature 2026-04-16T09:59:09Z monthly 0.7 https://www.moreblossom.com/papers/alphafold2-structures-guide-prospective-ligand-discovery 2026-04-16T09:59:11Z monthly 0.7 https://www.moreblossom.com/papers/alterations-of-consciousness-and-mystical-type-experiences-after-acute-lsd-in-hu 2026-04-16T10:49:38Z monthly 0.7 https://www.moreblossom.com/papers/altered-insula-connectivity-under-mdma 2026-04-16T10:49:40Z monthly 0.7 https://www.moreblossom.com/papers/altered-network-hub-connectivity-after-acute-lsd-administration 2026-05-05T14:59:16Z monthly 0.7 https://www.moreblossom.com/papers/altered-peripheral-immune-profiles-in-treatment-resistant-depression-response-to 2026-04-27T12:05:50Z monthly 0.7 https://www.moreblossom.com/papers/altered-state-of-consciousness-and-mental-imagery-as-a-function-of-n-n-dimethylt 2026-04-16T09:59:21Z monthly 0.7 https://www.moreblossom.com/papers/altered-states-of-consciousness-during-ceremonial-san-pedro-use 2026-04-16T09:59:23Z monthly 0.7 https://www.moreblossom.com/papers/alternative-beliefs-in-psychedelic-drug-users 2026-04-16T10:49:42Z monthly 0.7 https://www.moreblossom.com/papers/amanita-muscaria-chemistry-biology-toxicology-and-ethnomycology 2026-04-16T09:59:27Z monthly 0.7 https://www.moreblossom.com/papers/amanita-muscaria-fly-agaric-from-a-shamanistic-hallucinogen-to-the-search-for-ac 2026-04-16T09:59:28Z monthly 0.7 https://www.moreblossom.com/papers/american-psychiatrists-opinions-about-classic-hallucinogens-and-their-potential- 2026-04-16T09:59:30Z monthly 0.7 https://www.moreblossom.com/papers/among-psychedelic-experienced-users-only-past-use-of-psilocybin-reliably-predict 2026-04-16T09:59:31Z monthly 0.7 https://www.moreblossom.com/papers/an-analog-of-psychedelics-restores-functional-neural-circuits-disrupted-by-unpre 2026-04-16T10:49:44Z monthly 0.7 https://www.moreblossom.com/papers/an-encounter-with-the-other-a-thematic-analysis-of-accounts-of-dmt-experiences-f 2026-04-16T09:59:35Z monthly 0.7 https://www.moreblossom.com/papers/an-encounter-with-the-self-a-thematic-and-content-analysis-of-the-dmt-experience 2026-04-16T09:59:38Z monthly 0.7 https://www.moreblossom.com/papers/an-estimate-of-the-number-of-people-with-clinical-depression-eligible-for-psiloc 2026-04-16T09:59:40Z monthly 0.7 https://www.moreblossom.com/papers/an-exploratory-study-of-experiences-with-conventional-eating-disorder-treatment- 2026-04-16T10:49:45Z monthly 0.7 https://www.moreblossom.com/papers/an-integrated-theory-of-false-insights-and-beliefs-under-psychedelics 2026-04-16T10:49:47Z monthly 0.7 https://www.moreblossom.com/papers/an-international-delphi-consensus-for-reporting-of-setting-in-psychedelic-clinic 2026-04-16T10:49:48Z monthly 0.7 https://www.moreblossom.com/papers/an-investigation-of-acute-physiological-and-psychological-moderators-of-psychede 2026-04-16T09:59:48Z monthly 0.7 https://www.moreblossom.com/papers/an-online-survey-of-tobacco-smoking-cessation-associated-with-naturalistic-psych 2026-04-16T09:59:50Z monthly 0.7 https://www.moreblossom.com/papers/an-open-label-dose-escalation-trial-of-psilocybin-assisted-therapy-for-bipolar-2 2026-05-12T18:57:52Z monthly 0.7 https://www.moreblossom.com/papers/an-update-on-the-efficacy-and-tolerability-of-oral-ketamine-for-major-depression 2026-04-16T09:59:54Z monthly 0.7 https://www.moreblossom.com/papers/analgesic-potential-of-macrodoses-and-microdoses-of-classical-psychedelics-in-ch 2026-04-16T09:59:56Z monthly 0.7 https://www.moreblossom.com/papers/animal-models-of-serotonergic-psychedelics 2026-04-16T09:59:57Z monthly 0.7 https://www.moreblossom.com/papers/anti-anhedonic-effect-of-ketamine-and-its-neural-correlates-in-treatment-resista 2026-05-19T10:29:39Z monthly 0.7 https://www.moreblossom.com/papers/anti-inflammatory-activity-of-ayahuasca-and-its-implications-for-the-treatment-o 2026-04-16T10:00:03Z monthly 0.7 https://www.moreblossom.com/papers/anti-suicidal-effects-of-iv-ketamine-in-a-real-world-setting 2026-04-16T10:00:05Z monthly 0.7 https://www.moreblossom.com/papers/antianhedonic-effect-of-repeated-ketamine-infusions-in-patients-with-treatment-r 2026-05-12T14:53:34Z monthly 0.7 https://www.moreblossom.com/papers/antianhedonic-effects-of-serial-intravenous-subanaesthetic-ketamine-in-anxious-v 2026-05-11T17:08:41Z monthly 0.7 https://www.moreblossom.com/papers/antidepressant-actions-of-ketamine-from-molecular-mechanisms-to-clinical-practic 2026-04-16T10:00:14Z monthly 0.7 https://www.moreblossom.com/papers/antidepressant-and-neurocognitive-effects-of-serial-ketamine-administration-vers 2026-04-16T10:00:16Z monthly 0.7 https://www.moreblossom.com/papers/antidepressant-anxiolytic-and-procognitive-effects-of-subacute-and-chronic-ketam 2026-04-16T10:00:19Z monthly 0.7 https://www.moreblossom.com/papers/antidepressant-effects-of-a-psychedelic-experience-in-a-large-prospective-natura 2026-04-16T10:00:21Z monthly 0.7 https://www.moreblossom.com/papers/antidepressant-effects-of-a-single-dose-of-ayahuasca-in-patients-spect 2026-04-27T12:06:11Z monthly 0.7 https://www.moreblossom.com/papers/antidepressant-effects-of-a-single-dose-of-ayahuasca-in-patients-with-recurrent- 2026-05-05T13:26:50Z monthly 0.7 https://www.moreblossom.com/papers/antidepressant-effects-of-ketamine-in-depressed-patients 2026-05-19T09:31:37Z monthly 0.7 https://www.moreblossom.com/papers/antidepressant-efficacy-of-ketamine-in-treatment-resistant-major-depression-a-tw 2026-05-19T09:31:38Z monthly 0.7 https://www.moreblossom.com/papers/antidepressive-and-anxiolytic-effects-of-ayahuasca-a-systematic-literature-revie 2026-04-16T10:00:32Z monthly 0.7 https://www.moreblossom.com/papers/antidepressive-anxiolytic-and-antiaddictive-effects-of-ayahuasca-psilocybin-and- 2026-04-16T10:00:34Z monthly 0.7 https://www.moreblossom.com/papers/antisuicidal-and-antidepressant-effects-of-ketamine-and-esketamine-in-patients-w 2026-04-16T10:00:36Z monthly 0.7 https://www.moreblossom.com/papers/antisuicidal-response-following-ketamine-infusion-is-associated-with-decreased-n 2026-05-19T10:29:39Z monthly 0.7 https://www.moreblossom.com/papers/anxiety-panic-and-hopelessness-during-and-after-ritual-ayahuasca-intake-in-a-wom 2026-04-16T10:00:42Z monthly 0.7 https://www.moreblossom.com/papers/application-of-machine-learning-and-complex-network-measures-to-an-eeg-dataset-f 2026-04-16T10:00:44Z monthly 0.7 https://www.moreblossom.com/papers/arc-a-framework-for-access-reciprocity-and-conduct-in-psychedelic-therapies 2026-04-05T19:07:57Z monthly 0.7 https://www.moreblossom.com/papers/are-ecstasy-induced-serotonergic-alterations-overestimated-for-the-majority-of-u 2026-04-16T10:00:46Z monthly 0.7 https://www.moreblossom.com/papers/are-psychedelics-something-new-in-teaching-psychopharmacology 2026-04-16T10:49:51Z monthly 0.7 https://www.moreblossom.com/papers/arketamine-a-new-rapid-acting-antidepressant-a-historical-review-and-future-dire 2026-04-16T10:00:50Z monthly 0.7 https://www.moreblossom.com/papers/arketamine-as-adjunctive-therapy-for-treatment-resistant-depression-a-placebo-co 2026-05-12T05:34:16Z monthly 0.7 https://www.moreblossom.com/papers/ascending-dose-study-of-noribogaine-in-healthy-volunteers-pharmacokinetics-pharm 2026-04-16T10:49:52Z monthly 0.7 https://www.moreblossom.com/papers/ascending-single-dose-double-blind-placebo-controlled-safety-study-of-noribogain 2026-05-19T09:31:38Z monthly 0.7 https://www.moreblossom.com/papers/assessing-expectancy-and-suggestibility-in-a-trial-of-escitalopram-v-psilocybin- 2026-05-11T17:06:20Z monthly 0.7 https://www.moreblossom.com/papers/assessing-measures-of-suicidal-ideation-in-clinical-trials-with-a-rapid-acting-a 2026-05-19T10:55:39Z monthly 0.7 https://www.moreblossom.com/papers/assessing-the-effects-of-methodological-differences-on-outcomes-in-the-use-of-ps 2026-04-16T10:49:54Z monthly 0.7 https://www.moreblossom.com/papers/assessing-the-potential-cardiovascular-risk-of-microdosing-the-psychedelic-lsd-i 2026-04-16T10:01:00Z monthly 0.7 https://www.moreblossom.com/papers/assessing-the-psychedelic-after-glow-in-ayahuasca-users-post-acute-neurometaboli 2026-05-19T11:22:47Z monthly 0.7 https://www.moreblossom.com/papers/assessing-the-risk-of-symptom-worsening-in-psilocybin-assisted-therapy-for-depre 2026-04-16T10:01:04Z monthly 0.7 https://www.moreblossom.com/papers/assessment-of-addiction-severity-among-ritual-users-of-ayahuasca 2026-04-16T10:01:05Z monthly 0.7 https://www.moreblossom.com/papers/assessment-of-alcohol-and-tobacco-use-disorders-among-religious-users-of-ayahuas 2026-04-16T10:01:10Z monthly 0.7 https://www.moreblossom.com/papers/assessment-of-the-acute-effects-of-2c-b-vs-psilocybin-on-subjective-experience-m 2026-04-27T12:06:21Z monthly 0.7 https://www.moreblossom.com/papers/association-between-lifetime-classic-psychedelic-use-and-hypertension-in-the-pas 2026-04-16T10:01:12Z monthly 0.7 https://www.moreblossom.com/papers/association-between-lifetime-classic-psychedelic-use-and-sick-leave-in-a-populat 2026-04-16T10:01:14Z monthly 0.7 https://www.moreblossom.com/papers/association-between-mystical-type-experiences-under-psychedelics-and-improvement 2026-04-16T10:01:16Z monthly 0.7 https://www.moreblossom.com/papers/association-of-combined-naltrexone-and-ketamine-with-depressive-symptoms-in-a-ca 2026-05-19T10:29:39Z monthly 0.7 https://www.moreblossom.com/papers/associations-between-ayahuasca-consumption-in-naturalistic-settings-and-current- 2026-04-16T10:01:19Z monthly 0.7 https://www.moreblossom.com/papers/associations-between-classic-psychedelics-and-nicotine-dependence-in-a-nationall 2026-04-16T10:49:55Z monthly 0.7 https://www.moreblossom.com/papers/associations-between-classic-psychedelics-and-opioid-use-disorder-in-a-nationall 2026-04-16T10:49:56Z monthly 0.7 https://www.moreblossom.com/papers/associations-between-lifetime-classic-psychedelic-use-and-cardiometabolic-diseas 2026-04-16T10:49:57Z monthly 0.7 https://www.moreblossom.com/papers/associations-between-lifetime-classic-psychedelic-use-and-markers-of-physical-he 2026-04-16T10:01:27Z monthly 0.7 https://www.moreblossom.com/papers/associations-between-mdma-ecstasy-use-and-physical-health-in-a-u-s-population-ba 2026-04-16T10:01:28Z monthly 0.7 https://www.moreblossom.com/papers/asymmetry-in-psychoactive-research-a-bibliometric-study-on-15-psychoactive-drugs 2026-04-16T10:01:30Z monthly 0.7 https://www.moreblossom.com/papers/at-home-sublingual-ketamine-telehealth-is-a-safe-and-effective-treatment-for-mod 2026-04-27T12:06:32Z monthly 0.7 https://www.moreblossom.com/papers/attention-deficit-hyperactivity-disorder-symptoms-and-lifetime-use-of-psychoacti 2026-04-16T10:01:34Z monthly 0.7 https://www.moreblossom.com/papers/attenuation-and-anticipation-a-therapeutic-use-of-lysergic-acid-diethylamide 2026-05-11T17:07:30Z monthly 0.7 https://www.moreblossom.com/papers/attenuation-of-antidepressant-and-antisuicidal-effects-of-ketamine-by-opioid-rec 2026-05-19T10:29:40Z monthly 0.7 https://www.moreblossom.com/papers/attenuation-of-psilocybin-mushroom-effects-during-and-after-ssri-snri-antidepres 2026-04-16T10:01:40Z monthly 0.7 https://www.moreblossom.com/papers/attitudes-and-beliefs-about-the-therapeutic-use-of-psychedelic-drugs-among-psych 2026-04-16T10:01:41Z monthly 0.7 https://www.moreblossom.com/papers/attitudes-of-psychedelic-users-regarding-cost-of-treatment-and-non-hallucinogeni 2026-04-16T10:01:43Z monthly 0.7 https://www.moreblossom.com/papers/autistic-schizophrenic-children-an-experiment-in-the-use-of-d-lysergic-acid-diet 2026-05-11T17:07:30Z monthly 0.7 https://www.moreblossom.com/papers/autonomic-nervous-system-activity-correlates-with-peak-experiences-induced-by-dm 2026-04-16T10:01:47Z monthly 0.7 https://www.moreblossom.com/papers/awe-a-putative-mechanism-underlying-the-effects-of-classic-psychedelic-assisted- 2026-04-16T10:01:48Z monthly 0.7 https://www.moreblossom.com/papers/awe-as-a-pathway-to-mental-and-physical-health 2026-04-16T10:01:50Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-a-psychedelic-beverage-modulates-neuroplasticity-induced-by-ethanol-in 2026-04-16T10:01:52Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-and-cancer-treatment 2026-04-16T10:01:54Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-and-its-dmt-and-b-carbolines-containing-ingredients-block-the-expressi 2026-04-16T10:01:56Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-and-public-health-health-status-psychosocial-well-being-lifestyle-and- 2026-04-16T10:01:58Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-and-public-health-ii-health-status-in-a-large-sample-of-ayahuasca-cere 2026-04-16T10:01:59Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-and-spiritual-crisis-liminality-as-space-for-personal-growth 2026-04-16T10:50:00Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-and-tobacco-smoking-cessation-results-from-an-online-survey-in-brazil 2026-04-16T10:50:02Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-assisted-meaning-reconstruction-therapy-as-an-early-resource-for-berea 2026-04-27T13:25:28Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-assisted-therapy-for-addiction-results-from-a-preliminary-observationa 2026-04-16T10:02:10Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-beyond-the-amazon-the-benefits-and-risks-of-a-spreading-tradition 2026-03-24T14:58:01Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-ceremony-leaders-perspectives-on-special-considerations-for-eating-dis 2026-04-16T10:02:11Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-dimethyltryptamine-and-psychosis-a-systematic-review-of-human-studies 2026-04-16T10:02:13Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-enhances-creative-divergent-thinking-while-decreasing-conventional-con 2026-05-19T11:22:49Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-enhances-the-formation-of-hippocampal-dependent-episodic-memory-withou 2026-04-16T10:02:16Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-improves-emotion-dysregulation-in-a-community-sample-and-in-individual 2026-04-16T10:50:06Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-improves-self-perception-of-speech-performance-in-subjects-with-social 2026-04-27T12:06:46Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-in-adolescence-a-neuropsychological-assessment 2026-04-16T10:02:23Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-in-adolescence-a-preliminary-psychiatric-assessment 2026-04-16T10:02:25Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-in-adolescence-qualitative-results 2026-04-16T10:02:27Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-in-the-treatment-of-bipolar-disorder-with-psychotic-features-a-retrosp 2026-04-16T10:02:29Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-in-the-treatment-of-posttraumatic-stress-disorder-mixed-methods-case-s 2026-04-11T10:38:39Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-induced-personal-death-experiences-prevalence-characteristics-and-impa 2026-04-16T10:02:31Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-inspired-dmt-har-formulation-reduces-brain-differentiation-between-sel 2026-04-16T10:02:33Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-inspired-dmt-harmine-formulation-alters-creative-thinking-dynamics-dur 2026-04-27T12:06:52Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-lyophilization-freeze-drying-protocol-with-pre-and-post-procedure-alka 2026-04-16T10:02:36Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-may-help-to-improve-self-compassion-and-self-criticism-capacities 2026-04-16T10:02:38Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-personality-and-acute-psychological-effects-in-neo-shamanic-and-religi 2026-04-16T10:02:39Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-pharmacology-neuroscience-and-therapeutic-potential 2026-05-19T11:22:51Z monthly 0.7 https://www.moreblossom.com/papers/ayahuasca-treatment-outcome-project-atop-one-year-results-from-takiwasi-center-a 2026-04-16T10:02:43Z monthly 0.7 https://www.moreblossom.com/papers/ayahuascas-afterglow-improved-mindfulness-and-cognitive-flexibility-in-ayahuasca 2026-04-16T10:50:08Z monthly 0.7 https://www.moreblossom.com/papers/ayahuascas-entwined-efficacy-an-ethnographic-study-of-ritual-healing-from-addict 2026-04-16T10:02:47Z monthly 0.7 https://www.moreblossom.com/papers/b-carboline-compounds-including-harmine-inhibit-dyrk1a-and-tau-phosphorylation-a 2026-04-16T10:02:49Z monthly 0.7 https://www.moreblossom.com/papers/back-from-the-rabbit-hole-theoretical-considerations-and-practical-guidelines-on 2026-04-16T10:02:52Z monthly 0.7 https://www.moreblossom.com/papers/banisteriopsis-caapi-a-forgotten-potential-therapy-for-parkinsons-disease 2026-04-16T10:02:53Z monthly 0.7 https://www.moreblossom.com/papers/banisteriopsis-caapi-a-unique-combination-of-mao-inhibitory-and-antioxidative-co 2026-04-16T10:02:55Z monthly 0.7 https://www.moreblossom.com/papers/barriers-to-esketamine-nasal-spray-treatment-among-adults-with-treatment-resista 2026-04-16T10:02:58Z monthly 0.7 https://www.moreblossom.com/papers/baseline-power-of-theta-oscillations-predicts-mystical-type-experiences-induced- 2026-04-16T10:02:59Z monthly 0.7 https://www.moreblossom.com/papers/beating-pain-with-psychedelics-matter-over-mind 2026-04-16T10:03:01Z monthly 0.7 https://www.moreblossom.com/papers/behavioral-and-pharmacokinetic-interactions-between-monoamine-oxidase-inhibitors 2026-04-16T10:03:03Z monthly 0.7 https://www.moreblossom.com/papers/behavioral-neurochemical-and-pharmaco-eeg-profiles-of-the-psychedelic-drug-4-bro 2026-03-25T06:02:26Z monthly 0.7 https://www.moreblossom.com/papers/being-no-one-being-one-the-role-of-ego-dissolution-and-connectedness-in-the-ther 2026-04-16T10:03:05Z monthly 0.7 https://www.moreblossom.com/papers/belief-changes-associated-with-psychedelic-use 2026-04-05T19:09:00Z monthly 0.7 https://www.moreblossom.com/papers/beliefs-and-perceived-barriers-regarding-psychedelic-assisted-therapy-in-a-pilot 2026-04-16T10:03:06Z monthly 0.7 https://www.moreblossom.com/papers/beringian-origins-and-cryptic-speciation-events-in-the-fly-agaric-amanita-muscar 2026-04-16T10:03:08Z monthly 0.7 https://www.moreblossom.com/papers/bespoke-library-docking-for-5-ht2a-receptor-agonists-with-antidepressant-activit 2026-04-16T10:50:09Z monthly 0.7 https://www.moreblossom.com/papers/beyond-the-5-ht2a-receptor-classic-and-nonclassic-targets-in-psychedelic-drug-ac 2026-04-16T10:03:15Z monthly 0.7 https://www.moreblossom.com/papers/biochemical-mechanisms-underlying-psychedelic-induced-neuroplasticity 2026-04-16T10:03:16Z monthly 0.7 https://www.moreblossom.com/papers/bioisosteric-analogs-of-mdma-improving-the-pharmacological-profile 2026-04-16T10:03:18Z monthly 0.7 https://www.moreblossom.com/papers/biomarkers-of-ketamines-antidepressant-effect-an-umbrella-review 2026-04-16T10:03:20Z monthly 0.7 https://www.moreblossom.com/papers/blinding-and-expectancy-confounds-in-psychedelic-randomised-controlled-trials 2026-04-16T10:03:21Z monthly 0.7 https://www.moreblossom.com/papers/blockade-of-5-ht-2-receptor-selectively-prevents-mdma-induced-verbal-memory-impa 2026-04-16T10:50:10Z monthly 0.7 https://www.moreblossom.com/papers/blood-based-biomarkers-of-antidepressant-response-to-ketamine-and-esketamine-a-s 2026-04-16T10:50:12Z monthly 0.7 https://www.moreblossom.com/papers/blood-d-serine-levels-as-a-predictive-biomarker-for-the-rapid-antidepressant-eff 2026-04-16T10:50:13Z monthly 0.7 https://www.moreblossom.com/papers/blood-pressure-safety-of-subanesthetic-ketamine-for-depression-a-report-on-684-i 2026-04-16T10:03:30Z monthly 0.7 https://www.moreblossom.com/papers/body-mass-index-bmi-does-not-predict-responses-to-psilocybin 2026-05-05T13:32:06Z monthly 0.7 https://www.moreblossom.com/papers/brain-dynamics-predictive-of-response-to-psilocybin-for-treatment-resistant-depr 2026-05-11T17:06:20Z monthly 0.7 https://www.moreblossom.com/papers/brain-serotonin-2a-receptor-binding-predicts-subjective-temporal-and-mystical-ef 2026-04-16T10:03:33Z monthly 0.7 https://www.moreblossom.com/papers/brain-substates-induced-by-dmt-relate-to-sympathetic-output-and-meaningfulness-o 2026-04-16T10:03:35Z monthly 0.7 https://www.moreblossom.com/papers/breakdown-or-breakthrough-a-history-of-european-research-into-drugs-and-creativi 2026-04-16T10:03:37Z monthly 0.7 https://www.moreblossom.com/papers/breakthrough-for-trauma-treatment-safety-and-efficacy-of-mdma-assisted-psychothe 2026-04-16T10:03:39Z monthly 0.7 https://www.moreblossom.com/papers/bridging-the-gap-altered-thalamocortical-connectivity-in-psychotic-and-psychedel 2026-05-19T11:24:03Z monthly 0.7 https://www.moreblossom.com/papers/bridging-the-translational-neuroscience-gap-development-of-the-shiftability-para 2026-04-16T10:03:45Z monthly 0.7 https://www.moreblossom.com/papers/bringing-ayahuasca-to-the-clinical-research-laboratory 2026-04-16T10:03:46Z monthly 0.7 https://www.moreblossom.com/papers/broadband-cortical-desynchronization-underlies-the-human-psychedelic-state-2 2026-04-16T10:03:50Z monthly 0.7 https://www.moreblossom.com/papers/broadening-your-mind-to-include-others-the-relationship-between-serotonergic-psy 2026-04-16T10:50:15Z monthly 0.7 https://www.moreblossom.com/papers/can-mdma-play-a-role-in-the-treatment-of-substance-abuse 2026-04-16T10:03:55Z monthly 0.7 https://www.moreblossom.com/papers/can-pragmatic-research-real-world-data-and-digital-technologies-aid-the-developm 2026-04-16T10:03:57Z monthly 0.7 https://www.moreblossom.com/papers/can-psychedelic-compounds-play-a-part-in-drug-dependence-therapy 2026-04-16T10:03:59Z monthly 0.7 https://www.moreblossom.com/papers/can-psychedelic-use-benefit-meditation-practice-examining-individual-psychedelic 2026-04-16T10:04:00Z monthly 0.7 https://www.moreblossom.com/papers/can-psychedelics-enhance-group-psychotherapy-a-discussion-on-the-therapeutic-fac 2026-04-16T10:04:02Z monthly 0.7 https://www.moreblossom.com/papers/can-psychedelics-have-a-role-in-psychiatry-once-again 2026-04-16T10:04:04Z monthly 0.7 https://www.moreblossom.com/papers/can-quetiapine-prolong-the-antidepressant-effect-of-ketamine-a-5-year-follow-up- 2026-04-16T10:04:06Z monthly 0.7 https://www.moreblossom.com/papers/canalization-and-plasticity-in-psychopathology 2026-04-16T10:04:08Z monthly 0.7 https://www.moreblossom.com/papers/cancer-at-the-dinner-table-experiences-of-psilocybin-assisted-psychotherapy-for- 2026-05-11T17:06:04Z monthly 0.7 https://www.moreblossom.com/papers/cancer-healthcare-workers-perceptions-toward-psychedelic-assisted-therapy-a-prel 2026-04-16T10:04:11Z monthly 0.7 https://www.moreblossom.com/papers/cannabinoids-is-a-no-go-while-a-cancer-patient-is-on-immunotherapy-but-is-it-saf 2026-04-16T10:04:13Z monthly 0.7 https://www.moreblossom.com/papers/cannabis-and-ecstasy-mdma-empirical-measures-of-creativity-in-recreational-users 2026-04-16T10:04:14Z monthly 0.7 https://www.moreblossom.com/papers/cardiac-arrest-after-ibogaine-intoxication 2026-04-16T10:50:16Z monthly 0.7 https://www.moreblossom.com/papers/case-report-ketamine-for-pain-and-depression-in-advanced-cancer 2026-04-16T10:04:18Z monthly 0.7 https://www.moreblossom.com/papers/case-report-prolonged-amelioration-of-mild-red-green-color-vision-deficiency-fol 2026-04-16T10:04:19Z monthly 0.7 https://www.moreblossom.com/papers/catalysts-for-change-the-cellular-neurobiology-of-psychedelics 2026-04-16T10:04:21Z monthly 0.7 https://www.moreblossom.com/papers/cellular-rules-underlying-psychedelic-control-of-prefrontal-pyramidal-neurons 2026-04-16T10:04:23Z monthly 0.7 https://www.moreblossom.com/papers/central-nervous-system-related-safety-and-tolerability-of-add-on-ketamine-to-ant 2026-04-27T12:06:09Z monthly 0.7 https://www.moreblossom.com/papers/ceremonial-ayahuasca-in-amazonian-retreats-mental-health-and-epigenetic-outcomes 2026-04-16T10:04:28Z monthly 0.7 https://www.moreblossom.com/papers/ceremonial-plant-medicine-use-and-its-relationship-to-recreational-drug-use-an-e 2026-04-16T10:04:30Z monthly 0.7 https://www.moreblossom.com/papers/cessation-and-reduction-in-alcohol-consumption-and-misuse-after-psychedelic-use 2026-04-16T10:04:31Z monthly 0.7 https://www.moreblossom.com/papers/challenges-in-translational-research-mdma-in-the-laboratory-versus-therapeutic-s 2026-04-16T10:04:33Z monthly 0.7 https://www.moreblossom.com/papers/changed-substance-use-after-psychedelic-experiences-among-individuals-in-canada 2026-04-16T10:50:17Z monthly 0.7 https://www.moreblossom.com/papers/changes-in-global-and-thalamic-brain-connectivity-in-lsd-induced-altered-states- 2026-04-27T12:07:02Z monthly 0.7 https://www.moreblossom.com/papers/changes-in-inflammatory-biomarkers-are-related-to-the-antidepressant-effects-of- 2026-05-05T13:26:52Z monthly 0.7 https://www.moreblossom.com/papers/changes-in-mental-health-wellbeing-and-personality-following-ayahuasca-consumpti 2026-04-16T10:04:42Z monthly 0.7 https://www.moreblossom.com/papers/changes-in-music-evoked-emotion-and-ventral-striatal-functional-connectivity-aft 2026-05-12T23:47:15Z monthly 0.7 https://www.moreblossom.com/papers/changes-in-self-rumination-and-self-compassion-mediate-the-effect-of-psychedelic 2026-04-16T10:04:45Z monthly 0.7 https://www.moreblossom.com/papers/changes-in-spirituality-among-ayahuasca-ceremony-novice-participants 2026-04-16T10:04:46Z monthly 0.7 https://www.moreblossom.com/papers/changes-in-withdrawal-and-craving-scores-in-participants-undergoing-opioid-detox 2026-04-27T12:07:20Z monthly 0.7 https://www.moreblossom.com/papers/characterization-and-prediction-of-acute-and-sustained-response-to-psychedelic-p 2026-04-16T10:50:18Z monthly 0.7 https://www.moreblossom.com/papers/characterization-of-behavioral-and-endocrine-effects-of-lsd-on-zebrafish 2026-04-16T10:04:53Z monthly 0.7 https://www.moreblossom.com/papers/characterizing-thalamocortical-dysconnectivity-following-d-amphetamine-lsd-and-m 2026-05-19T11:24:05Z monthly 0.7 https://www.moreblossom.com/papers/chemical-cousins-with-contrasting-behavioural-profiles-mdma-users-and-methamphet 2026-04-16T10:04:56Z monthly 0.7 https://www.moreblossom.com/papers/chemistry-and-structure-activity-relationships-of-psychedelics 2026-04-16T10:50:20Z monthly 0.7 https://www.moreblossom.com/papers/childhood-trauma-challenging-experiences-and-posttraumatic-growth-in-ayahuasca-u 2026-04-16T10:05:00Z monthly 0.7 https://www.moreblossom.com/papers/chronic-34-methylenedioxymethamphetamine-mdma-use-is-related-to-glutamate-and-ga 2026-04-16T10:05:02Z monthly 0.7 https://www.moreblossom.com/papers/chronic-administration-of-serotonergic-antidepressants-attenuates-the-subjective 2026-04-16T10:50:21Z monthly 0.7 https://www.moreblossom.com/papers/chronic-intermittent-microdoses-of-the-psychedelic-n-n-dimethyltryptamine-dmt-pr 2026-04-16T10:05:06Z monthly 0.7 https://www.moreblossom.com/papers/chronic-pain-and-psychedelics-a-review-and-proposed-mechanism-of-action 2026-04-16T10:05:08Z monthly 0.7 https://www.moreblossom.com/papers/chronic-treatment-with-psilocybin-decreases-changes-in-body-weight-in-a-rodent-m 2026-04-16T10:05:12Z monthly 0.7 https://www.moreblossom.com/papers/classic-and-dissociative-psychedelics-induce-similar-hyper-synchronous-states-in 2026-04-16T10:05:14Z monthly 0.7 https://www.moreblossom.com/papers/classic-hallucinogens-and-mystical-experiences-phenomenology-and-neural-correlat 2026-04-16T10:50:23Z monthly 0.7 https://www.moreblossom.com/papers/classic-hallucinogens-in-the-treatment-of-addictions 2026-04-16T10:05:18Z monthly 0.7 https://www.moreblossom.com/papers/classic-psychedelic-coadministration-with-lithium-but-not-lamotrigine-is-associa 2026-04-16T10:05:20Z monthly 0.7 https://www.moreblossom.com/papers/classic-psychedelic-drugs-update-on-biological-mechanisms 2026-04-16T10:05:22Z monthly 0.7 https://www.moreblossom.com/papers/classic-psychedelic-use-and-current-meditation-practice 2026-04-16T10:50:24Z monthly 0.7 https://www.moreblossom.com/papers/classic-psychedelic-use-and-mechanisms-of-mental-health-exploring-the-mediating- 2026-04-16T10:05:26Z monthly 0.7 https://www.moreblossom.com/papers/classic-psychedelic-use-is-associated-with-reduced-psychological-distress-and-su 2026-04-16T10:05:27Z monthly 0.7 https://www.moreblossom.com/papers/classic-psychedelics-an-integrative-review-of-epidemiology-therapeutics-mystical 2026-04-16T10:05:29Z monthly 0.7 https://www.moreblossom.com/papers/classic-psychedelics-and-alcohol-use-disorders-a-systematic-review-of-human-and- 2026-04-16T10:05:31Z monthly 0.7 https://www.moreblossom.com/papers/classic-psychedelics-as-a-psychotherapeutic-aid-in-the-treatment-of-stimulant-us 2026-04-16T10:50:25Z monthly 0.7 https://www.moreblossom.com/papers/classic-psychedelics-as-therapeutics-for-psychiatric-disorders 2026-04-16T10:05:35Z monthly 0.7 https://www.moreblossom.com/papers/classic-psychedelics-do-not-affect-t-cell-and-monocyte-immune-responses 2026-04-16T10:05:38Z monthly 0.7 https://www.moreblossom.com/papers/classic-psychedelics-health-behavior-and-physical-health 2026-04-16T10:05:40Z monthly 0.7 https://www.moreblossom.com/papers/classic-psychedelics-in-addiction-treatment-the-case-for-psilocybin-in-tobacco-s 2026-04-16T10:50:26Z monthly 0.7 https://www.moreblossom.com/papers/classic-psychedelics-in-the-treatment-of-substance-use-disorder-potential-synerg 2026-04-16T10:05:43Z monthly 0.7 https://www.moreblossom.com/papers/classic-serotonergic-psychedelics-for-mood-and-depressive-symptoms-a-meta-analys 2026-04-16T10:50:27Z monthly 0.7 https://www.moreblossom.com/papers/classical-and-non-classical-psychedelic-drugs-induce-common-network-changes-in-h 2026-04-16T10:05:47Z monthly 0.7 https://www.moreblossom.com/papers/classical-hallucinogens-and-neuroimaging-a-systematic-review-of-human-studies-ha 2026-04-16T10:05:49Z monthly 0.7 https://www.moreblossom.com/papers/classical-hallucinogens-as-antidepressants-a-review-of-pharmacodynamics-and-puta 2026-04-16T10:05:51Z monthly 0.7 https://www.moreblossom.com/papers/classical-psychedelics-as-therapeutics-in-psychiatry-current-clinical-evidence-a 2026-04-16T10:05:52Z monthly 0.7 https://www.moreblossom.com/papers/clinical-and-biological-predictors-of-psychedelic-response-in-the-treatment-of-p 2026-04-16T10:05:54Z monthly 0.7 https://www.moreblossom.com/papers/clinical-applications-of-hallucinogens-a-review 2026-04-16T10:05:56Z monthly 0.7 https://www.moreblossom.com/papers/clinical-effectiveness-of-intravenous-racemic-ketamine-infusions-in-a-large-comm 2026-04-11T10:42:06Z monthly 0.7 https://www.moreblossom.com/papers/clinical-interpretations-of-patient-experience-in-a-trial-of-psilocybin-assisted 2026-05-11T17:06:06Z monthly 0.7 https://www.moreblossom.com/papers/clinical-investigations-of-the-therapeutic-potential-of-ayahuasca-rationale-and- 2026-04-16T10:06:01Z monthly 0.7 https://www.moreblossom.com/papers/clinical-predictors-of-depressive-symptom-remission-and-response-after-racemic-k 2026-04-27T12:07:36Z monthly 0.7 https://www.moreblossom.com/papers/clinical-studies-of-lysergic-acid-diethylamide 2026-05-13T09:36:58Z monthly 0.7 https://www.moreblossom.com/papers/clinical-trials-for-rapid-changes-in-suicidal-ideation-lessons-from-ketamine 2026-04-16T10:06:04Z monthly 0.7 https://www.moreblossom.com/papers/clinical-utility-of-fmri-in-evaluating-of-lsd-effect-on-pain-related-brain-netwo 2026-04-16T10:06:06Z monthly 0.7 https://www.moreblossom.com/papers/clinically-relevant-acute-subjective-effects-of-psychedelics-beyond-mystical-exp 2026-04-16T10:50:29Z monthly 0.7 https://www.moreblossom.com/papers/clonazepam-treatment-of-lysergic-acid-diethylamide-induced-hallucinogen-persisti 2026-04-27T12:07:41Z monthly 0.7 https://www.moreblossom.com/papers/co-administration-of-midazolam-and-psilocybin-differential-effects-on-subjective 2026-04-16T10:50:30Z monthly 0.7 https://www.moreblossom.com/papers/co-use-of-mdma-with-psilocybin-lsd-may-buffer-against-challenging-experiences-an 2026-04-16T10:50:32Z monthly 0.7 https://www.moreblossom.com/papers/cocaine-self-administration-disrupted-by-the-n-methyl-d-aspartate-receptor-antag 2026-05-19T10:29:40Z monthly 0.7 https://www.moreblossom.com/papers/cognitive-and-subjective-effects-of-psilocybin-microdosing-results-from-two-doub 2026-05-05T14:59:47Z monthly 0.7 https://www.moreblossom.com/papers/cognitive-behavioral-therapy-to-sustain-the-antidepressant-effects-of-ketamine-i 2026-04-27T12:07:43Z monthly 0.7 https://www.moreblossom.com/papers/cognitive-function-mediates-the-anti-suicide-effect-of-repeated-intravenous-keta 2026-05-19T10:29:40Z monthly 0.7 https://www.moreblossom.com/papers/collective-self-experimentation-in-patient-led-research-how-online-health-commun 2026-04-16T10:06:27Z monthly 0.7 https://www.moreblossom.com/papers/combination-therapy-with-transcranial-magnetic-stimulation-and-ketamine-for-trea 2026-04-16T10:06:29Z monthly 0.7 https://www.moreblossom.com/papers/combined-ketamine-and-psychotherapy-provide-no-additional-benefit-beyond-ketamin 2026-04-16T10:06:31Z monthly 0.7 https://www.moreblossom.com/papers/combining-cognitive-behavioral-conjoint-therapy-for-ptsd-with-34-methylenedioxym 2026-05-05T14:59:58Z monthly 0.7 https://www.moreblossom.com/papers/combining-psychedelic-and-mindfulness-interventions-synergies-to-inform-clinical 2026-04-16T10:06:34Z monthly 0.7 https://www.moreblossom.com/papers/coming-back-together-a-qualitative-survey-study-of-coping-and-support-strategies 2026-04-16T10:06:36Z monthly 0.7 https://www.moreblossom.com/papers/common-neural-signatures-of-psychedelics-frequency-specific-energy-changes-and-r 2026-04-16T10:06:38Z monthly 0.7 https://www.moreblossom.com/papers/communalistic-use-of-psychoactive-plants-as-a-bridge-between-traditional-healing 2026-04-16T10:06:40Z monthly 0.7 https://www.moreblossom.com/papers/comparative-acute-effects-of-mescaline-lysergic-acid-diethylamide-and-psilocybin 2026-04-27T12:07:46Z monthly 0.7 https://www.moreblossom.com/papers/comparative-effectiveness-of-repeated-ketamine-infusions-in-treating-anhedonia-i 2026-05-19T10:29:40Z monthly 0.7 https://www.moreblossom.com/papers/comparative-efficacy-of-racemic-ketamine-and-esketamine-for-depression-a-systema 2026-04-16T10:06:44Z monthly 0.7 https://www.moreblossom.com/papers/comparing-antidepressant-effects-of-psilocybin-assisted-psychotherapy-in-individ 2026-05-13T08:36:38Z monthly 0.7 https://www.moreblossom.com/papers/comparing-neural-correlates-of-consciousness-from-psychedelics-to-hypnosis-and-m 2026-04-27T12:07:04Z monthly 0.7 https://www.moreblossom.com/papers/comparison-between-single-dose-and-two-dose-psilocybin-administration-in-the-tre 2026-04-16T10:06:48Z monthly 0.7 https://www.moreblossom.com/papers/comparison-of-psychedelic-and-near-death-or-other-non-ordinary-experiences-in-ch 2026-04-16T10:06:54Z monthly 0.7 https://www.moreblossom.com/papers/comparison-of-rapid-antidepressant-and-antisuicidal-effects-of-intramuscular-ket 2026-05-19T10:29:40Z monthly 0.7 https://www.moreblossom.com/papers/compass-psychological-support-model-for-comp360-psilocybin-treatment-of-serious- 2026-05-05T13:27:57Z monthly 0.7 https://www.moreblossom.com/papers/compassionate-use-of-psychedelics 2026-04-16T10:50:34Z monthly 0.7 https://www.moreblossom.com/papers/complex-slow-waves-radically-reorganise-human-brain-dynamics-under-5-meo-dmt 2026-04-16T10:07:01Z monthly 0.7 https://www.moreblossom.com/papers/composition-standardization-and-chemical-profiling-of-banisteriopsis-caapi-a-pla 2026-04-16T10:07:03Z monthly 0.7 https://www.moreblossom.com/papers/concomitant-medications-associated-with-ischemic-hypertensive-and-arrhythmic-eve 2026-05-12T10:35:39Z monthly 0.7 https://www.moreblossom.com/papers/conflict-monitoring-and-emotional-processing-in-34-methylenedioxymethamphetamine 2026-04-16T10:07:12Z monthly 0.7 https://www.moreblossom.com/papers/connectome-harmonic-decomposition-of-human-brain-activity-reveals-dynamical-repe 2026-04-16T10:50:36Z monthly 0.7 https://www.moreblossom.com/papers/consciousness-in-active-inference-deep-self-models-other-minds-and-the-challenge 2026-04-16T10:07:16Z monthly 0.7 https://www.moreblossom.com/papers/consciousness-religion-and-gurus-pitfalls-of-psychedelic-medicine 2026-04-16T10:07:17Z monthly 0.7 https://www.moreblossom.com/papers/constructing-drug-effects-a-history-of-set-and-setting 2026-04-16T10:07:19Z monthly 0.7 https://www.moreblossom.com/papers/consumption-of-ayahuasca-by-children-and-pregnant-women-medical-controversies-an 2026-04-16T10:07:20Z monthly 0.7 https://www.moreblossom.com/papers/contextual-parameters-associated-with-positive-and-negative-mental-health-in-rec 2026-04-16T10:07:22Z monthly 0.7 https://www.moreblossom.com/papers/control-conditions-in-randomized-trials-of-psychedelics-an-acttion-systematic-re 2026-04-16T10:07:24Z monthly 0.7 https://www.moreblossom.com/papers/control-group-outcomes-in-trials-of-psilocybin-ssris-or-esketamine-for-depressio 2026-04-16T10:07:26Z monthly 0.7 https://www.moreblossom.com/papers/convergent-mechanisms-underlying-rapid-antidepressant-action 2026-04-16T10:50:37Z monthly 0.7 https://www.moreblossom.com/papers/correlation-between-the-potency-of-hallucinogens-in-the-mouse-head-twitch-respon 2026-04-16T10:07:30Z monthly 0.7 https://www.moreblossom.com/papers/cortical-structural-differences-following-repeated-ayahuasca-use-hold-molecular- 2026-04-16T10:07:33Z monthly 0.7 https://www.moreblossom.com/papers/cost-effectiveness-of-esketamine-nasal-spray-compared-to-intravenous-ketamine-fo 2026-04-16T10:07:35Z monthly 0.7 https://www.moreblossom.com/papers/cost-effectiveness-of-midomafetamine-assisted-therapy-mdma-at-in-chronic-and-tre 2026-04-16T10:07:37Z monthly 0.7 https://www.moreblossom.com/papers/cost-effectiveness-of-psilocybin-assisted-therapy-for-severe-depression-explorat 2026-04-16T10:07:39Z monthly 0.7 https://www.moreblossom.com/papers/cost-per-remitter-for-esketamine-nasal-spray-versus-quetiapine-for-treatment-res 2026-04-16T10:07:41Z monthly 0.7 https://www.moreblossom.com/papers/cost-utility-analysis-of-esketamine-for-patients-with-treatment-resistant-depres 2026-04-16T10:50:39Z monthly 0.7 https://www.moreblossom.com/papers/couple-therapy-with-mdma-proposed-pathways-of-action 2026-04-16T10:07:47Z monthly 0.7 https://www.moreblossom.com/papers/creativity-and-psychoactive-substance-use-a-systematic-review 2026-04-16T10:50:40Z monthly 0.7 https://www.moreblossom.com/papers/crisis-intervention-related-to-the-use-of-psychoactive-substances-in-recreationa 2026-04-16T10:07:51Z monthly 0.7 https://www.moreblossom.com/papers/critical-period-plasticity-as-a-framework-for-psychedelic-assisted-psychotherapy 2026-04-16T10:07:54Z monthly 0.7 https://www.moreblossom.com/papers/cross-sectional-associations-between-lifetime-use-of-psychedelic-drugs-and-psych 2026-04-16T10:07:57Z monthly 0.7 https://www.moreblossom.com/papers/cross-species-evidence-for-psilocin-induced-visual-distortions-apparent-motion-i 2026-05-12T19:17:50Z monthly 0.7 https://www.moreblossom.com/papers/crystal-structure-of-an-lsd-bound-human-serotonin-receptor 2026-04-16T10:08:00Z monthly 0.7 https://www.moreblossom.com/papers/culture-and-psychedelic-psychotherapy-ethnic-and-racial-themes-from-three-black- 2026-04-16T10:08:02Z monthly 0.7 https://www.moreblossom.com/papers/current-perspectives-on-psychedelic-therapy-use-of-serotonergic-hallucinogens-in 2026-04-16T10:08:03Z monthly 0.7 https://www.moreblossom.com/papers/cytochrome-p450-enzymes-contribute-to-the-metabolism-of-lsd-to-nor-lsd-and-2-oxo 2026-04-16T10:08:05Z monthly 0.7 https://www.moreblossom.com/papers/dark-classics-in-chemical-neuroscience-34-methylenedioxymethamphetamine 2026-04-16T10:08:07Z monthly 0.7 https://www.moreblossom.com/papers/dark-classics-in-chemical-neuroscience-ibogaine 2026-04-16T10:08:09Z monthly 0.7 https://www.moreblossom.com/papers/dark-classics-in-chemical-neuroscience-lysergic-acid-diethylamide-lsd 2026-04-16T10:08:10Z monthly 0.7 https://www.moreblossom.com/papers/dark-classics-in-chemical-neuroscience-mescaline 2026-04-16T10:08:12Z monthly 0.7 https://www.moreblossom.com/papers/dark-classics-in-chemical-neuroscience-n-n-dimethyltryptamine-dmt 2026-04-16T10:08:13Z monthly 0.7 https://www.moreblossom.com/papers/dark-classics-in-chemical-neuroscience-psilocybin 2026-04-16T10:08:15Z monthly 0.7 https://www.moreblossom.com/papers/dark-classics-in-chemical-neuroscience-salvinorin-a 2026-04-16T10:08:16Z monthly 0.7 https://www.moreblossom.com/papers/dark-loops-contagion-effects-consistency-and-chemosocial-matrices-in-psychedelic 2026-04-16T10:08:18Z monthly 0.7 https://www.moreblossom.com/papers/day-trip-to-hell-a-mixed-methods-study-of-challenging-psychedelic-experiences 2026-04-16T10:08:20Z monthly 0.7 https://www.moreblossom.com/papers/daytime-ayahuasca-administration-modulates-rem-and-slow-wave-sleep-in-healthy-vo 2026-04-16T10:50:41Z monthly 0.7 https://www.moreblossom.com/papers/debunking-the-myth-of-blue-mondays-no-evidence-of-affect-drop-after-taking-clini 2026-05-19T10:29:41Z monthly 0.7 https://www.moreblossom.com/papers/decreased-brain-modularity-after-psilocybin-therapy-for-depression 2026-04-16T10:08:24Z monthly 0.7 https://www.moreblossom.com/papers/decreased-directed-functional-connectivity-in-the-psychedelic-state 2026-04-16T10:08:26Z monthly 0.7 https://www.moreblossom.com/papers/decreased-mental-time-travel-to-the-past-correlates-with-default-mode-network-di 2026-04-16T10:08:28Z monthly 0.7 https://www.moreblossom.com/papers/decreases-in-state-and-trait-anxiety-post-psilocybin-a-naturalistic-observationa 2026-04-16T10:08:30Z monthly 0.7 https://www.moreblossom.com/papers/decreases-in-suicidality-following-psychedelic-therapy-a-meta-analysis-of-indivi 2026-04-16T10:08:33Z monthly 0.7 https://www.moreblossom.com/papers/default-mode-network-modulation-by-psychedelics-a-systematic-review 2026-04-16T10:08:34Z monthly 0.7 https://www.moreblossom.com/papers/depression-estrogens-and-neuroinflammation-a-preclinical-review-of-ketamine-trea 2026-04-16T10:08:38Z monthly 0.7 https://www.moreblossom.com/papers/depression-mindfulness-and-psilocybin-possible-complementary-effects-of-mindfuln 2026-04-16T10:08:41Z monthly 0.7 https://www.moreblossom.com/papers/depressive-mood-ratings-are-reduced-by-mdma-in-female-polydrug-ecstasy-users-hom 2026-04-16T10:50:43Z monthly 0.7 https://www.moreblossom.com/papers/determination-of-tryptamines-and-b-carbolines-in-ayahuasca-beverage-consumed-dur 2026-04-16T10:08:44Z monthly 0.7 https://www.moreblossom.com/papers/detoxification-from-methadone-using-low-repeated-and-increasing-doses-of-ibogain 2026-04-16T10:08:46Z monthly 0.7 https://www.moreblossom.com/papers/developing-a-new-national-mdma-policy-results-of-a-multi-decision-multi-criterio 2026-04-16T10:08:48Z monthly 0.7 https://www.moreblossom.com/papers/developing-an-ethics-and-policy-framework-for-psychedelic-clinical-care-a-consen 2026-04-16T10:08:50Z monthly 0.7 https://www.moreblossom.com/papers/developing-guidelines-and-competencies-for-the-training-of-psychedelic-therapist 2026-04-16T10:08:51Z monthly 0.7 https://www.moreblossom.com/papers/development-and-evaluation-of-a-therapist-training-program-for-psilocybin-therap 2026-04-16T10:08:55Z monthly 0.7 https://www.moreblossom.com/papers/development-of-a-psychotherapeutic-model-for-psilocybin-assisted-treatment-of-al 2026-04-16T10:08:56Z monthly 0.7 https://www.moreblossom.com/papers/development-of-the-psychological-insight-questionnaire-among-a-sample-of-people- 2026-04-16T10:08:58Z monthly 0.7 https://www.moreblossom.com/papers/developmental-outcomes-of-34-methylenedioxymethamphetamine-ecstasy-exposed-infan 2026-04-16T10:08:59Z monthly 0.7 https://www.moreblossom.com/papers/differences-between-the-mechanism-of-action-of-mdma-mbdb-and-the-classic-halluci 2026-04-16T10:09:01Z monthly 0.7 https://www.moreblossom.com/papers/differences-in-personality-cognitive-abilities-illicit-drug-use-and-white-matter 2026-04-16T10:09:02Z monthly 0.7 https://www.moreblossom.com/papers/differential-contributions-of-serotonergic-and-dopaminergic-functional-connectiv 2026-04-16T10:50:44Z monthly 0.7 https://www.moreblossom.com/papers/differential-tolerance-to-biological-and-subjective-effects-of-four-closely-spac 2026-04-16T10:09:07Z monthly 0.7 https://www.moreblossom.com/papers/dimensions-of-consciousness-and-the-psychedelic-state 2026-04-16T10:09:08Z monthly 0.7 https://www.moreblossom.com/papers/dimethyltryptamine-dmt-a-biochemical-swiss-army-knife-in-neuroinflammation-and-n 2026-04-16T10:09:10Z monthly 0.7 https://www.moreblossom.com/papers/dimethyltryptamine-dmt-prevalence-user-characteristics-and-abuse-liability-in-a- 2026-04-16T10:09:11Z monthly 0.7 https://www.moreblossom.com/papers/dimethyltryptamine-dmt-subjective-effects-and-patterns-of-use-among-australian-r 2026-04-16T10:09:13Z monthly 0.7 https://www.moreblossom.com/papers/direct-comparison-of-the-acute-effects-of-lysergic-acid-diethylamide-and-psilocy 2026-05-05T14:59:42Z monthly 0.7 https://www.moreblossom.com/papers/direct-comparison-of-the-acute-subjective-emotional-autonomic-and-endocrine-effe 2026-04-27T12:05:18Z monthly 0.7 https://www.moreblossom.com/papers/direct-phosphorylation-of-psilocin-enables-optimized-cgmp-kilogram-scale-manufac 2026-04-16T10:09:19Z monthly 0.7 https://www.moreblossom.com/papers/discontinuation-of-medications-classified-as-reuptake-inhibitors-affects-treatme 2026-04-27T11:58:26Z monthly 0.7 https://www.moreblossom.com/papers/discovery-of-g-protein-biased-antagonists-against-5-ht7r 2026-03-25T05:58:28Z monthly 0.7 https://www.moreblossom.com/papers/discriminative-stimulus-effects-of-substituted-tryptamines-in-rats 2026-04-16T10:09:22Z monthly 0.7 https://www.moreblossom.com/papers/disentangling-the-association-of-depression-on-the-anti-fatigue-effects-of-ketam 2026-05-11T17:08:28Z monthly 0.7 https://www.moreblossom.com/papers/disintegrating-and-reintegrating-the-self-inflexible-self-models-in-depersonalis 2026-04-16T10:09:26Z monthly 0.7 https://www.moreblossom.com/papers/dissociable-effects-of-lsd-and-mdma-on-striato-cortical-connectivity-in-healthy- 2026-04-16T10:09:28Z monthly 0.7 https://www.moreblossom.com/papers/dissociable-effects-of-psilocybin-and-escitalopram-for-depression-on-processing- 2026-05-12T22:55:11Z monthly 0.7 https://www.moreblossom.com/papers/dissociative-symptoms-with-intravenous-ketamine-in-treatment-resistant-depressio 2026-04-16T10:09:32Z monthly 0.7 https://www.moreblossom.com/papers/dissolving-the-self-active-inference-psychedelics-and-ego-dissolution 2026-04-16T10:09:34Z monthly 0.7 https://www.moreblossom.com/papers/distinct-5-ht-receptor-subtypes-regulate-claustrum-excitability-by-serotonin-and 2026-04-16T10:09:36Z monthly 0.7 https://www.moreblossom.com/papers/distinct-acute-effects-of-lsd-mdma-and-d-amphetamine-in-healthy-subjects 2026-04-27T12:08:27Z monthly 0.7 https://www.moreblossom.com/papers/distinct-trajectories-of-antidepressant-response-to-intravenous-ketamine 2026-04-16T10:09:40Z monthly 0.7 https://www.moreblossom.com/papers/distributed-harmonic-patterns-of-structure-function-dependence-orchestrate-human 2026-04-16T10:50:52Z monthly 0.7 https://www.moreblossom.com/papers/dmt-alters-cortical-travelling-waves 2026-04-16T10:09:44Z monthly 0.7 https://www.moreblossom.com/papers/dmt-and-harmala-alkaloids-an-exploratory-study-of-oral-acacia-based-formulations 2026-04-27T12:08:36Z monthly 0.7 https://www.moreblossom.com/papers/dmt-induces-a-transient-destabilization-of-whole-brain-dynamics 2026-04-16T10:50:54Z monthly 0.7 https://www.moreblossom.com/papers/dmt-micro-phenomenology 2026-04-16T10:09:50Z monthly 0.7 https://www.moreblossom.com/papers/dmt-models-the-near-death-experience 2026-04-16T10:09:53Z monthly 0.7 https://www.moreblossom.com/papers/do-classic-psychedelics-increase-the-risk-of-seizures-a-scoping-review 2026-04-16T10:09:55Z monthly 0.7 https://www.moreblossom.com/papers/do-entheogen-induced-mystical-experiences-boost-the-immune-system-psychedelics-p 2026-03-24T15:01:50Z monthly 0.7 https://www.moreblossom.com/papers/do-hallucinogens-cause-residual-neuropsychological-toxicity 2026-04-16T10:09:57Z monthly 0.7 https://www.moreblossom.com/papers/do-hallucinogens-have-a-role-in-the-treatment-of-addictions-a-review-of-the-curr 2026-04-16T10:50:55Z monthly 0.7 https://www.moreblossom.com/papers/do-nmda-r-antagonists-re-create-patterns-of-spontaneous-gamma-band-activity-in-s 2026-04-16T10:10:01Z monthly 0.7 https://www.moreblossom.com/papers/do-psychedelics-change-beliefs 2026-04-16T10:10:03Z monthly 0.7 https://www.moreblossom.com/papers/do-sleep-changes-mediate-the-anti-depressive-and-anti-suicidal-response-of-intra 2026-04-16T10:10:05Z monthly 0.7 https://www.moreblossom.com/papers/do-the-dissociative-side-effects-of-ketamine-mediate-its-antidepressant-effects 2026-04-16T10:10:07Z monthly 0.7 https://www.moreblossom.com/papers/does-34-methylenedioxymethamphetamine-ecstasy-induce-subjective-feelings-of-soci 2026-04-16T10:10:09Z monthly 0.7 https://www.moreblossom.com/papers/does-getting-high-hurt-characterization-of-cases-of-lsd-and-psilocybin-containin 2026-04-16T10:10:10Z monthly 0.7 https://www.moreblossom.com/papers/does-mdma-have-treatment-potential-in-sexual-dysfunction-a-systematic-review-of- 2026-04-16T10:10:12Z monthly 0.7 https://www.moreblossom.com/papers/does-psychedelic-drug-use-reduce-risk-of-suicidality-evidence-from-a-longitudina 2026-04-16T10:10:13Z monthly 0.7 https://www.moreblossom.com/papers/does-psychedelic-therapy-have-a-transdiagnostic-action-and-prophylactic-potentia 2026-04-16T10:10:16Z monthly 0.7 https://www.moreblossom.com/papers/dont-be-afraid-try-to-meditate-potential-effects-on-neural-activity-and-connecti 2026-04-16T10:10:18Z monthly 0.7 https://www.moreblossom.com/papers/dose-related-behavioral-subjective-endocrine-and-psychophysiological-effects-of- 2026-04-27T12:08:40Z monthly 0.7 https://www.moreblossom.com/papers/dose-related-effects-of-adjunctive-ketamine-in-taiwanese-patients-with-treatment 2026-05-11T22:45:06Z monthly 0.7 https://www.moreblossom.com/papers/dose-related-effects-of-ketamine-for-antidepressant-resistant-symptoms-of-posttr 2026-05-11T23:00:43Z monthly 0.7 https://www.moreblossom.com/papers/dose-related-effects-of-salvinorin-a-in-humans-dissociative-hallucinogenic-and-m 2026-04-16T10:50:59Z monthly 0.7 https://www.moreblossom.com/papers/dose-response-relationships-of-lsd-induced-subjective-experiences-in-humans 2026-04-16T10:51:01Z monthly 0.7 https://www.moreblossom.com/papers/dose-response-relationships-of-psilocybin-induced-subjective-experiences-in-huma 2026-04-16T10:10:30Z monthly 0.7 https://www.moreblossom.com/papers/dose-response-study-of-nn-dimethyltryptamine-in-humans-i-neuroendocrine-autonomi 2026-04-16T10:10:32Z monthly 0.7 https://www.moreblossom.com/papers/dose-response-study-of-nn-dimethyltryptamine-in-humans-subjective-effects-and-pr 2026-04-16T10:10:34Z monthly 0.7 https://www.moreblossom.com/papers/dosing-and-therapeutic-conduct-in-administration-sessions-in-substance-assisted- 2026-04-16T10:10:36Z monthly 0.7 https://www.moreblossom.com/papers/double-blind-comparison-of-the-two-hallucinogens-dextromethorphan-and-psilocybin 2026-04-27T12:08:49Z monthly 0.7 https://www.moreblossom.com/papers/double-blind-comparison-of-the-two-hallucinogens-psilocybin-and-dextromethorphan 2026-04-27T12:08:52Z monthly 0.7 https://www.moreblossom.com/papers/double-blind-comparison-of-the-two-hallucinogens-psilocybin-cognition 2026-04-16T10:51:03Z monthly 0.7 https://www.moreblossom.com/papers/dpt-as-an-adjunct-in-psychotherapy-of-alcoholics 2026-05-19T11:24:23Z monthly 0.7 https://www.moreblossom.com/papers/dr-learys-concord-prison-experiment-a-34-year-follow-up-study 2026-04-16T10:10:45Z monthly 0.7 https://www.moreblossom.com/papers/dreamlike-effects-of-lsd-on-waking-imagery-in-humans-depend-on-serotonin-2a-rece 2026-04-16T10:51:05Z monthly 0.7 https://www.moreblossom.com/papers/dreams-and-psychedelics-neurophenomenological-comparison-and-therapeutic-implica 2026-04-16T10:10:50Z monthly 0.7 https://www.moreblossom.com/papers/drug-drug-interactions-between-psychiatric-medications-and-mdma-or-psilocybin-a- 2026-04-16T10:51:06Z monthly 0.7 https://www.moreblossom.com/papers/drug-drug-interactions-involving-classic-psychedelics-a-systematic-review 2026-04-16T10:10:54Z monthly 0.7 https://www.moreblossom.com/papers/drug-induced-social-connection-both-mdma-and-methamphetamine-increase-feelings-o 2026-05-19T13:16:23Z monthly 0.7 https://www.moreblossom.com/papers/drug-models-of-schizophrenia 2026-04-16T10:10:58Z monthly 0.7 https://www.moreblossom.com/papers/drugs-as-instruments-a-new-framework-for-non-addictive-psychoactive-drug-use 2026-04-16T10:11:00Z monthly 0.7 https://www.moreblossom.com/papers/dual-action-of-ketamine-confines-addiction-liability 2026-04-16T10:51:09Z monthly 0.7 https://www.moreblossom.com/papers/durability-of-improvement-in-post-traumatic-stress-disorder-symptoms-and-absence 2026-05-19T13:19:18Z monthly 0.7 https://www.moreblossom.com/papers/dynamic-coupling-of-whole-brain-neuronal-and-neurotransmitter-systems 2026-04-16T10:11:05Z monthly 0.7 https://www.moreblossom.com/papers/dynamic-functional-hyperconnectivity-after-psilocybin-intake-is-primarily-associ 2026-04-16T10:11:07Z monthly 0.7 https://www.moreblossom.com/papers/dynamic-reconfiguration-of-frequency-specific-cortical-coactivation-patterns-dur 2026-04-16T10:11:08Z monthly 0.7 https://www.moreblossom.com/papers/dynamical-exploration-of-the-repertoire-of-brain-networks-at-rest-is-modulated-b 2026-04-16T10:11:10Z monthly 0.7 https://www.moreblossom.com/papers/early-effects-predict-trajectories-of-response-to-esketamine-in-treatment-resist 2026-04-16T10:11:12Z monthly 0.7 https://www.moreblossom.com/papers/economic-evaluation-of-subcutaneous-ketamine-injections-for-treatment-resistant- 2026-05-19T09:31:38Z monthly 0.7 https://www.moreblossom.com/papers/eeg-gamma-band-alterations-and-rem-like-traits-underpin-the-acute-effect-of-the- 2026-04-16T10:11:16Z monthly 0.7 https://www.moreblossom.com/papers/effect-of-ecstasy-34-methylenedioxymethamphetamine-mdma-on-cerebral-blood-flow-a 2026-04-16T10:11:18Z monthly 0.7 https://www.moreblossom.com/papers/effect-of-esketamine-on-depressive-symptoms-in-adolescents-with-major-depressive 2026-05-19T09:31:38Z monthly 0.7 https://www.moreblossom.com/papers/effect-of-iboga-alkaloids-on-u-opioid-receptor-coupled-g-protein-activation 2026-04-16T10:11:22Z monthly 0.7 https://www.moreblossom.com/papers/effect-of-ketamine-on-anxiety-findings-from-the-ketamine-for-adult-depression-st 2026-05-11T23:07:28Z monthly 0.7 https://www.moreblossom.com/papers/effect-of-lsd-and-music-on-the-time-varying-brain-dynamics 2026-04-16T10:51:10Z monthly 0.7 https://www.moreblossom.com/papers/effect-of-lysergic-acid-diethylamide-lsd-on-reinforcement-learning-in-humans 2026-04-16T10:11:27Z monthly 0.7 https://www.moreblossom.com/papers/effect-of-psilocybin-and-ketamine-on-brain-neurotransmitters-glutamate-receptors 2026-04-16T10:11:28Z monthly 0.7 https://www.moreblossom.com/papers/effect-of-psilocybin-on-empathy-and-moral-decision-making 2026-04-16T10:11:30Z monthly 0.7 https://www.moreblossom.com/papers/effect-of-psilocybin-versus-escitalopram-on-depression-symptom-severity-in-patie 2026-05-19T11:31:32Z monthly 0.7 https://www.moreblossom.com/papers/effect-of-repeated-intravenous-esketamine-on-adolescents-with-major-depressive-d 2026-05-11T19:08:47Z monthly 0.7 https://www.moreblossom.com/papers/effect-of-ritualistic-consumption-of-ayahuasca-on-hepatic-function-in-chronic-us 2026-04-16T10:11:35Z monthly 0.7 https://www.moreblossom.com/papers/effective-connectivity-changes-in-lsd-induced-altered-states-of-consciousness-in 2026-04-27T12:07:07Z monthly 0.7 https://www.moreblossom.com/papers/effective-connectivity-of-emotion-and-cognition-under-psilocybin 2026-04-27T12:09:11Z monthly 0.7 https://www.moreblossom.com/papers/effective-connectivity-of-functionally-anticorrelated-networks-under-lsd 2026-04-27T12:07:10Z monthly 0.7 https://www.moreblossom.com/papers/effective-connectivity-of-lsd-induced-ego-dissolution 2026-04-27T12:07:14Z monthly 0.7 https://www.moreblossom.com/papers/effective-connectivity-of-thalamocortical-interactions-following-d-amphetamine-l 2026-05-19T11:24:06Z monthly 0.7 https://www.moreblossom.com/papers/effects-and-safety-of-psilocybe-cubensis-and-panaeolus-cyanescens-magic-mushroom 2026-04-16T10:51:12Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-34-methylenedioxymethamphetamine-on-conditioned-fear-extinction-and-r 2026-04-27T12:09:25Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-a-b-blocker-on-the-cardiovascular-response-to-mdma-ecstasy 2026-04-27T12:09:28Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-a-dissociative-drug-on-fronto-limbic-resting-state-functional-connect 2026-05-11T17:08:49Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-a-serotonergic-psychedelic-on-the-lipid-bilayer 2026-04-16T10:11:55Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-a-single-dose-of-ayahuasca-in-college-students-with-harmful-alcohol-u 2026-04-27T12:09:37Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-acute-and-repeated-treatment-with-serotonin-5-ht2a-receptor-agonist-h 2026-04-16T10:12:00Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-acute-drug-administration-on-emotion-a-review-of-pharmacological-mri- 2026-04-16T10:51:14Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-acute-mdma-intoxication-on-mood-and-impulsivity-role-of-the-5-ht-2-an 2026-04-27T12:09:40Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-ayahuasca-and-its-alkaloids-on-drug-dependence-a-systematic-literatur 2026-04-16T10:12:06Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-ayahuasca-and-its-alkaloids-on-substance-use-disorders-an-updated-201 2026-04-16T10:51:15Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-ayahuasca-on-gratitude-and-relationships-with-nature-a-prospective-na 2026-04-16T10:12:11Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-ayahuasca-on-gratitude-and-relationships-with-nature-an-open-label-na 2026-04-16T10:12:12Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-ayahuasca-on-mental-health-and-quality-of-life-in-naive-users-a-longi 2026-04-16T10:51:17Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-ayahuasca-on-personality-results-of-two-randomized-placebo-controlled 2026-04-16T10:12:18Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-ayahuasca-on-psychometric-measures-of-anxiety-panic-like-and-hopeless 2026-04-16T10:12:20Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-ayahuasca-on-sensory-and-sensorimotor-gating-in-humans-as-measured-by 2026-04-16T10:51:18Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-ayahuasca-on-the-recognition-of-facial-expressions-of-emotions-in-nai 2026-04-16T10:12:25Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-classic-psychedelic-drugs-on-turbulent-signatures-in-brain-dynamics 2026-04-16T10:12:26Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-classical-psychedelics-on-implicit-and-explicit-emotional-empathy-and 2026-04-16T10:51:19Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-discontinuation-of-serotonergic-antidepressants-prior-to-psilocybin-t 2026-05-19T11:05:16Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-dmt-on-mental-health-outcomes-in-healthy-volunteers 2026-04-16T10:51:20Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-ecstasy-on-cooperative-behaviour-and-perception-of-trustworthiness-a- 2026-04-16T10:12:34Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-esketamine-on-patient-reported-outcomes-in-major-depressive-disorder- 2026-04-27T12:09:43Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-external-stimulation-on-psychedelic-state-neurodynamics 2026-04-16T10:12:37Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-hallucinogenic-drugs-on-the-human-heart 2026-04-16T10:12:40Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-ketamine-dexmedetomidine-and-propofol-anesthesia-on-emotional-memory- 2026-04-16T10:12:42Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-ketamine-on-brain-activity-during-emotional-processing-differential-f 2026-05-19T13:26:11Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-ketamine-on-brain-function-during-metacognition-of-episodic-memory 2026-04-16T10:12:46Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-ketamine-versus-midazolam-on-neurocognition-at-24-hours-in-depressed- 2026-05-12T12:50:28Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-long-term-ayahuasca-administration-on-memory-and-anxiety-in-rats 2026-04-16T10:12:51Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-low-dose-ibogaine-on-subjective-mood-state-and-psychological-performa 2026-04-16T10:12:53Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-lsd-on-music-evoked-brain-activity 2026-04-16T10:12:55Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-mdma-alone-and-after-pretreatment-with-reboxetine-duloxetine-clonidin 2026-04-16T10:51:22Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-mdma-and-intranasal-oxytocin-on-social-and-emotional-processing 2026-04-16T10:51:23Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-mdma-on-attention-to-positive-social-cues-and-pleasantness-of-affecti 2026-04-27T12:09:58Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-mdma-on-socioemotional-feelings-authenticity-and-autobiographical-dis 2026-04-16T10:13:03Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-mescaline-and-lysergic-acid-d-lsd-25 2026-04-16T10:13:05Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-n-n-dimethyltryptamine-on-rat-behaviors-relevant-to-anxiety-and-depre 2026-04-16T10:13:06Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-naturalistic-psychedelic-use-on-depression-anxiety-and-well-being-ass 2026-04-16T10:13:09Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-psilocybin-assisted-therapy-on-major-depressive-disorder 2026-05-13T07:22:28Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-psilocybin-microdosing-on-awe-and-aesthetic-experiences-a-preregister 2026-04-16T10:51:25Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-psilocybin-on-religious-and-spiritual-attitudes-and-behaviors-in-cler 2026-04-05T19:12:22Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-psilocybin-on-time-perception-and-temporal-control-of-behaviour-in-hu 2026-04-16T10:13:14Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-psilocybin-therapy-on-personality-structure 2026-05-12T17:36:13Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-psilocybin-versus-escitalopram-on-rumination-and-thought-suppression- 2026-05-19T13:08:20Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-psychedelic-microdosing-versus-conventional-adhd-medication-use-on-em 2026-04-16T10:13:20Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-psychedelics-on-neurogenesis-a-systematic-review-of-pre-clinical-stud 2026-04-16T10:13:21Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-psychoplastogens-on-blood-levels-of-brain-derived-neurotrophic-factor 2026-04-16T10:51:26Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-schedule-i-drug-laws-on-neuroscience-research-and-treatment-innovatio 2026-04-16T10:51:28Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-selective-serotonin-reuptake-inhibitor-use-on-34-methylenedioxymetham 2026-04-16T10:13:27Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-serotonin-2a-1a-receptor-stimulation-on-social-exclusion-processing 2026-04-16T10:13:29Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-setting-on-psychedelic-experiences-therapies-and-outcomes-a-rapid-sco 2026-04-16T10:51:29Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-the-5-ht2a-agonist-psilocybin-on-mismatch-negativity-generation-and-a 2026-04-16T10:51:30Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-the-natural-b-carboline-alkaloid-harmine-a-main-constituent-of-ayahua 2026-04-16T10:13:36Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-the-psychedelic-amphetamine-mda-3-4-methylenedioxyamphetamine-in-heal 2026-04-16T10:13:37Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-the-south-american-psychoactive-beverage-ayahuasca-on-regional-brain- 2026-04-16T10:13:39Z monthly 0.7 https://www.moreblossom.com/papers/effects-of-varied-doses-of-psilocybin-on-time-interval-reproduction-in-human-sub 2026-04-16T10:13:41Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-a-4-week-course-of-repeated-subcutaneous-ketamine-injecti 2026-05-12T06:00:12Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-esketamine-for-smoking-cessation-among-patients-diagnosed 2026-05-19T09:31:39Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-esketamine-nasal-spray-by-sex-in-patients-with-treatment- 2026-04-27T12:10:08Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-esketamine-nasal-spray-in-patients-with-treatment-resista 2026-04-27T12:10:11Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-flexibly-dosed-esketamine-nasal-spray-plus-a-newly-initia 2026-05-19T09:31:39Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-intranasal-esketamine-in-treatment-resistant-depression-i 2026-04-16T10:13:53Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-ketamine-in-bipolar-depression-a-systematic-review 2026-04-16T10:13:55Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-ketamine-vs-electroconvulsive-therapy-among-patients-with 2026-04-16T10:13:56Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-low-versus-high-dose-lsd-assisted-therapy-in-patients-wit 2026-05-13T10:16:20Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-oral-ketamine-versus-diclofenac-to-alleviate-mild-to-mode 2026-05-11T22:12:50Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-psilocybin-assisted-treatment-for-major-depressive-disord 2026-05-13T07:29:56Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-and-safety-of-subcutaneous-esketamine-in-the-treatment-of-suicidality-i 2026-04-16T10:51:33Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-of-34-methylenedioxymethamphetamine-mdma-assisted-psychotherapy-for-pos 2026-04-16T10:14:05Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-of-esketamine-nasal-spray-over-quetiapine-extended-release-over-the-sho 2026-05-13T14:27:38Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-of-intravenous-ketamine-for-treatment-of-chronic-posttraumatic-stress-d 2026-05-19T13:31:17Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-of-intravenous-ketamine-treatment-in-anxious-versus-nonanxious-unipolar 2026-05-12T06:25:51Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-of-ketamine-for-major-depressive-episodes-at-2-4-and-6-weeks-post-treat 2026-04-16T10:51:34Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-of-ketamine-in-the-rapid-treatment-of-major-depressive-disorder-a-meta- 2026-04-16T10:14:21Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-of-ketamine-in-the-treatment-of-migraines-and-other-unspecified-primary 2026-04-16T10:14:25Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-of-ketamine-in-the-treatment-of-substance-use-disorders-a-systematic-re 2026-04-16T10:14:27Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-of-psychoactive-drugs-for-the-treatment-of-posttraumatic-stress-disorde 2026-04-16T10:14:29Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-safety-and-durability-of-repeated-ketamine-infusions-for-comorbid-postt 2026-05-12T08:45:18Z monthly 0.7 https://www.moreblossom.com/papers/efficacy-tolerability-and-safety-of-serotonergic-psychedelics-for-the-management 2026-04-16T10:14:33Z monthly 0.7 https://www.moreblossom.com/papers/ego-dissolution-and-psychedelics-validation-of-the-ego-dissolution-inventory-edi 2026-04-16T10:14:36Z monthly 0.7 https://www.moreblossom.com/papers/embedding-existential-psychology-within-psychedelic-science-reduced-death-anxiet 2026-04-16T10:51:35Z monthly 0.7 https://www.moreblossom.com/papers/embracing-neurodiversity-in-psychedelic-science-a-mixed-methods-inquiry-into-the 2026-04-16T10:14:40Z monthly 0.7 https://www.moreblossom.com/papers/emotional-breakthrough-and-psychedelics-validation-of-the-emotional-breakthrough 2026-04-16T10:14:41Z monthly 0.7 https://www.moreblossom.com/papers/emotions-and-brain-function-are-altered-up-to-one-month-after-a-single-high-dose 2026-04-27T12:11:01Z monthly 0.7 https://www.moreblossom.com/papers/employing-synergistic-interactions-of-virtual-reality-and-psychedelics-in-neurop 2026-04-16T10:14:45Z monthly 0.7 https://www.moreblossom.com/papers/enantio-selective-cognitive-and-brain-activation-effects-of-n-ethyl-34-methylene 2026-04-16T10:14:47Z monthly 0.7 https://www.moreblossom.com/papers/endogenous-hallucinogens-as-ligands-of-the-trace-amine-receptors-a-possible-role 2026-04-16T10:14:49Z monthly 0.7 https://www.moreblossom.com/papers/endogenous-psychoactive-tryptamines-reconsidered-an-anxiolytic-role-for-dimethyl 2026-04-16T10:14:51Z monthly 0.7 https://www.moreblossom.com/papers/enhanced-meaning-in-life-following-psychedelic-use-converging-evidence-from-cont 2026-04-16T10:48:43Z monthly 0.7 https://www.moreblossom.com/papers/enhanced-visual-contrast-suppression-during-peak-psilocybin-effects-psychophysic 2026-05-12T17:52:51Z monthly 0.7 https://www.moreblossom.com/papers/enhancement-of-creative-expression-and-entoptic-phenomena-as-after-effects-of-re 2026-04-16T10:14:57Z monthly 0.7 https://www.moreblossom.com/papers/enhancing-mindfulness-and-compassion-through-an-ayahuasca-inspired-formulation-c 2026-04-27T12:06:49Z monthly 0.7 https://www.moreblossom.com/papers/ensuring-the-affordable-becomes-accessible-lessons-from-ketamine-a-new-treatment 2026-04-16T10:15:00Z monthly 0.7 https://www.moreblossom.com/papers/entactogen-effects-of-ketamine-a-reverse-translational-study 2026-04-27T12:11:07Z monthly 0.7 https://www.moreblossom.com/papers/entactogens-how-the-name-for-a-novel-class-of-psychoactive-agents-originated 2026-04-16T10:15:04Z monthly 0.7 https://www.moreblossom.com/papers/entheogenic-experience-and-spirituality 2026-04-16T10:15:06Z monthly 0.7 https://www.moreblossom.com/papers/epidemiology-of-classic-psychedelic-substances-results-from-a-norwegian-internet 2026-04-16T10:15:08Z monthly 0.7 https://www.moreblossom.com/papers/epidemiology-of-hospitalizations-with-hallucinogen-use-disorder-a-17-year-u-s-na 2026-04-16T10:15:09Z monthly 0.7 https://www.moreblossom.com/papers/equal-unblinding-meta-analysis-of-psychedelic-therapy-vs-antidepressants-for-the 2026-04-16T10:15:11Z monthly 0.7 https://www.moreblossom.com/papers/esketamine-combined-with-a-mindfulness-based-intervention-for-individuals-with-a 2026-05-19T09:31:39Z monthly 0.7 https://www.moreblossom.com/papers/esketamine-monotherapy-in-adults-with-treatment-resistant-depression-a-randomize 2026-05-13T14:27:41Z monthly 0.7 https://www.moreblossom.com/papers/esketamine-nasal-spray-for-major-depressive-disorder-with-acute-suicidal-ideatio 2026-04-16T10:15:16Z monthly 0.7 https://www.moreblossom.com/papers/esketamine-nasal-spray-for-rapid-reduction-of-depressive-symptoms-in-patients-wi 2026-05-19T09:31:40Z monthly 0.7 https://www.moreblossom.com/papers/esketamine-nasal-spray-for-rapid-reduction-of-major-depressive-disorder-symptoms 2026-05-19T09:31:40Z monthly 0.7 https://www.moreblossom.com/papers/esketamine-nasal-spray-for-the-rapid-reduction-of-depressive-symptoms-in-major-d 2026-04-16T10:15:23Z monthly 0.7 https://www.moreblossom.com/papers/esketamine-nasal-spray-versus-quetiapine-for-treatment-resistant-depression 2026-05-19T09:31:40Z monthly 0.7 https://www.moreblossom.com/papers/esketamine-nasal-spray-versus-quetiapine-xr-in-adults-with-treatment-resistant-d 2026-05-19T09:31:41Z monthly 0.7 https://www.moreblossom.com/papers/esketamine-nasal-spray-vs-quetiapine-extended-release-examining-work-productivit 2026-05-18T20:28:41Z monthly 0.7 https://www.moreblossom.com/papers/esketamine-treatment-for-depression-in-adults-a-prisma-systematic-review-and-met 2026-04-16T10:15:29Z monthly 0.7 https://www.moreblossom.com/papers/esketamine-vs-midazolam-in-boosting-the-efficacy-of-oral-antidepressants-for-maj 2026-05-11T18:40:01Z monthly 0.7 https://www.moreblossom.com/papers/ethical-and-legal-issues-in-psychedelic-harm-reduction-and-integration-therapy 2026-04-16T10:51:38Z monthly 0.7 https://www.moreblossom.com/papers/ethical-concerns-about-psilocybin-intellectual-property 2026-04-16T10:15:34Z monthly 0.7 https://www.moreblossom.com/papers/ethics-and-ego-dissolution-the-case-of-psilocybin 2026-04-16T10:15:36Z monthly 0.7 https://www.moreblossom.com/papers/evaluating-the-potential-use-of-serotonergic-psychedelics-in-autism-spectrum-dis 2026-04-16T10:15:39Z monthly 0.7 https://www.moreblossom.com/papers/evaluating-the-risk-of-psilocybin-for-the-treatment-of-bipolar-depression-a-syst 2026-04-16T10:15:41Z monthly 0.7 https://www.moreblossom.com/papers/evaluation-of-individual-items-of-the-patient-health-questionnaire-phq-9-and-mon 2026-05-11T18:34:06Z monthly 0.7 https://www.moreblossom.com/papers/evaluation-of-the-peak-experience-scale-as-a-rapid-assessment-tool-for-the-stren 2026-04-27T11:58:54Z monthly 0.7 https://www.moreblossom.com/papers/evenings-with-molly-adult-couples-use-of-mdma-for-relationship-enhancement 2026-04-16T10:51:41Z monthly 0.7 https://www.moreblossom.com/papers/evidence-for-altered-neural-activity-patterns-after-mdma-assisted-therapy-in-adu 2026-05-19T13:34:07Z monthly 0.7 https://www.moreblossom.com/papers/evidence-for-tolerance-in-psychedelic-microdosing-from-the-self-blinding-microdo 2026-04-16T10:15:50Z monthly 0.7 https://www.moreblossom.com/papers/evidence-of-health-and-safety-in-american-members-of-a-religion-who-use-a-halluc 2026-04-13T18:49:28Z monthly 0.7 https://www.moreblossom.com/papers/evolving-guidelines-for-the-use-of-touch-during-a-clinical-trial-of-group-psiloc 2026-04-27T11:57:06Z monthly 0.7 https://www.moreblossom.com/papers/examining-associations-between-mdma-ecstasy-and-classic-psychedelic-use-and-impa 2026-04-16T10:51:42Z monthly 0.7 https://www.moreblossom.com/papers/examining-changes-in-personality-following-shamanic-ceremonial-use-of-ayahuasca 2026-04-16T10:51:43Z monthly 0.7 https://www.moreblossom.com/papers/examining-mystical-experiences-as-a-predictor-of-psilocybin-assisted-psychothera 2026-05-19T09:31:41Z monthly 0.7 https://www.moreblossom.com/papers/examining-psychedelic-induced-changes-in-social-functioning-and-connectedness-in 2026-04-16T10:16:35Z monthly 0.7 https://www.moreblossom.com/papers/examining-the-pharmacokinetic-and-pharmacodynamic-interaction-of-nn-dimethyltryp 2026-04-27T12:11:24Z monthly 0.7 https://www.moreblossom.com/papers/examining-the-therapeutic-effect-of-ceremonial-ayahuasca-on-narcissistic-persona 2026-04-16T10:16:39Z monthly 0.7 https://www.moreblossom.com/papers/expectancy-effects-in-psychedelic-trials 2026-04-16T10:16:41Z monthly 0.7 https://www.moreblossom.com/papers/experience-of-music-used-with-psychedelic-therapy-a-rapid-review-and-implication 2026-04-16T10:16:42Z monthly 0.7 https://www.moreblossom.com/papers/experienced-drug-users-assess-the-relative-harms-and-benefits-of-drugs-a-web-bas 2026-04-16T10:16:44Z monthly 0.7 https://www.moreblossom.com/papers/experiences-of-awe-mediate-ketamines-antidepressant-effects-findings-from-a-rand 2026-05-19T13:38:15Z monthly 0.7 https://www.moreblossom.com/papers/experiences-of-encounters-with-ayahuasca-the-vine-of-the-soul 2026-04-16T10:16:47Z monthly 0.7 https://www.moreblossom.com/papers/experiences-of-microdosing-psychedelics-in-an-attempt-to-support-wellbeing-and-m 2026-04-16T10:51:45Z monthly 0.7 https://www.moreblossom.com/papers/experiences-of-psychedelic-drug-use-among-people-with-psychotic-symptoms-and-dis 2026-04-16T10:16:51Z monthly 0.7 https://www.moreblossom.com/papers/experimental-psychiatry-v-psilocybine-a-new-psychotogenic-drug 2026-04-16T10:16:53Z monthly 0.7 https://www.moreblossom.com/papers/expert-opinion-on-psychedelic-assisted-psychotherapy-for-people-with-psychopatho 2026-04-16T10:51:46Z monthly 0.7 https://www.moreblossom.com/papers/expert-opinion-on-psychedelic-assisted-psychotherapy-for-people-with-psychotic-s 2026-04-16T10:16:57Z monthly 0.7 https://www.moreblossom.com/papers/expert-opinions-on-implementation-of-mdma-assisted-therapy-in-europe-critical-ap 2026-04-16T10:16:58Z monthly 0.7 https://www.moreblossom.com/papers/exploratory-controlled-study-of-the-migraine-suppressing-effects-of-psilocybin 2026-05-12T21:58:16Z monthly 0.7 https://www.moreblossom.com/papers/exploratory-investigation-of-a-patient-informed-low-dose-psilocybin-pulse-regime 2026-05-12T20:56:16Z monthly 0.7 https://www.moreblossom.com/papers/exploratory-study-of-the-dose-related-safety-tolerability-and-efficacy-of-dimeth 2026-05-19T13:43:33Z monthly 0.7 https://www.moreblossom.com/papers/exploring-5-meo-dmt-as-a-pharmacological-model-for-deconstructed-consciousness 2026-04-16T10:17:02Z monthly 0.7 https://www.moreblossom.com/papers/exploring-ayahuasca-assisted-therapy-for-addiction-a-qualitative-analysis-of-pre 2026-04-16T10:17:03Z monthly 0.7 https://www.moreblossom.com/papers/exploring-mechanisms-of-psychedelic-action-using-neuroimaging 2026-04-16T10:51:49Z monthly 0.7 https://www.moreblossom.com/papers/exploring-protective-associations-between-the-use-of-classic-psychedelics-and-co 2026-04-16T10:51:50Z monthly 0.7 https://www.moreblossom.com/papers/exploring-psychedelic-assisted-therapy-in-the-treatment-of-functional-seizures-a 2026-04-16T10:17:09Z monthly 0.7 https://www.moreblossom.com/papers/exploring-the-credibility-of-psilocybin-assisted-therapy-and-cognitive-behaviora 2026-04-16T10:17:11Z monthly 0.7 https://www.moreblossom.com/papers/exploring-the-effect-of-microdosing-psychedelics-on-creativity-in-an-open-label- 2026-04-16T10:51:52Z monthly 0.7 https://www.moreblossom.com/papers/exploring-the-relationship-between-microdosing-personality-and-emotional-insight 2026-04-16T10:17:15Z monthly 0.7 https://www.moreblossom.com/papers/exploring-the-therapeutic-effects-of-psychedelics-administered-to-military-veter 2026-04-16T10:17:16Z monthly 0.7 https://www.moreblossom.com/papers/exploring-the-therapeutic-potential-of-ayahuasca-acute-intake-increases-mindfuln 2026-04-16T10:51:53Z monthly 0.7 https://www.moreblossom.com/papers/exploring-the-use-of-psilocybin-therapy-for-existential-distress-a-qualitative-s 2026-04-16T10:17:20Z monthly 0.7 https://www.moreblossom.com/papers/extended-difficulties-following-the-use-of-psychedelic-drugs-a-mixed-methods-stu 2026-04-16T10:17:23Z monthly 0.7 https://www.moreblossom.com/papers/facing-death-returning-to-life-a-qualitative-analysis-of-mdma-assisted-therapy-f 2026-05-11T17:05:14Z monthly 0.7 https://www.moreblossom.com/papers/factor-analysis-of-the-mystical-experience-questionnaire-a-study-of-experiences- 2026-04-16T10:17:37Z monthly 0.7 https://www.moreblossom.com/papers/factors-associated-with-antidepressant-effects-of-ketamine-a-reanalysis-of-doubl 2026-05-19T09:31:41Z monthly 0.7 https://www.moreblossom.com/papers/family-of-structurally-related-bioconjugates-yields-antibodies-with-differential 2026-04-16T10:17:40Z monthly 0.7 https://www.moreblossom.com/papers/features-of-dissociation-differentially-predict-antidepressant-response-to-ketam 2026-05-12T09:31:53Z monthly 0.7 https://www.moreblossom.com/papers/finding-the-self-by-losing-the-self-neural-correlates-of-ego-dissolution-under-p 2026-04-16T10:17:43Z monthly 0.7 https://www.moreblossom.com/papers/first-study-of-safety-and-tolerability-of-34-methylenedioxymethamphetamine-assis 2026-05-19T08:55:37Z monthly 0.7 https://www.moreblossom.com/papers/first-study-of-safety-and-tolerability-of-34-methylenedioxymethamphetamine-mdma- 2026-05-11T17:05:11Z monthly 0.7 https://www.moreblossom.com/papers/first-time-view-on-human-metabolome-changes-after-a-single-intake-of-34-methylen 2026-04-27T12:11:47Z monthly 0.7 https://www.moreblossom.com/papers/flashback-phenomena-after-administration-of-lsd-and-psilocybin-in-controlled-stu 2026-04-16T10:51:54Z monthly 0.7 https://www.moreblossom.com/papers/flashback-psychiatric-experimentation-with-lsd-in-historical-perspective 2026-04-16T10:17:50Z monthly 0.7 https://www.moreblossom.com/papers/flashbacks-and-hppd-a-clinical-oriented-concise-review 2026-04-16T10:51:56Z monthly 0.7 https://www.moreblossom.com/papers/focusing-on-the-negative-cases-of-long-term-negative-psychological-responses-to- 2026-04-16T10:51:57Z monthly 0.7 https://www.moreblossom.com/papers/four-weekly-ayahuasca-sessions-lead-to-increases-in-acceptance-capacities-a-comp 2026-04-16T10:17:57Z monthly 0.7 https://www.moreblossom.com/papers/frequency-analysis-of-symptomatic-worsening-following-ketamine-infusions-for-tre 2026-04-16T10:17:59Z monthly 0.7 https://www.moreblossom.com/papers/from-egoism-to-ecoism-psychedelics-increase-nature-relatedness-in-a-state-mediat 2026-04-16T10:18:00Z monthly 0.7 https://www.moreblossom.com/papers/from-hallucinations-to-synaesthesia-a-circular-inference-account-of-unimodal-and 2026-04-16T10:18:02Z monthly 0.7 https://www.moreblossom.com/papers/from-hofmann-to-the-haight-ashbury-and-into-the-future-the-past-and-potential-of 2026-04-16T10:18:04Z monthly 0.7 https://www.moreblossom.com/papers/from-psychiatry-to-neurology-psychedelics-as-prospective-therapeutics-for-neurod 2026-04-16T10:18:06Z monthly 0.7 https://www.moreblossom.com/papers/from-relaxed-beliefs-under-psychedelics-rebus-to-revised-beliefs-after-psychedel 2026-04-16T10:51:58Z monthly 0.7 https://www.moreblossom.com/papers/fully-validated-multi-kilogram-cgmp-synthesis-of-mdma 2026-04-16T10:18:10Z monthly 0.7 https://www.moreblossom.com/papers/functional-changes-in-sleep-related-arousal-after-ketamine-administration-in-ind 2026-05-19T13:46:16Z monthly 0.7 https://www.moreblossom.com/papers/functional-connectivity-measures-after-psilocybin-inform-a-novel-hypothesis-of-e 2026-04-16T10:18:13Z monthly 0.7 https://www.moreblossom.com/papers/functional-connectivity-of-the-amygdala-and-the-antidepressant-and-antisuicidal- 2026-05-19T10:29:41Z monthly 0.7 https://www.moreblossom.com/papers/functional-imaging-studies-of-acute-administration-of-classic-psychedelics-ketam 2026-04-16T10:18:18Z monthly 0.7 https://www.moreblossom.com/papers/functional-selectivity-of-hallucinogenic-phenethylamine-and-phenylisopropylamine 2026-03-24T19:00:47Z monthly 0.7 https://www.moreblossom.com/papers/future-directions-for-clinical-psilocybin-research-the-relaxed-symptom-network 2026-04-16T10:18:20Z monthly 0.7 https://www.moreblossom.com/papers/gaddum-and-lsd-the-birth-and-growth-of-experimental-and-clinical-neuropharmacolo 2026-04-16T10:18:22Z monthly 0.7 https://www.moreblossom.com/papers/gas-chromatographic-analysis-of-dimethyltryptamine-and-beta-carboline-alkaloids- 2026-04-16T10:18:23Z monthly 0.7 https://www.moreblossom.com/papers/gender-differences-in-the-subjective-effects-of-mdma 2026-05-12T10:36:09Z monthly 0.7 https://www.moreblossom.com/papers/genetic-influence-of-cyp2d6-on-pharmacokinetics-and-acute-subjective-effects-of- 2026-04-16T10:52:02Z monthly 0.7 https://www.moreblossom.com/papers/genie-in-a-blotter-a-comparative-study-of-lsd-and-lsd-analogues-effects-and-user 2026-04-16T10:18:29Z monthly 0.7 https://www.moreblossom.com/papers/genuine-and-drug-induced-synesthesia-a-comparison 2026-04-16T10:18:32Z monthly 0.7 https://www.moreblossom.com/papers/getting-in-touch-with-touch-the-importance-of-studying-touch-in-mdma-assisted-th 2026-04-16T10:18:33Z monthly 0.7 https://www.moreblossom.com/papers/global-trends-in-psychedelic-microdosing-demographics-substance-testing-behavior 2026-04-16T10:18:35Z monthly 0.7 https://www.moreblossom.com/papers/glutamate-and-gamma-aminobutyric-acid-systems-in-the-pathophysiology-of-major-de 2026-04-16T10:18:37Z monthly 0.7 https://www.moreblossom.com/papers/glutamate-and-the-neural-basis-of-the-subjective-effects-of-ketamine-a-pharmaco- 2026-04-16T10:18:39Z monthly 0.7 https://www.moreblossom.com/papers/glutamatergic-model-psychoses-prediction-error-learning-and-inference 2026-04-16T10:52:03Z monthly 0.7 https://www.moreblossom.com/papers/great-expectations-recommendations-for-improving-the-methodological-rigor-of-psy 2026-04-16T10:18:43Z monthly 0.7 https://www.moreblossom.com/papers/greater-empathy-in-mdma-users 2026-04-16T10:18:44Z monthly 0.7 https://www.moreblossom.com/papers/greater-subjective-effects-of-a-low-dose-of-lsd-in-participants-with-depressed-m 2026-04-16T10:52:05Z monthly 0.7 https://www.moreblossom.com/papers/group-format-psychedelic-assisted-therapy-interventions-observations-and-impress 2026-05-19T15:39:28Z monthly 0.7 https://www.moreblossom.com/papers/group-psychedelic-therapy-empirical-estimates-of-cost-savings-and-improved-acces 2026-04-16T10:18:49Z monthly 0.7 https://www.moreblossom.com/papers/group-vr-experiences-can-produce-ego-attenuation-and-connectedness-comparable-to 2026-04-16T10:52:06Z monthly 0.7 https://www.moreblossom.com/papers/hallucinations-under-psychedelics-and-in-the-schizophrenia-spectrum-an-interdisc 2026-04-16T10:18:52Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogen-persisting-perception-disorder-after-ibogaine-treatment-for-opioid- 2026-04-16T10:18:54Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogen-persisting-perception-disorder-and-the-serotonergic-system-a-compre 2026-04-16T10:18:56Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogen-persisting-perception-disorder-etiology-clinical-features-and-thera 2026-04-16T10:18:58Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogen-persisting-perception-disorder-what-do-we-know-after-50-years 2026-04-16T10:19:00Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogen-persisting-perceptual-disorder-a-scoping-review-covering-frequency- 2026-04-16T10:19:01Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogen-use-among-young-adults-ages-19-30-in-the-united-states-changes-from 2026-04-16T10:19:03Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogen-use-and-intimate-partner-violence-prospective-evidence-consistent-w 2026-04-16T10:19:04Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogen-use-predicts-reduced-recidivism-among-substance-involved-offenders- 2026-04-16T10:19:06Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogenic-drugs-and-their-potential-for-treating-fear-related-disorders-thr 2026-04-16T10:19:07Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogenic-drugs-in-psychiatric-research-and-treatment-perspectives-and-pros 2026-04-16T10:19:10Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogenic-persisting-perception-disorder-a-case-series-and-review-of-the-li 2026-04-16T10:19:14Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogenic-psychedelic-5ht2a-receptor-agonists-as-rapid-antidepressant-thera 2026-04-16T10:19:15Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogens 2026-04-16T10:19:17Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogens-and-serotonin-5-ht2a-receptor-mediated-signaling-pathways 2026-04-16T10:52:07Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogens-as-discriminative-stimuli-in-animals-lsd-phenethylamines-and-trypt 2026-04-16T10:52:09Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogens-in-mental-health-preclinical-and-clinical-studies-on-lsd-psilocybi 2026-04-16T10:19:27Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogens-recruit-specific-cortical-5-ht2a-receptor-mediated-signaling-pathw 2026-04-16T10:19:29Z monthly 0.7 https://www.moreblossom.com/papers/hallucinogens-serotonin-and-obsessive-compulsive-disorder 2026-04-16T10:19:31Z monthly 0.7 https://www.moreblossom.com/papers/haoma-soma-in-the-world-of-ancient-greece 2026-04-16T10:19:32Z monthly 0.7 https://www.moreblossom.com/papers/harm-potential-of-magic-mushroom-use-a-review 2026-04-16T10:19:34Z monthly 0.7 https://www.moreblossom.com/papers/harmine-produces-antidepressant-like-effects-via-restoration-of-astrocytic-funct 2026-04-16T10:19:36Z monthly 0.7 https://www.moreblossom.com/papers/harmine-stimulates-proliferation-of-human-neural-progenitors 2026-04-16T10:19:39Z monthly 0.7 https://www.moreblossom.com/papers/harmines-inhibit-cancer-cell-growth-through-coordinated-activation-of-apoptosis- 2026-04-16T10:19:40Z monthly 0.7 https://www.moreblossom.com/papers/harmonic-decomposition-of-spacetime-hades-framework-characterises-the-spacetime- 2026-04-16T10:19:42Z monthly 0.7 https://www.moreblossom.com/papers/harnessing-placebo-lessons-from-psychedelic-science 2026-04-16T10:19:44Z monthly 0.7 https://www.moreblossom.com/papers/harnessing-psilocybin-antidepressant-like-behavioral-and-synaptic-actions-of-psi 2026-04-16T10:19:45Z monthly 0.7 https://www.moreblossom.com/papers/health-care-resource-use-and-medical-costs-among-patients-with-major-depressive- 2026-04-16T10:19:47Z monthly 0.7 https://www.moreblossom.com/papers/health-care-workers-attitudes-toward-and-knowledge-of-the-clinical-application-o 2026-04-16T10:52:10Z monthly 0.7 https://www.moreblossom.com/papers/health-related-behavioral-changes-following-the-use-of-psychedelics-in-naturalis 2026-04-16T10:19:51Z monthly 0.7 https://www.moreblossom.com/papers/health-status-of-ayahuasca-users 2026-04-16T10:19:53Z monthly 0.7 https://www.moreblossom.com/papers/heaven-and-hell-a-phenomenological-study-of-recreational-use-of-4-ho-met-in-swed 2026-04-16T10:19:54Z monthly 0.7 https://www.moreblossom.com/papers/hemorheological-and-metabolic-consequences-of-renal-ischemia-reperfusion-and-the 2026-04-16T10:19:56Z monthly 0.7 https://www.moreblossom.com/papers/high-dose-ketamine-infusion-for-the-treatment-of-posttraumatic-stress-disorder-i 2026-05-19T10:29:42Z monthly 0.7 https://www.moreblossom.com/papers/high-dose-psilocybin-is-associated-with-positive-subjective-effects-in-healthy-v 2026-04-16T10:19:59Z monthly 0.7 https://www.moreblossom.com/papers/historic-psychedelic-drug-trials-and-the-treatment-of-anxiety-disorders 2026-04-16T10:20:01Z monthly 0.7 https://www.moreblossom.com/papers/history-and-future-of-the-multidisciplinary-association-for-psychedelic-studies- 2026-04-16T10:20:03Z monthly 0.7 https://www.moreblossom.com/papers/history-repeating-guidelines-to-address-common-problems-in-psychedelic-science 2026-04-16T10:20:04Z monthly 0.7 https://www.moreblossom.com/papers/hitting-highs-at-rock-bottom-lsd-treatment-for-alcoholism-1950-1970 2026-04-16T10:20:06Z monthly 0.7 https://www.moreblossom.com/papers/hofmann-vs-paracelsus-do-psychedelics-defy-the-basics-of-toxicology-a-systematic 2026-04-16T10:20:07Z monthly 0.7 https://www.moreblossom.com/papers/holding-on-or-letting-go-patient-experiences-of-control-context-and-care-in-oral 2026-04-16T10:20:10Z monthly 0.7 https://www.moreblossom.com/papers/hope-a-pilot-study-of-psilocybin-enhanced-group-psychotherapy-in-patients-with-c 2026-05-19T12:44:04Z monthly 0.7 https://www.moreblossom.com/papers/hopelessness-suicidality-and-co-occurring-substance-use-among-adolescent-halluci 2026-04-16T10:20:12Z monthly 0.7 https://www.moreblossom.com/papers/how-could-mdma-ecstasy-help-anxiety-disorders-a-neurobiological-rationale 2026-04-16T10:20:14Z monthly 0.7 https://www.moreblossom.com/papers/how-do-i-learn-more-about-this-utilization-and-trust-of-psychedelic-information- 2026-04-16T10:20:15Z monthly 0.7 https://www.moreblossom.com/papers/how-do-psychedelics-reduce-fear-of-death 2026-04-16T10:52:11Z monthly 0.7 https://www.moreblossom.com/papers/how-do-psychedelics-work 2026-04-16T10:20:19Z monthly 0.7 https://www.moreblossom.com/papers/how-does-psilocybin-therapy-work-an-exploration-of-experiential-avoidance-as-a-p 2026-05-19T10:29:42Z monthly 0.7 https://www.moreblossom.com/papers/how-low-doses-of-psychedelics-compliment-high-dose-experiences-observational-evi 2026-04-13T18:51:17Z monthly 0.7 https://www.moreblossom.com/papers/how-mdmas-pharmacology-and-pharmacokinetics-drive-desired-effects-and-harms 2026-04-16T10:20:22Z monthly 0.7 https://www.moreblossom.com/papers/how-psychedelic-assisted-treatment-works-in-the-bayesian-brain 2026-04-16T10:20:25Z monthly 0.7 https://www.moreblossom.com/papers/how-psychedelic-researchers-self-admitted-substance-use-and-their-association-wi 2026-04-16T10:20:27Z monthly 0.7 https://www.moreblossom.com/papers/how-religion-race-and-the-weedy-agency-of-plants-shape-amazonian-home-gardens 2026-04-16T10:20:28Z monthly 0.7 https://www.moreblossom.com/papers/how-toxic-is-ibogaine 2026-04-16T10:20:30Z monthly 0.7 https://www.moreblossom.com/papers/human-behavioral-pharmacology-of-psychedelics 2026-04-16T10:20:32Z monthly 0.7 https://www.moreblossom.com/papers/human-brain-changes-after-first-psilocybin-use 2026-05-06T13:15:47Z monthly 0.7 https://www.moreblossom.com/papers/human-brain-effects-of-dmt-assessed-via-eeg-fmri 2026-04-16T10:20:35Z monthly 0.7 https://www.moreblossom.com/papers/human-cortical-serotonin-2a-receptor-occupancy-by-psilocybin-measured-using-11cm 2026-04-16T10:20:40Z monthly 0.7 https://www.moreblossom.com/papers/human-hallucinogen-research-guidelines-for-safety 2026-04-16T10:20:41Z monthly 0.7 https://www.moreblossom.com/papers/human-pharmacology-of-ayahuasca-subjective-and-cardiovascular-effects-monoamine- 2026-04-16T10:20:43Z monthly 0.7 https://www.moreblossom.com/papers/human-pharmacology-of-mephedrone-in-comparison-with-mdma 2026-04-16T10:52:13Z monthly 0.7 https://www.moreblossom.com/papers/human-psychopharmacology-and-dose-effects-of-salvinorin-a-a-kappa-opioid-agonist 2026-04-16T10:20:47Z monthly 0.7 https://www.moreblossom.com/papers/hype-or-hope-high-placebo-response-in-major-depression-treatment-with-ketamine-a 2026-04-16T10:20:52Z monthly 0.7 https://www.moreblossom.com/papers/hypotheses-regarding-the-mechanisms-of-ayahuasca-in-the-treatment-of-addictions 2026-04-16T10:20:53Z monthly 0.7 https://www.moreblossom.com/papers/ibogaine-a-legacy-within-the-current-renaissance-of-psychedelic-therapy 2026-04-16T10:20:55Z monthly 0.7 https://www.moreblossom.com/papers/ibogaine-a-review 2026-04-16T10:20:57Z monthly 0.7 https://www.moreblossom.com/papers/ibogaine-acute-administration-in-rats-promotes-wakefulness-long-lasting-rem-slee 2026-05-05T13:31:07Z monthly 0.7 https://www.moreblossom.com/papers/ibogaine-administration-modifies-gdnf-and-bdnf-expression-in-brain-regions-invol 2026-04-16T10:21:06Z monthly 0.7 https://www.moreblossom.com/papers/ibogaine-blocks-cue-and-drug-induced-reinstatement-of-conditioned-place-preferen 2026-04-16T10:21:08Z monthly 0.7 https://www.moreblossom.com/papers/ibogaine-detoxification-transitions-opioid-and-cocaine-abusers-between-dependenc 2026-04-16T10:21:11Z monthly 0.7 https://www.moreblossom.com/papers/ibogaine-for-treating-drug-dependence-what-is-a-safe-dose 2026-04-16T10:21:13Z monthly 0.7 https://www.moreblossom.com/papers/ibogaine-in-the-treatment-of-substance-dependence 2026-04-16T10:21:14Z monthly 0.7 https://www.moreblossom.com/papers/ibogaine-treatment-outcomes-for-opioid-dependence-from-a-twelve-month-follow-up- 2026-04-16T10:21:16Z monthly 0.7 https://www.moreblossom.com/papers/identification-of-5-ht-2a-receptor-signaling-pathways-responsible-for-psychedeli 2026-04-16T10:21:18Z monthly 0.7 https://www.moreblossom.com/papers/identification-of-an-optimal-dose-of-intravenous-ketamine-for-late-life-treatmen 2026-05-19T09:31:42Z monthly 0.7 https://www.moreblossom.com/papers/immunological-effects-of-ayahuasca-in-humans 2026-04-16T10:21:22Z monthly 0.7 https://www.moreblossom.com/papers/impact-analysis-of-expanded-access-to-ketamine-for-treatment-resistant-depressio 2026-04-16T10:21:24Z monthly 0.7 https://www.moreblossom.com/papers/impact-of-a-naturalistic-psychedelic-experience-on-smoking-a-retrospective-surve 2026-04-16T10:21:25Z monthly 0.7 https://www.moreblossom.com/papers/implementing-psychedelic-assisted-therapy-history-and-characteristics-of-the-swi 2026-04-16T10:21:27Z monthly 0.7 https://www.moreblossom.com/papers/implications-for-psychedelic-assisted-psychotherapy-functional-magnetic-resonanc 2026-04-16T10:21:29Z monthly 0.7 https://www.moreblossom.com/papers/improved-colour-blindness-symptoms-associated-with-recreational-psychedelic-use- 2026-04-16T10:21:31Z monthly 0.7 https://www.moreblossom.com/papers/improved-mental-health-outcomes-and-normalised-spontaneous-eeg-activity-in-veter 2026-04-16T10:21:33Z monthly 0.7 https://www.moreblossom.com/papers/improvement-in-ocd-symptoms-associated-with-serotoninergic-psychedelics-a-retros 2026-04-16T10:52:16Z monthly 0.7 https://www.moreblossom.com/papers/improvement-in-suicidal-ideation-after-ketamine-infusion-relationship-to-reducti 2026-04-16T10:21:37Z monthly 0.7 https://www.moreblossom.com/papers/improvement-of-functional-neurological-disorder-after-administration-of-esketami 2026-04-16T10:21:38Z monthly 0.7 https://www.moreblossom.com/papers/improvements-in-well-being-following-naturalistic-psychedelic-use-and-underlying 2026-03-25T05:02:31Z monthly 0.7 https://www.moreblossom.com/papers/improving-cognitive-functioning-in-major-depressive-disorder-with-psychedelics-a 2026-04-16T10:21:40Z monthly 0.7 https://www.moreblossom.com/papers/in-vivo-effects-of-34-methylenedioxymethamphetamine-mdma-and-its-deuterated-form 2026-04-16T10:21:42Z monthly 0.7 https://www.moreblossom.com/papers/in-vivo-effects-of-ketamine-on-glutamate-glutamine-and-gamma-aminobutyric-acid-i 2026-05-19T10:29:42Z monthly 0.7 https://www.moreblossom.com/papers/in-vivo-imaging-of-cerebral-serotonin-transporter-and-serotonin-2a-receptor-bind 2026-04-16T10:21:46Z monthly 0.7 https://www.moreblossom.com/papers/in-vivo-production-of-psilocybin-in-e-coli 2026-04-16T10:21:48Z monthly 0.7 https://www.moreblossom.com/papers/incilius-alvarius-cell-based-synthesis-of-5-meo-dmt 2026-04-16T10:21:49Z monthly 0.7 https://www.moreblossom.com/papers/increased-activation-of-indirect-semantic-associations-under-psilocybin 2026-04-16T10:21:51Z monthly 0.7 https://www.moreblossom.com/papers/increased-amygdala-responses-to-emotional-faces-after-psilocybin-for-treatment-r 2026-05-19T09:31:42Z monthly 0.7 https://www.moreblossom.com/papers/increased-entropic-brain-dynamics-during-deepdream-induced-altered-perceptual-ph 2026-04-16T10:21:55Z monthly 0.7 https://www.moreblossom.com/papers/increased-global-functional-connectivity-correlates-with-lsd-induced-ego-dissolu 2026-04-16T10:21:57Z monthly 0.7 https://www.moreblossom.com/papers/increased-global-integration-in-the-brain-after-psilocybin-therapy-for-depressio 2026-05-12T23:52:33Z monthly 0.7 https://www.moreblossom.com/papers/increased-low-frequency-brain-responses-to-music-after-psilocybin-therapy-for-de 2026-05-11T17:06:17Z monthly 0.7 https://www.moreblossom.com/papers/increased-nature-relatedness-and-decreased-authoritarian-political-views-after-p 2026-05-13T04:59:00Z monthly 0.7 https://www.moreblossom.com/papers/increased-oxytocin-concentrations-and-prosocial-feelings-in-humans-after-ecstasy 2026-04-16T10:22:05Z monthly 0.7 https://www.moreblossom.com/papers/increased-sensitivity-to-strong-perturbations-in-a-whole-brain-model-of-lsd 2026-04-16T10:22:07Z monthly 0.7 https://www.moreblossom.com/papers/increased-spontaneous-meg-signal-diversity-for-psychoactive-doses-of-ketamine-ls 2026-04-16T10:52:19Z monthly 0.7 https://www.moreblossom.com/papers/increased-thalamic-resting-state-connectivity-as-a-core-driver-of-lsd-induced-ha 2026-04-16T10:22:11Z monthly 0.7 https://www.moreblossom.com/papers/increased-use-of-illicit-drugs-in-a-dutch-cluster-headache-population 2026-04-16T10:22:12Z monthly 0.7 https://www.moreblossom.com/papers/increases-in-aesthetic-experience-following-ayahuasca-use-an-open-label-naturali 2026-04-16T10:22:14Z monthly 0.7 https://www.moreblossom.com/papers/increases-in-psychological-flexibility-mediate-relationship-between-acute-psyche 2026-04-16T10:22:16Z monthly 0.7 https://www.moreblossom.com/papers/indigenous-voices-in-psychedelic-therapy-experiential-learnings-from-a-community 2026-05-11T17:08:48Z monthly 0.7 https://www.moreblossom.com/papers/individual-experiences-in-four-cancer-patients-following-psilocybin-assisted-psy 2026-05-11T17:06:07Z monthly 0.7 https://www.moreblossom.com/papers/indole-alkaloids-from-plants-as-potential-leads-for-antidepressant-drugs-a-mini- 2026-04-16T10:22:23Z monthly 0.7 https://www.moreblossom.com/papers/indoleamine-hallucinogens-in-cluster-headache-results-of-the-clusterbusters-medi 2026-04-16T10:22:24Z monthly 0.7 https://www.moreblossom.com/papers/influence-of-context-and-setting-on-the-mental-health-and-wellbeing-outcomes-of- 2026-04-16T10:22:28Z monthly 0.7 https://www.moreblossom.com/papers/influence-of-cyp2d6-activity-on-the-pharmacokinetics-and-pharmacodynamics-of-a-s 2026-04-16T10:22:29Z monthly 0.7 https://www.moreblossom.com/papers/influence-of-environmental-factors-and-cultural-methods-on-the-content-of-nndmt 2026-04-16T10:22:33Z monthly 0.7 https://www.moreblossom.com/papers/influence-of-lysergic-acid-diethylamide-lsd-25-on-subjective-time 2026-04-05T19:15:13Z monthly 0.7 https://www.moreblossom.com/papers/information-parity-increases-on-functional-brain-networks-under-influence-of-a-p 2026-04-13T18:39:53Z monthly 0.7 https://www.moreblossom.com/papers/inhibition-of-alpha-oscillations-through-serotonin-2a-receptor-activation-underl 2026-04-16T10:22:35Z monthly 0.7 https://www.moreblossom.com/papers/inhibition-of-serotonin-transporters-disrupts-the-enhancement-of-fear-memory-ext 2026-04-05T19:15:15Z monthly 0.7 https://www.moreblossom.com/papers/inhibitory-effects-of-ibogaine-on-cocaine-self-administration-in-rats 2026-04-05T19:15:16Z monthly 0.7 https://www.moreblossom.com/papers/insights-for-the-use-of-ketamine-from-randomized-controlled-trials-that-compared 2026-03-24T15:07:24Z monthly 0.7 https://www.moreblossom.com/papers/insights-on-psychedelics-a-systematic-review-of-therapeutic-effects 2026-04-16T10:52:21Z monthly 0.7 https://www.moreblossom.com/papers/integrating-psychedelic-medicines-and-psychiatry-theory-and-methods-of-a-model-c 2026-03-25T06:14:18Z monthly 0.7 https://www.moreblossom.com/papers/integrating-psychotherapy-and-psychopharmacology-psychedelic-assisted-psychother 2026-04-05T19:15:19Z monthly 0.7 https://www.moreblossom.com/papers/integration-in-psychedelic-assisted-treatments-recurring-themes-in-current-provi 2026-04-16T10:22:36Z monthly 0.7 https://www.moreblossom.com/papers/intensity-of-mystical-experiences-occasioned-by-5-meo-dmt-and-comparison-with-a- 2026-04-16T10:22:38Z monthly 0.7 https://www.moreblossom.com/papers/inter-individual-variability-in-neural-response-to-low-doses-of-lsd 2026-04-16T10:52:22Z monthly 0.7 https://www.moreblossom.com/papers/interaction-of-psychoactive-tryptamines-with-biogenic-amine-transporters-and-ser 2026-05-05T13:31:08Z monthly 0.7 https://www.moreblossom.com/papers/interaction-of-sex-and-age-on-the-dissociative-effects-of-ketamine-action-in-you 2026-04-16T10:22:45Z monthly 0.7 https://www.moreblossom.com/papers/interactions-between-classic-psychedelics-and-serotonergic-antidepressants-effec 2026-04-16T10:22:47Z monthly 0.7 https://www.moreblossom.com/papers/interactions-of-hallucinogens-with-the-glutamatergic-system-permissive-network-e 2026-03-24T15:07:36Z monthly 0.7 https://www.moreblossom.com/papers/interactive-effects-of-ayahuasca-and-cannabidiol-in-social-cognition-in-healthy- 2026-04-16T10:22:49Z monthly 0.7 https://www.moreblossom.com/papers/interest-in-receiving-psychedelic-assisted-therapy-among-marginalized-women-impl 2026-04-16T10:22:51Z monthly 0.7 https://www.moreblossom.com/papers/international-pooled-patient-level-meta-analysis-of-ketamine-infusion-for-depres 2026-05-05T15:01:00Z monthly 0.7 https://www.moreblossom.com/papers/interrupting-the-psychedelic-experience-through-contextual-manipulation-to-study 2026-04-13T18:59:17Z monthly 0.7 https://www.moreblossom.com/papers/intimate-insight-mdma-changes-how-people-talk-about-significant-others 2026-04-16T10:22:53Z monthly 0.7 https://www.moreblossom.com/papers/intranasal-drug-delivery-in-neuropsychiatry-focus-on-intranasal-ketamine-for-ref 2026-03-24T15:07:42Z monthly 0.7 https://www.moreblossom.com/papers/intranasal-esketamine-effectively-treats-treatment-resistant-depression-in-adult 2026-04-27T12:10:14Z monthly 0.7 https://www.moreblossom.com/papers/intranasal-ketamine-and-cognitive-behavioral-therapy-for-treatment-refractory-ob 2026-04-13T18:55:59Z monthly 0.7 https://www.moreblossom.com/papers/intranasal-ketamine-for-acute-cluster-headache-attacks-results-from-a-proof-of-c 2026-05-12T09:55:23Z monthly 0.7 https://www.moreblossom.com/papers/intranasal-ketamine-for-depression-in-adults-a-systematic-review-and-meta-analys 2026-04-05T19:15:31Z monthly 0.7 https://www.moreblossom.com/papers/intravenous-arketamine-for-treatment-resistant-depression-open-label-pilot-study 2026-05-19T09:31:42Z monthly 0.7 https://www.moreblossom.com/papers/intravenous-ketamine-for-adolescents-with-treatment-resistant-depression-an-open 2026-05-12T11:33:29Z monthly 0.7 https://www.moreblossom.com/papers/intravenous-ketamine-for-late-life-treatment-resistant-depression-a-pilot-study- 2026-05-19T13:58:20Z monthly 0.7 https://www.moreblossom.com/papers/investigating-emotional-reactivity-in-experienced-users-of-psychedelics-a-cross- 2026-04-13T10:00:58Z monthly 0.7 https://www.moreblossom.com/papers/investigating-the-mechanisms-of-hallucinogen-induced-visions-using-34-methylened 2026-04-16T10:23:01Z monthly 0.7 https://www.moreblossom.com/papers/investigating-the-relationship-between-changes-in-metaphysical-beliefs-and-death 2026-04-16T10:23:02Z monthly 0.7 https://www.moreblossom.com/papers/investigating-the-safety-and-tolerability-of-single-dose-psilocybin-for-post-tra 2026-05-18T20:31:27Z monthly 0.7 https://www.moreblossom.com/papers/investigation-of-medical-effect-of-multiple-ketamine-infusions-on-patients-with- 2026-05-12T11:48:55Z monthly 0.7 https://www.moreblossom.com/papers/investigation-of-self-treatment-with-lysergic-acid-diethylamide-and-psilocybin-m 2026-04-16T10:23:05Z monthly 0.7 https://www.moreblossom.com/papers/investigation-of-serotonin-1a-receptor-function-in-the-human-psychopharmacology- 2026-04-16T10:23:07Z monthly 0.7 https://www.moreblossom.com/papers/investigation-of-the-structure-activity-relationships-of-psilocybin-analogues 2026-03-25T05:55:49Z monthly 0.7 https://www.moreblossom.com/papers/is-ecstasy-an-empathogen-effects-of-34-methylenedioxymethamphetamine-on-prosocia 2026-04-16T10:23:09Z monthly 0.7 https://www.moreblossom.com/papers/is-it-time-to-revisit-the-role-of-psychedelic-drugs-in-enhancing-human-creativit 2026-03-24T15:08:00Z monthly 0.7 https://www.moreblossom.com/papers/is-ketamine-an-appropriate-alternative-to-ect-for-patients-with-treatment-resist 2026-04-05T19:15:41Z monthly 0.7 https://www.moreblossom.com/papers/is-lsd-toxic 2026-03-30T09:03:20Z monthly 0.7 https://www.moreblossom.com/papers/is-microdosing-a-placebo 2026-03-25T05:52:28Z monthly 0.7 https://www.moreblossom.com/papers/is-psychedelic-use-associated-with-cancer-interrogating-a-half-century-old-claim 2026-04-16T10:23:10Z monthly 0.7 https://www.moreblossom.com/papers/isness-using-multi-person-vr-to-design-peak-mystical-type-experiences-comparable 2026-04-16T10:23:12Z monthly 0.7 https://www.moreblossom.com/papers/iv-low-dose-ketamine-infusions-for-treatment-resistant-depression-results-from-a 2026-04-16T10:52:28Z monthly 0.7 https://www.moreblossom.com/papers/jekyll-and-hyde-revisited-paradoxes-in-the-appreciation-of-drug-experiences-and- 2026-04-16T10:23:14Z monthly 0.7 https://www.moreblossom.com/papers/journeying-to-ixtlan-ethics-of-psychedelic-medicine-and-research-for-alzheimers- 2026-03-24T15:08:06Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-a-paradigm-shift-for-depression-research-and-treatment 2026-03-30T09:03:20Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-a-tale-of-two-enantiomers 2026-03-30T09:03:20Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-abuse-potential-and-use-disorder 2026-03-24T15:08:12Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-accelerates-fear-extinction-via-mtorc1-signaling 2026-04-16T10:23:15Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-administration-in-depressive-disorders-a-systematic-review-and-meta-ana 2026-04-05T19:15:44Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-and-attentional-bias-toward-emotional-faces-dynamic-causal-modeling-of- 2026-05-19T10:29:43Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-and-other-n-methyl-d-aspartate-receptor-antagonists-in-the-treatment-of 2026-03-25T05:50:18Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-and-other-nmda-antagonists-early-clinical-trials-and-possible-mechanism 2026-04-05T19:15:46Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-and-other-potential-glutamate-antidepressants 2026-03-24T15:08:17Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-and-rapid-acting-antidepressants-a-window-into-a-new-neurobiology-for-m 2026-03-30T09:03:20Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-and-serotonergic-psychedelics-common-mechanisms-underlying-the-effects- 2026-04-05T19:15:48Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-anesthesia-enhances-fear-memory-consolidation-via-noradrenergic-activat 2026-04-16T10:23:20Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-as-a-novel-psychopharmacotherapy-for-eating-disorders-evidence-and-futu 2026-03-24T15:08:23Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-as-a-promising-prototype-for-a-new-generation-of-rapid-acting-antidepre 2026-03-30T09:03:20Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-as-a-treatment-for-anorexia-nervosa-a-narrative-review 2026-03-24T15:08:23Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-as-add-on-treatment-in-psychotic-treatment-resistant-depression 2026-04-13T18:50:38Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-as-an-adjunctive-therapy-for-major-depression-a-randomised-controlled-p 2026-05-19T09:31:43Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-as-the-prototype-glutamatergic-antidepressant-pharmacodynamic-actions-a 2026-03-24T15:08:23Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-as-treatment-for-post-traumatic-stress-disorder-a-review 2026-03-24T15:08:23Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-assisted-psychotherapy-for-ptsd-related-to-racial-discrimination 2026-04-13T18:50:39Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-assisted-psychotherapy-treatment-of-chronic-pain-and-comorbid-depressio 2026-05-12T10:57:05Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-associated-brain-changes-a-review-of-the-neuroimaging-literature 2026-03-24T15:08:53Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-blocks-bursting-in-the-lateral-habenula-to-rapidly-relieve-depression 2026-04-16T10:52:29Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-effects-on-eeg-during-therapy-of-treatment-resistant-generalized-anxiet 2026-05-19T09:31:43Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-for-bipolar-depression-a-systematic-review 2026-04-05T19:15:53Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-for-depression-4-in-what-dose-at-what-rate-by-what-route-for-how-long-a 2026-04-05T19:15:54Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-for-post-traumatic-stress-disorders-and-its-possible-therapeutic-mechan 2026-03-24T15:08:12Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-for-rapid-reduction-of-suicidal-thoughts-in-major-depression-a-midazola 2026-05-19T09:31:43Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-for-refractory-chronic-migraine-an-observational-pilot-study-and-metabo 2026-05-12T14:49:20Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-for-social-anxiety-disorder-a-randomized-placebo-controlled-crossover-t 2026-05-12T08:07:45Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-for-suicidality-an-umbrella-review 2026-03-24T15:08:36Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-for-the-treatment-of-addiction-evidence-and-potential-mechanisms 2026-03-25T05:30:10Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-for-the-treatment-of-major-depression-a-systematic-review-and-meta-anal 2026-04-05T19:15:58Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-for-the-treatment-of-major-depressive-disorder-and-bipolar-depression-a 2026-04-05T19:16:00Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-for-treatment-resistant-depression-recent-developments-and-clinical-app 2026-04-16T10:52:32Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-for-treatment-resistant-obsessive-compulsive-disorder-double-blind-acti 2026-05-19T09:31:43Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-for-treatment-resistant-unipolar-and-bipolar-major-depression-critical- 2026-03-25T05:45:22Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-has-distinct-electrophysiological-and-behavioral-effects-in-depressed-a 2026-05-12T09:27:31Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-improves-short-term-plasticity-in-depression-by-enhancing-sensitivity-t 2026-05-19T10:29:43Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-in-bipolar-disorder-a-review 2026-03-25T05:58:59Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-induced-deficits-in-auditory-and-visual-context-dependent-processing-in 2026-04-16T10:23:40Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-induced-modulation-of-the-thalamo-cortical-network-in-healthy-volunteer 2026-04-16T10:23:42Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-induces-a-robust-whole-brain-connectivity-pattern-that-can-be-different 2026-04-13T18:40:46Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-induces-multiple-individually-distinct-whole-brain-functional-connectiv 2026-04-13T18:40:47Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-interactions-with-gut-microbiota-in-rats-relevance-to-its-antidepressan 2026-04-05T19:16:08Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-modulates-the-neural-correlates-of-reward-processing-in-unmedicated-pat 2026-05-19T15:52:41Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-normalizes-brain-activity-during-emotionally-valenced-attentional-proce 2026-05-12T06:35:03Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-plus-imipramine-treatment-induces-antidepressant-like-behavior-and-incr 2026-03-24T15:08:42Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-plus-propofol-electroconvulsive-therapy-ect-transiently-improves-the-an 2026-05-19T15:43:49Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-promising-path-or-false-prophecy-in-the-development-of-novel-therapeuti 2026-03-30T09:03:28Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-psychedelic-therapy-kpt-a-review-of-the-results-of-ten-years-of-researc 2026-03-24T15:08:42Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-psychotherapy-for-heroin-addiction-immediate-effects-and-two-year-follo 2026-05-11T20:50:24Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-safety-and-tolerability-in-clinical-trials-for-treatment-resistant-depr 2026-04-05T19:16:13Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-treatment-and-global-brain-connectivity-in-major-depression 2026-05-11T22:04:16Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-treatment-effects-on-dna-methylation-and-epigenetic-biomarkers-of-aging 2026-05-19T10:29:43Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-treatment-for-depression-in-patients-with-a-history-of-psychosis-or-cur 2026-04-05T19:16:16Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-treatment-for-individuals-with-treatment-resistant-depression-longitudi 2026-04-16T10:23:47Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-use-for-suicidal-ideation-in-the-general-hospital-case-report-and-short 2026-04-13T18:50:40Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-use-in-pediatric-depression-a-systematic-review 2026-04-16T10:52:35Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-users-have-high-rates-of-psychosis-and-or-depression 2026-04-05T19:16:19Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-versus-ect-for-nonpsychotic-treatment-resistant-major-depression 2026-05-19T09:31:44Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-versus-midazolam-in-bipolar-depression-with-suicidal-thoughts-a-pilot-m 2026-05-19T09:31:44Z monthly 0.7 https://www.moreblossom.com/papers/ketamine-vs-electroconvulsive-therapy-for-major-depressive-episode-a-systematic- 2026-04-05T19:16:23Z monthly 0.7 https://www.moreblossom.com/papers/ketamines-acute-effects-on-negative-brain-states-are-mediated-through-distinct-a 2026-04-13T18:40:49Z monthly 0.7 https://www.moreblossom.com/papers/ketamines-antidepressant-effect-is-mediated-by-energy-metabolism-and-antioxidant 2026-03-24T15:08:59Z monthly 0.7 https://www.moreblossom.com/papers/ketamines-dose-related-effects-on-anxiety-symptoms-in-patients-with-treatment-re 2026-05-19T16:50:43Z monthly 0.7 https://www.moreblossom.com/papers/ketamines-effect-on-inflammation-and-kynurenine-pathway-in-depression-a-systemat 2026-04-16T10:52:36Z monthly 0.7 https://www.moreblossom.com/papers/ketanserin-reverses-the-acute-response-to-lsd-in-a-randomized-double-blind-place 2026-04-27T12:13:08Z monthly 0.7 https://www.moreblossom.com/papers/ketogenic-diet-and-ketamine-infusion-treatment-to-target-chronic-persistent-eati 2026-05-19T11:07:54Z monthly 0.7 https://www.moreblossom.com/papers/key-interindividual-determinants-in-mdma-pharmacodynamics 2026-03-30T09:03:28Z monthly 0.7 https://www.moreblossom.com/papers/knocking-at-the-doors-of-perception-relating-lsd-effects-on-low-frequency-fluctu 2026-04-16T10:23:56Z monthly 0.7 https://www.moreblossom.com/papers/knowledge-perceptions-and-use-of-psychedelics-among-individuals-with-fibromyalgi 2026-04-16T10:23:58Z monthly 0.7 https://www.moreblossom.com/papers/language-as-a-window-into-the-altered-state-of-consciousness-elicited-by-psyched 2026-04-16T10:52:39Z monthly 0.7 https://www.moreblossom.com/papers/language-models-learn-sentiment-and-substance-from-11000-psychoactive-experience 2026-04-16T10:23:59Z monthly 0.7 https://www.moreblossom.com/papers/large-scale-brain-connectivity-changes-following-the-administration-of-lysergic- 2026-05-19T11:24:08Z monthly 0.7 https://www.moreblossom.com/papers/lasting-effects-of-a-single-psilocybin-dose-on-resting-state-functional-connecti 2026-04-16T10:24:03Z monthly 0.7 https://www.moreblossom.com/papers/lasting-increases-in-trait-mindfulness-after-psilocybin-correlate-positively-wit 2026-04-16T10:24:05Z monthly 0.7 https://www.moreblossom.com/papers/lay-perceptions-of-treating-mental-illness-with-psychedelic-assisted-therapy 2026-04-13T18:48:02Z monthly 0.7 https://www.moreblossom.com/papers/learned-helplessness-as-a-potential-transdiagnostic-therapeutic-mechanism-of-cla 2026-03-25T04:48:33Z monthly 0.7 https://www.moreblossom.com/papers/learning-to-let-go-a-cognitive-behavioral-model-of-how-psychedelic-therapy-promo 2026-04-16T10:52:41Z monthly 0.7 https://www.moreblossom.com/papers/life-after-ayahuasca-a-qualitative-analysis-of-the-psychedelic-integration-exper 2026-04-16T10:24:07Z monthly 0.7 https://www.moreblossom.com/papers/lifetime-experience-with-classic-psychedelics-predicts-pro-environmental-behavio 2026-04-16T10:24:08Z monthly 0.7 https://www.moreblossom.com/papers/lifetime-use-of-mdma-ecstasy-and-psilocybin-is-associated-with-reduced-odds-of-m 2026-04-16T10:24:10Z monthly 0.7 https://www.moreblossom.com/papers/lifetime-use-of-psychedelics-is-associated-with-better-mental-health-indicators- 2026-04-16T10:24:12Z monthly 0.7 https://www.moreblossom.com/papers/linkages-between-psychedelics-and-meditation-in-a-population-based-sample-in-the 2026-04-16T10:24:13Z monthly 0.7 https://www.moreblossom.com/papers/long-lasting-analgesic-effect-of-the-psychedelic-drug-changa-a-case-report 2026-04-13T18:49:31Z monthly 0.7 https://www.moreblossom.com/papers/long-lasting-subjective-effects-of-lsd-in-normal-subjects 2026-04-27T12:13:14Z monthly 0.7 https://www.moreblossom.com/papers/long-term-amelioration-of-ocd-symptoms-in-a-patient-with-chronic-consumption-of- 2026-04-16T10:24:17Z monthly 0.7 https://www.moreblossom.com/papers/long-term-ayahuasca-use-is-associated-with-preserved-global-cognitive-function-a 2026-04-13T18:49:33Z monthly 0.7 https://www.moreblossom.com/papers/long-term-benefits-of-single-dose-psilocybin-in-depressed-patients-with-cancer 2026-05-13T06:54:07Z monthly 0.7 https://www.moreblossom.com/papers/long-term-effects-of-psychedelic-drugs-a-systematic-review 2026-03-25T05:22:42Z monthly 0.7 https://www.moreblossom.com/papers/long-term-efficacy-of-combination-therapy-of-transcranial-magnetic-stimulation-w 2026-04-05T19:16:41Z monthly 0.7 https://www.moreblossom.com/papers/long-term-follow-up-of-psilocybin-assisted-psychotherapy-for-psychiatric-and-exi 2026-05-12T20:14:38Z monthly 0.7 https://www.moreblossom.com/papers/long-term-follow-up-of-psilocybin-facilitated-smoking-cessation 2026-05-19T10:29:43Z monthly 0.7 https://www.moreblossom.com/papers/long-term-follow-up-outcomes-of-mdma-assisted-psychotherapy-for-treatment-of-pts 2026-04-27T11:58:29Z monthly 0.7 https://www.moreblossom.com/papers/long-term-mental-health-and-wellbeing-outcomes-associated-with-naturalistic-ayah 2026-04-16T10:52:46Z monthly 0.7 https://www.moreblossom.com/papers/long-term-outcomes-of-single-dose-psilocybin-for-u-s-military-veterans-with-seve 2026-05-13T06:02:16Z monthly 0.7 https://www.moreblossom.com/papers/long-term-structural-and-functional-neural-changes-following-a-single-infusion-o 2026-04-27T12:13:24Z monthly 0.7 https://www.moreblossom.com/papers/long-term-use-of-psychedelic-drugs-is-associated-with-differences-in-brain-struc 2026-05-05T13:26:54Z monthly 0.7 https://www.moreblossom.com/papers/longitudinal-and-transcultural-assessment-of-the-relationship-between-hallucinog 2026-04-16T10:52:47Z monthly 0.7 https://www.moreblossom.com/papers/longitudinal-associations-between-psychedelic-use-and-meditation-practices-in-th 2026-04-16T10:24:27Z monthly 0.7 https://www.moreblossom.com/papers/longitudinal-experiences-of-canadians-receiving-compassionate-access-to-psilocyb 2026-04-16T10:52:48Z monthly 0.7 https://www.moreblossom.com/papers/longterm-effects-of-ayahuasca-in-patients-with-recurrent-depression-a-5-year-qua 2026-04-27T11:56:15Z monthly 0.7 https://www.moreblossom.com/papers/looking-for-the-self-phenomenology-neurophysiology-and-philosophical-significanc 2026-03-24T15:10:15Z monthly 0.7 https://www.moreblossom.com/papers/low-dose-ketamine-as-an-adjuvant-for-pain-control-in-a-cancer-patient-a-case-rep 2026-04-13T18:50:42Z monthly 0.7 https://www.moreblossom.com/papers/low-dose-ketamine-does-not-improve-the-speed-of-recovery-from-depression-in-elec 2026-05-12T10:14:13Z monthly 0.7 https://www.moreblossom.com/papers/low-dose-ketamine-for-treatment-resistant-depression-in-an-academic-clinical-pra 2026-04-13T18:54:47Z monthly 0.7 https://www.moreblossom.com/papers/low-dose-ketamine-reduces-pain-perception-and-blood-pressure-but-not-muscle-symp 2026-04-16T10:24:33Z monthly 0.7 https://www.moreblossom.com/papers/low-dose-lsd-alters-early-and-late-event-related-potentials-to-emotional-faces 2026-04-16T10:24:35Z monthly 0.7 https://www.moreblossom.com/papers/low-dose-lsd-and-the-stream-of-thought-increased-discontinuity-of-mind-deep-thou 2026-04-16T10:52:50Z monthly 0.7 https://www.moreblossom.com/papers/low-dose-oral-ketamine-treatment-in-chronic-suicidality-an-open-label-pilot-stud 2026-05-12T14:07:21Z monthly 0.7 https://www.moreblossom.com/papers/low-dose-psilocybin-in-short-lasting-unilateral-neuralgiform-headache-attacks-re 2026-05-12T19:39:56Z monthly 0.7 https://www.moreblossom.com/papers/low-doses-of-lsd-acutely-increase-bdnf-blood-plasma-levels-in-healthy-volunteers 2026-04-16T10:24:46Z monthly 0.7 https://www.moreblossom.com/papers/low-doses-of-lsd-reduce-broadband-oscillatory-power-and-modulate-event-related-p 2026-04-16T10:52:52Z monthly 0.7 https://www.moreblossom.com/papers/low-doses-of-lysergic-acid-diethylamide-lsd-increase-reward-related-brain-activi 2026-04-16T10:52:53Z monthly 0.7 https://www.moreblossom.com/papers/lower-dose-psycholytic-therapy-a-neglected-approach 2026-03-30T09:03:28Z monthly 0.7 https://www.moreblossom.com/papers/lsd-acutely-impairs-fear-recognition-and-enhances-emotional-empathy-and-socialit 2026-05-05T14:59:18Z monthly 0.7 https://www.moreblossom.com/papers/lsd-afterglow-and-hangover-increased-episodic-memory-and-verbal-fluency-decrease 2026-04-16T10:24:54Z monthly 0.7 https://www.moreblossom.com/papers/lsd-alters-dynamic-integration-and-segregation-in-the-human-brain 2026-04-16T10:24:56Z monthly 0.7 https://www.moreblossom.com/papers/lsd-alters-eyes-closed-functional-connectivity-within-the-early-visual-cortex-in 2026-04-16T10:24:58Z monthly 0.7 https://www.moreblossom.com/papers/lsd-and-creativity 2026-03-24T15:09:11Z monthly 0.7 https://www.moreblossom.com/papers/lsd-and-creativity-increased-novelty-and-symbolic-thinking-decreased-utility-and 2026-04-16T10:24:59Z monthly 0.7 https://www.moreblossom.com/papers/lsd-and-ketanserin-and-their-impact-on-the-human-autonomic-nervous-system 2026-04-16T10:25:01Z monthly 0.7 https://www.moreblossom.com/papers/lsd-and-language-decreased-structural-connectivity-increased-semantic-similarity 2026-04-16T10:25:03Z monthly 0.7 https://www.moreblossom.com/papers/lsd-assisted-psychotherapy-and-the-human-encounter-with-death 2026-05-19T11:24:25Z monthly 0.7 https://www.moreblossom.com/papers/lsd-assisted-psychotherapy-for-anxiety-associated-with-a-life-threatening-diseas 2026-05-19T10:55:40Z monthly 0.7 https://www.moreblossom.com/papers/lsd-assisted-psychotherapy-in-patients-with-terminal-cancer 2026-05-13T09:55:52Z monthly 0.7 https://www.moreblossom.com/papers/lsd-assisted-therapy-in-patients-with-anxiety-open-label-prospective-12-month-fo 2026-05-19T17:11:03Z monthly 0.7 https://www.moreblossom.com/papers/lsd-associated-alice-in-wonderland-syndromeaiws-a-hallucinogen-persisting-percep 2026-04-16T10:52:55Z monthly 0.7 https://www.moreblossom.com/papers/lsd-degrades-hippocampal-spatial-representations-and-suppresses-hippocampal-visu 2026-04-16T10:25:09Z monthly 0.7 https://www.moreblossom.com/papers/lsd-enhances-suggestibility-in-healthy-volunteers 2026-04-16T10:52:56Z monthly 0.7 https://www.moreblossom.com/papers/lsd-enhances-the-emotional-response-to-music 2026-05-05T15:00:34Z monthly 0.7 https://www.moreblossom.com/papers/lsd-experiments-by-the-united-states-army 2026-03-24T15:09:17Z monthly 0.7 https://www.moreblossom.com/papers/lsd-flattens-the-functional-hierarchy-of-the-human-brain 2026-04-16T10:25:16Z monthly 0.7 https://www.moreblossom.com/papers/lsd-flattens-the-hierarchy-of-directed-information-flow-in-fast-whole-brain-dyna 2026-04-16T10:25:18Z monthly 0.7 https://www.moreblossom.com/papers/lsd-in-the-supportive-care-of-the-terminally-ill-cancer-patient 2026-05-19T11:24:27Z monthly 0.7 https://www.moreblossom.com/papers/lsd-increases-primary-process-thinking-via-serotonin-2a-receptor-activation 2026-04-16T10:25:22Z monthly 0.7 https://www.moreblossom.com/papers/lsd-increases-sleep-duration-the-night-after-microdosing 2026-05-19T11:14:22Z monthly 0.7 https://www.moreblossom.com/papers/lsd-induced-changes-in-the-functional-connectivity-of-distinct-thalamic-nuclei 2026-04-16T10:25:25Z monthly 0.7 https://www.moreblossom.com/papers/lsd-induced-entropic-brain-activity-predicts-subsequent-personality-change 2026-04-16T10:25:27Z monthly 0.7 https://www.moreblossom.com/papers/lsd-induced-increase-of-ising-temperature-and-algorithmic-complexity-of-brain-dy 2026-04-16T10:25:30Z monthly 0.7 https://www.moreblossom.com/papers/lsd-induced-increases-in-social-adaptation-to-opinions-similar-to-ones-own-are-a 2026-04-27T12:07:17Z monthly 0.7 https://www.moreblossom.com/papers/lsd-induces-increased-signalling-entropy-in-rats-prefrontal-cortex 2026-04-16T10:25:34Z monthly 0.7 https://www.moreblossom.com/papers/lsd-madness-and-healing-mystical-experiences-as-possible-link-between-psychosis- 2026-04-16T10:25:36Z monthly 0.7 https://www.moreblossom.com/papers/lsd-microdosing-attenuates-the-impact-of-temporal-priors-in-time-perception 2026-04-16T10:25:38Z monthly 0.7 https://www.moreblossom.com/papers/lsd-microdosing-in-major-depressive-disorder-results-from-an-open-label-trial 2026-05-19T17:08:55Z monthly 0.7 https://www.moreblossom.com/papers/lsd-modulates-effective-connectivity-and-neural-adaptation-mechanisms-in-an-audi 2026-04-16T10:25:45Z monthly 0.7 https://www.moreblossom.com/papers/lsd-modulates-music-induced-imagery-via-changes-in-parahippocampal-connectivity 2026-04-16T10:25:47Z monthly 0.7 https://www.moreblossom.com/papers/lsd-overdoses-three-case-reports 2026-04-16T10:25:49Z monthly 0.7 https://www.moreblossom.com/papers/lsd-response-in-eysenckian-trait-types-identified-by-polypredictive-cfa 2026-03-24T15:09:29Z monthly 0.7 https://www.moreblossom.com/papers/lsd-stimulated-behaviors-in-mice-require-b-arrestin-2-but-not-b-arrestin-1 2026-03-24T15:57:10Z monthly 0.7 https://www.moreblossom.com/papers/lsd-treatment-in-scandinavia-emphasizing-indications-and-short-term-treatment-ou 2026-04-16T10:25:50Z monthly 0.7 https://www.moreblossom.com/papers/lsd-use-in-the-united-states-examining-user-demographics-and-their-evolution-fro 2026-04-16T10:25:52Z monthly 0.7 https://www.moreblossom.com/papers/lysergic-acid-diethylamide-a-drug-of-use 2026-03-24T15:57:10Z monthly 0.7 https://www.moreblossom.com/papers/lysergic-acid-diethylamide-assisted-therapy-in-patients-with-anxiety-with-and-wi 2026-05-19T12:00:52Z monthly 0.7 https://www.moreblossom.com/papers/lysergic-acid-diethylamide-lsd-for-alcoholism-meta-analysis-of-randomized-contro 2026-03-24T15:10:28Z monthly 0.7 https://www.moreblossom.com/papers/lysergic-acid-diethylamide-side-effects-and-complications 2026-03-24T15:10:34Z monthly 0.7 https://www.moreblossom.com/papers/lysergide-treatment-of-schizophrenic-and-nonschizophrenic-alcoholics-a-controlle 2026-05-19T10:29:45Z monthly 0.7 https://www.moreblossom.com/papers/macrodosing-to-microdosing-with-psychedelics-clinical-social-and-cultural-perspe 2026-03-24T15:11:15Z monthly 0.7 https://www.moreblossom.com/papers/magic-mushroom-use-a-qualitative-interview-study-of-post-trip-impacts-and-strate 2026-04-16T10:25:58Z monthly 0.7 https://www.moreblossom.com/papers/magnesium-ibogaine-therapy-effects-on-cortical-oscillations-and-neural-complexit 2026-05-19T11:37:30Z monthly 0.7 https://www.moreblossom.com/papers/magnesium-ibogaine-therapy-in-veterans-with-traumatic-brain-injuries 2026-05-19T11:26:04Z monthly 0.7 https://www.moreblossom.com/papers/main-targets-of-ibogaine-and-noribogaine-associated-with-its-putative-anti-addic 2026-04-16T10:53:00Z monthly 0.7 https://www.moreblossom.com/papers/maintenance-ketamine-treatment-for-depression-a-systematic-review-of-efficacy-sa 2026-03-25T05:39:11Z monthly 0.7 https://www.moreblossom.com/papers/major-life-changes-following-psychedelic-use-a-retrospective-survey-among-people 2026-04-24T19:31:45Z monthly 0.7 https://www.moreblossom.com/papers/making-a-medicine-out-of-mdma 2026-03-24T15:57:15Z monthly 0.7 https://www.moreblossom.com/papers/making-bad-trips-good-how-users-of-psychedelics-narratively-transform-challengin 2026-04-16T10:26:00Z monthly 0.7 https://www.moreblossom.com/papers/management-of-treatment-resistant-depression-challenges-and-strategies 2026-03-24T15:11:21Z monthly 0.7 https://www.moreblossom.com/papers/mania-following-use-of-ibogaine-a-case-series 2026-04-13T18:50:43Z monthly 0.7 https://www.moreblossom.com/papers/mapping-an-agenda-for-psychedelic-assisted-therapy-research-in-patients-with-ser 2026-04-05T19:17:34Z monthly 0.7 https://www.moreblossom.com/papers/mapping-pharmacologically-induced-functional-reorganisation-onto-the-brains-neur 2026-05-05T13:26:55Z monthly 0.7 https://www.moreblossom.com/papers/mda-mdma-and-other-mescaline-like-substances-in-the-us-militarys-search-for-a-tr 2026-03-24T15:10:34Z monthly 0.7 https://www.moreblossom.com/papers/mdma-alters-emotional-processing-and-facilitates-positive-social-interaction 2026-04-05T19:17:36Z monthly 0.7 https://www.moreblossom.com/papers/mdma-and-brain-activity-during-neurocognitive-performance-an-overview-of-neuroim 2026-04-05T19:17:37Z monthly 0.7 https://www.moreblossom.com/papers/mdma-and-human-sexual-function 2026-04-16T10:26:03Z monthly 0.7 https://www.moreblossom.com/papers/mdma-and-memory-addiction-and-depression-dose-effect-analysis 2026-04-05T19:17:39Z monthly 0.7 https://www.moreblossom.com/papers/mdma-and-ptsd-treatment-ptsd-from-novel-pathophysiology-to-innovative-therapeuti 2026-03-24T15:10:40Z monthly 0.7 https://www.moreblossom.com/papers/mdma-and-sexual-behavior-ecstasy-users-perceptions-about-sexuality-and-sexual-ri 2026-04-16T10:26:04Z monthly 0.7 https://www.moreblossom.com/papers/mdma-and-the-ecstasy-paradigm 2026-03-23T22:10:38Z monthly 0.7 https://www.moreblossom.com/papers/mdma-as-a-probe-and-treatment-for-social-behaviors 2026-03-24T15:10:40Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-psychotherapy-decreases-ptsd-symptoms-dissociation-functional-disa 2026-03-24T15:10:34Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-psychotherapy-for-aud-bayesian-analysis-of-who-drinking-risk-level 2026-05-19T17:08:56Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-psychotherapy-for-borderline-personality-disorder 2026-03-24T15:10:52Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-psychotherapy-for-people-diagnosed-with-treatment-resistant-ptsd-w 2026-04-05T19:17:43Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-psychotherapy-for-ptsd-are-memory-reconsolidation-and-fear-extinct 2026-03-30T09:03:28Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-psychotherapy-for-ptsd-growing-evidence-for-memory-effects-mediati 2026-04-16T10:53:02Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-psychotherapy-for-ptsd-in-adolescents-rationale-potential-risks-an 2026-03-24T15:10:57Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-psychotherapy-for-treatment-of-anxiety-and-other-psychological-dis 2026-05-19T11:55:59Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-psychotherapy-for-treatment-of-post-traumatic-stress-disorder-a-sy 2026-03-24T15:57:21Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-psychotherapy-for-treatment-of-ptsd-study-design-and-rationale-for 2026-04-27T11:58:32Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-psychotherapy-using-low-doses-in-a-small-sample-of-women-with-chro 2026-05-19T10:29:45Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-psychotherapy-with-adolescents-suffering-from-ptsd-do-or-dont-a-qu 2026-04-05T19:17:47Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-therapy-a-new-treatment-model-for-social-anxiety-in-autistic-adult 2026-03-30T09:03:28Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-therapy-as-a-means-to-alter-affective-cognitive-behavioral-and-neu 2026-03-24T15:10:52Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-therapy-as-a-treatment-for-major-depressive-disorder-proof-of-prin 2026-05-19T14:18:26Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-therapy-for-moderate-to-severe-ptsd-a-randomized-placebo-controlle 2026-05-19T14:24:10Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-therapy-for-posttraumatic-stress-disorder-a-mixed-methods-case-stu 2026-04-27T12:14:05Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-therapy-for-posttraumatic-stress-disorder-a-pooled-analysis-of-eth 2026-04-05T19:17:50Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-therapy-for-severe-ptsd-a-randomized-double-blind-placebo-controll 2026-05-19T14:45:13Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-therapy-is-associated-with-a-reduction-in-chronic-pain-among-peopl 2026-05-19T08:07:31Z monthly 0.7 https://www.moreblossom.com/papers/mdma-assisted-therapy-significantly-reduces-eating-disorder-symptoms-in-a-random 2026-05-19T09:31:44Z monthly 0.7 https://www.moreblossom.com/papers/mdma-cannabis-and-cocaine-produce-acute-dissociative-symptoms 2026-04-16T10:26:22Z monthly 0.7 https://www.moreblossom.com/papers/mdma-decreases-the-effects-of-simulated-social-rejection 2026-04-16T10:26:24Z monthly 0.7 https://www.moreblossom.com/papers/mdma-does-not-alter-responses-to-the-trier-social-stress-test-in-humans 2026-04-16T10:53:07Z monthly 0.7 https://www.moreblossom.com/papers/mdma-ecstasy-use-and-psilocybin-use-are-associated-with-lowered-odds-of-psycholo 2026-04-05T19:17:59Z monthly 0.7 https://www.moreblossom.com/papers/mdma-enhances-emotional-empathy-and-prosocial-behavior 2026-04-16T10:26:28Z monthly 0.7 https://www.moreblossom.com/papers/mdma-enhances-positive-affective-responses-to-social-feedback 2026-04-27T12:10:01Z monthly 0.7 https://www.moreblossom.com/papers/mdma-facilitated-cognitive-behavioural-conjoint-therapy-for-posttraumatic-stress 2026-05-19T11:20:44Z monthly 0.7 https://www.moreblossom.com/papers/mdma-for-the-treatment-of-negative-symptoms-in-schizophrenia 2026-04-16T10:26:33Z monthly 0.7 https://www.moreblossom.com/papers/mdma-impairs-both-the-encoding-and-retrieval-of-emotional-recollections 2026-04-16T10:53:08Z monthly 0.7 https://www.moreblossom.com/papers/mdma-induced-changes-in-within-network-connectivity-contradict-the-specificity-o 2026-04-27T12:05:11Z monthly 0.7 https://www.moreblossom.com/papers/mdma-induced-dissociative-state-not-mediated-by-the-5-ht2a-receptor 2026-04-16T10:26:38Z monthly 0.7 https://www.moreblossom.com/papers/mdma-induced-indifference-to-negative-sounds-is-mediated-by-the-5-ht2a-receptor 2026-05-05T15:00:29Z monthly 0.7 https://www.moreblossom.com/papers/mdma-pharmacokinetics-a-population-and-physiologically-based-pharmacokinetics-mo 2026-04-16T10:26:42Z monthly 0.7 https://www.moreblossom.com/papers/mdma-related-neuroinflammation-and-adenosine-receptors 2026-04-16T10:53:11Z monthly 0.7 https://www.moreblossom.com/papers/me-myself-bye-regional-alterations-in-glutamate-and-the-experience-of-ego-dissol 2026-04-27T12:14:21Z monthly 0.7 https://www.moreblossom.com/papers/measuring-the-subjective-revisiting-the-psychometric-properties-of-three-rating- 2026-04-16T10:26:46Z monthly 0.7 https://www.moreblossom.com/papers/mechanisms-and-molecular-targets-surrounding-the-potential-therapeutic-effects-o 2026-03-24T15:11:26Z monthly 0.7 https://www.moreblossom.com/papers/mechanisms-of-antiaddictive-actions-of-ibogaine 2026-04-16T10:26:48Z monthly 0.7 https://www.moreblossom.com/papers/mechanisms-of-ketamine-action-as-an-antidepressant 2026-03-25T05:13:15Z monthly 0.7 https://www.moreblossom.com/papers/medicine-religion-and-ayahuasca-in-catalonia-considering-ayahuasca-networks-from 2026-03-24T15:11:32Z monthly 0.7 https://www.moreblossom.com/papers/meditating-on-psychedelics-a-randomized-placebo-controlled-study-of-dmt-and-harm 2026-04-27T11:55:41Z monthly 0.7 https://www.moreblossom.com/papers/meditation-psychedelics-and-brain-connectivity-a-randomized-controlled-resting-s 2026-04-27T11:55:44Z monthly 0.7 https://www.moreblossom.com/papers/meditation-trips-a-thematic-analysis-of-the-combined-naturalistic-use-of-psyched 2026-04-16T10:26:51Z monthly 0.7 https://www.moreblossom.com/papers/meeting-the-medicine-halfway-ayahuasca-ceremony-leaders-perspectives-on-preparat 2026-04-16T10:26:53Z monthly 0.7 https://www.moreblossom.com/papers/membrane-permeation-of-psychedelic-tryptamines-by-dynamic-simulations 2026-03-25T05:43:13Z monthly 0.7 https://www.moreblossom.com/papers/menstrual-changes-and-reversal-of-amenorrhea-induced-by-classic-psychedelics-a-c 2026-04-16T10:26:54Z monthly 0.7 https://www.moreblossom.com/papers/mental-changes-experimentally-produced-by-d-lysergic-acid-diethylamide-tartrate 2026-04-05T19:18:12Z monthly 0.7 https://www.moreblossom.com/papers/mental-health-of-a-self-selected-sample-of-psychedelic-users-and-self-medication 2026-04-16T10:26:56Z monthly 0.7 https://www.moreblossom.com/papers/mescaline-the-forgotten-psychedelic 2026-04-16T10:53:15Z monthly 0.7 https://www.moreblossom.com/papers/meta-analysis-of-executive-functioning-in-ecstasy-polydrug-users 2026-04-05T19:18:15Z monthly 0.7 https://www.moreblossom.com/papers/meta-analysis-of-short-and-mid-term-efficacy-of-ketamine-in-unipolar-and-bipolar 2026-04-05T19:18:16Z monthly 0.7 https://www.moreblossom.com/papers/meta-correlation-of-the-effect-of-ketamine-and-psilocybin-induced-subjective-eff 2026-03-24T15:11:38Z monthly 0.7 https://www.moreblossom.com/papers/metabolism-and-disposition-of-nn-dimethyltryptamine-and-harmala-alkaloids-after- 2026-04-16T10:26:57Z monthly 0.7 https://www.moreblossom.com/papers/metabolism-of-lysergic-acid-diethylamide-lsd-an-update 2026-04-16T10:53:17Z monthly 0.7 https://www.moreblossom.com/papers/metabolism-of-psilocybin-and-psilocin-clinical-and-forensic-toxicological-releva 2026-03-24T15:11:44Z monthly 0.7 https://www.moreblossom.com/papers/metabolite-profiling-of-antiaddictive-alkaloids-from-four-mexican-tabernaemontan 2026-04-16T10:53:18Z monthly 0.7 https://www.moreblossom.com/papers/metabolomics-and-integrated-network-analysis-reveal-roles-of-endocannabinoids-an 2026-04-13T18:39:10Z monthly 0.7 https://www.moreblossom.com/papers/methodological-challenges-in-psychedelic-drug-trials-efficacy-and-safety-of-psil 2026-05-11T17:06:12Z monthly 0.7 https://www.moreblossom.com/papers/methyl-transfer-in-psilocybin-biosynthesis 2026-04-16T10:53:20Z monthly 0.7 https://www.moreblossom.com/papers/methylenedioxymethamphetamine-is-a-connectogen-with-empathogenic-entactogenic-an 2026-03-30T09:03:28Z monthly 0.7 https://www.moreblossom.com/papers/methylone-a-rapid-acting-entactogen-with-robust-anxiolytic-and-antidepressant-li 2026-04-16T10:27:03Z monthly 0.7 https://www.moreblossom.com/papers/methylone-and-mdma-pharmacokinetics-following-controlled-administration-in-human 2026-04-16T10:27:05Z monthly 0.7 https://www.moreblossom.com/papers/methylone-is-a-rapid-acting-neuroplastogen-with-less-off-target-activity-than-md 2026-04-16T10:27:08Z monthly 0.7 https://www.moreblossom.com/papers/micro-dose-macro-impact-leveraging-psychedelics-in-frontline-healthcare-workers- 2026-04-13T18:54:49Z monthly 0.7 https://www.moreblossom.com/papers/micro-dosing-psychedelics-as-a-plausible-adjunct-to-psychosexual-and-couples-the 2026-04-16T10:27:09Z monthly 0.7 https://www.moreblossom.com/papers/microdosing-as-a-response-to-the-meaning-crisis-a-qualitative-analysis 2026-04-16T10:27:11Z monthly 0.7 https://www.moreblossom.com/papers/microdosing-psilocybin-for-chronic-pain-a-case-series 2026-04-16T10:27:12Z monthly 0.7 https://www.moreblossom.com/papers/microdosing-psychedelics-and-its-effect-on-creativity-lessons-learned-from-three 2026-04-16T10:53:21Z monthly 0.7 https://www.moreblossom.com/papers/microdosing-psychedelics-and-the-risk-of-cardiac-fibrosis-and-valvulopathy-compa 2026-03-25T06:10:36Z monthly 0.7 https://www.moreblossom.com/papers/microdosing-psychedelics-as-a-promising-new-pharmacotherapeutic 2026-03-30T09:03:28Z monthly 0.7 https://www.moreblossom.com/papers/microdosing-psychedelics-current-evidence-from-controlled-studies 2026-03-25T05:03:22Z monthly 0.7 https://www.moreblossom.com/papers/microdosing-psychedelics-demographics-practices-and-psychiatric-comorbidities 2026-04-16T10:27:14Z monthly 0.7 https://www.moreblossom.com/papers/microdosing-psychedelics-does-it-have-an-impact-on-emodiversity 2026-04-05T19:18:27Z monthly 0.7 https://www.moreblossom.com/papers/microdosing-psychedelics-has-no-impact-on-cognitive-function-in-naturalistic-set 2026-04-16T10:27:20Z monthly 0.7 https://www.moreblossom.com/papers/microdosing-psychedelics-more-questions-than-answers-an-overview-and-suggestions 2026-04-05T19:18:30Z monthly 0.7 https://www.moreblossom.com/papers/microdosing-psychedelics-motivations-subjective-effects-and-harm-reduction 2026-04-16T10:27:22Z monthly 0.7 https://www.moreblossom.com/papers/microdosing-psychedelics-personality-mental-health-and-creativity-differences-in 2026-04-16T10:53:22Z monthly 0.7 https://www.moreblossom.com/papers/microdosing-with-psilocybin-mushrooms-a-double-blind-placebo-controlled-study 2026-04-16T10:53:24Z monthly 0.7 https://www.moreblossom.com/papers/microdosing-with-psychedelics-to-self-medicate-for-adhd-symptoms-in-adults-a-pro 2026-04-16T10:27:28Z monthly 0.7 https://www.moreblossom.com/papers/microevidence-for-microdosing-with-psilocybin-mushrooms-a-double-blind-placebo-c 2026-04-16T10:27:30Z monthly 0.7 https://www.moreblossom.com/papers/might-microdosing-psychedelics-be-safe-and-beneficial-an-initial-exploration 2026-04-16T10:27:31Z monthly 0.7 https://www.moreblossom.com/papers/migraine-prevalence-in-visual-snow-with-prior-illicit-drug-use-hallucinogen-pers 2026-04-16T10:27:33Z monthly 0.7 https://www.moreblossom.com/papers/mind-over-matter-the-microbial-mindscapes-of-psychedelics-and-the-gut-brain-axis 2026-03-25T05:20:23Z monthly 0.7 https://www.moreblossom.com/papers/mind-the-psychedelic-hype-characterizing-the-risks-and-benefits-of-psychedelics- 2026-04-05T19:18:38Z monthly 0.7 https://www.moreblossom.com/papers/mini-review-the-emerging-science-of-psychedelics-for-treatment-of-brain-injury 2026-04-05T19:18:39Z monthly 0.7 https://www.moreblossom.com/papers/models-of-psychedelic-assisted-psychotherapy-a-contemporary-assessment-and-an-in 2026-04-16T10:27:35Z monthly 0.7 https://www.moreblossom.com/papers/models-of-psychedelic-drug-action-modulation-of-cortical-subcortical-circuits 2026-03-25T04:48:35Z monthly 0.7 https://www.moreblossom.com/papers/moderating-factors-in-psilocybin-assisted-treatment-affecting-mood-and-personali 2026-05-13T03:45:31Z monthly 0.7 https://www.moreblossom.com/papers/modern-clinical-research-on-lsd 2026-03-30T09:03:28Z monthly 0.7 https://www.moreblossom.com/papers/modulation-of-long-term-potentiation-following-microdoses-of-lsd-captured-by-tha 2026-04-16T10:53:26Z monthly 0.7 https://www.moreblossom.com/papers/modulation-of-serum-brain-derived-neurotrophic-factor-by-a-single-dose-of-ayahua 2026-05-05T13:26:57Z monthly 0.7 https://www.moreblossom.com/papers/modulation-of-social-cognition-via-hallucinogens-and-entactogens 2026-03-24T15:12:12Z monthly 0.7 https://www.moreblossom.com/papers/modulation-of-the-antidepressant-effects-of-ketamine-by-the-mtorc1-inhibitor-rap 2026-05-19T15:23:11Z monthly 0.7 https://www.moreblossom.com/papers/modulatory-effect-of-the-5-ht1a-agonist-buspirone-and-the-mixed-non-hallucinogen 2026-04-16T10:27:44Z monthly 0.7 https://www.moreblossom.com/papers/modulatory-effects-of-ayahuasca-on-personality-structure-in-a-traditional-framew 2026-04-13T18:49:35Z monthly 0.7 https://www.moreblossom.com/papers/molecular-haemodynamic-and-functional-effects-of-lsd-in-the-human-brain 2026-04-27T12:14:39Z monthly 0.7 https://www.moreblossom.com/papers/monoamine-oxidase-inhibitors-in-south-american-hallucinogenic-plants-tryptamine- 2026-04-13T18:55:24Z monthly 0.7 https://www.moreblossom.com/papers/mood-and-cognition-after-administration-of-low-lsd-doses-in-healthy-volunteers-a 2026-04-16T10:27:48Z monthly 0.7 https://www.moreblossom.com/papers/mood-and-neuropsychological-effects-of-different-doses-of-ketamine-in-electrocon 2026-05-12T13:46:29Z monthly 0.7 https://www.moreblossom.com/papers/moral-psychopharmacology-needs-moral-inquiry-the-case-of-psychedelics 2026-04-16T10:27:52Z monthly 0.7 https://www.moreblossom.com/papers/more-evolved-than-you-evolutionary-spirituality-as-a-cultural-frame-for-psychede 2026-04-16T10:27:54Z monthly 0.7 https://www.moreblossom.com/papers/more-realistic-forecasting-of-future-life-events-after-psilocybin-for-treatment- 2026-05-19T16:04:46Z monthly 0.7 https://www.moreblossom.com/papers/more-than-meets-the-eye-the-role-of-sensory-dimensions-in-psychedelic-brain-dyna 2026-04-16T10:53:28Z monthly 0.7 https://www.moreblossom.com/papers/motives-and-side-effects-of-microdosing-with-psychedelics-among-users 2026-04-16T10:27:58Z monthly 0.7 https://www.moreblossom.com/papers/motives-for-the-use-of-serotonergic-psychedelics-a-systematic-review 2026-04-16T10:27:59Z monthly 0.7 https://www.moreblossom.com/papers/moving-past-mysticism-in-psychedelic-science 2026-03-23T22:14:49Z monthly 0.7 https://www.moreblossom.com/papers/multidimensional-personality-changes-following-psilocybin-assisted-therapy-in-pa 2026-05-19T13:02:05Z monthly 0.7 https://www.moreblossom.com/papers/multifaceted-empathy-of-healthy-volunteers-after-single-doses-of-mdma-a-pooled-s 2026-04-16T10:28:02Z monthly 0.7 https://www.moreblossom.com/papers/multimodal-creativity-assessments-following-acute-and-sustained-microdosing-of-l 2026-04-27T12:05:30Z monthly 0.7 https://www.moreblossom.com/papers/multiple-receptors-contribute-to-the-behavioral-effects-of-indoleamine-hallucino 2026-03-25T04:48:11Z monthly 0.7 https://www.moreblossom.com/papers/mushroom-derived-indole-alkaloids 2026-03-23T22:15:00Z monthly 0.7 https://www.moreblossom.com/papers/must-psilocybin-always-assist-psychotherapy 2026-04-05T19:18:56Z monthly 0.7 https://www.moreblossom.com/papers/mystical-experiences-in-retrospective-reports-of-first-times-using-a-psychedelic 2026-04-16T10:28:06Z monthly 0.7 https://www.moreblossom.com/papers/mystical-experiences-occasioned-by-the-hallucinogen-psilocybin-lead-to-increases 2026-03-24T15:12:36Z monthly 0.7 https://www.moreblossom.com/papers/mystical-type-experiences-occasioned-by-ketamine-mediate-its-impact-on-at-risk-d 2026-05-19T10:29:46Z monthly 0.7 https://www.moreblossom.com/papers/mystical-type-experiences-occasioned-by-psilocybin-mediate-the-attribution-of-pe 2026-04-16T10:28:09Z monthly 0.7 https://www.moreblossom.com/papers/n-n-dimethyltryptamine-dmt-an-endogenous-hallucinogen-past-present-and-future-re 2026-03-25T05:12:57Z monthly 0.7 https://www.moreblossom.com/papers/n-n-dimethyltryptamine-dmt-occasioned-familiarity-and-the-sense-of-familiarity-q 2026-04-16T10:28:11Z monthly 0.7 https://www.moreblossom.com/papers/narrative-identity-rationality-and-microdosing-classic-psychedelics 2026-04-05T19:18:58Z monthly 0.7 https://www.moreblossom.com/papers/narratives-of-the-mystical-among-users-of-psychedelics 2026-04-16T10:28:12Z monthly 0.7 https://www.moreblossom.com/papers/natural-language-signatures-of-psilocybin-microdosing 2026-04-16T10:53:31Z monthly 0.7 https://www.moreblossom.com/papers/natural-psychoplastogens-as-antidepressant-agents 2026-03-24T15:12:47Z monthly 0.7 https://www.moreblossom.com/papers/natural-speech-algorithm-applied-to-baseline-interview-data-can-predict-which-pa 2026-05-11T17:06:07Z monthly 0.7 https://www.moreblossom.com/papers/naturalism-and-the-hard-problem-of-mysticism-in-psychedelic-science 2026-03-23T22:15:31Z monthly 0.7 https://www.moreblossom.com/papers/naturalistic-entheogenics-precis-of-philosophy-of-psychedelics 2026-04-16T10:28:18Z monthly 0.7 https://www.moreblossom.com/papers/naturalistic-psilocybin-use-increases-mind-perception-but-not-atheist-believer-s 2026-04-16T10:28:19Z monthly 0.7 https://www.moreblossom.com/papers/naturalistic-psilocybin-use-is-associated-with-persisting-improvements-in-mental 2026-04-16T10:28:21Z monthly 0.7 https://www.moreblossom.com/papers/naturalistic-psychedelic-therapy-the-role-of-relaxation-and-subjective-drug-effe 2026-04-16T10:28:23Z monthly 0.7 https://www.moreblossom.com/papers/naturalistic-psychedelic-use-a-world-apart-from-clinical-care 2026-04-16T10:28:24Z monthly 0.7 https://www.moreblossom.com/papers/naturalistic-psychedelic-use-and-changes-in-depressive-symptoms 2026-04-16T10:28:26Z monthly 0.7 https://www.moreblossom.com/papers/naturalistic-use-of-mescaline-is-associated-with-self-reported-psychiatric-impro 2026-04-16T10:28:28Z monthly 0.7 https://www.moreblossom.com/papers/naturalistic-use-of-psychedelics-does-not-modulate-processing-of-self-related-st 2026-04-16T10:28:29Z monthly 0.7 https://www.moreblossom.com/papers/naturalistic-use-of-psychedelics-is-related-to-emotional-reactivity-and-self-con 2026-04-16T10:28:31Z monthly 0.7 https://www.moreblossom.com/papers/nature-themed-video-intervention-may-improve-cardiovascular-safety-of-psilocybin 2026-05-13T04:00:54Z monthly 0.7 https://www.moreblossom.com/papers/navigating-groundlessness-an-interview-study-on-dealing-with-ontological-shock-a 2026-04-16T10:28:34Z monthly 0.7 https://www.moreblossom.com/papers/navigating-the-chaos-of-psychedelic-neuroimaging-a-multi-metric-evaluation-of-ac 2026-04-27T12:15:08Z monthly 0.7 https://www.moreblossom.com/papers/negative-affect-circuit-subtypes-and-neural-behavioral-and-affective-responses-t 2026-04-27T12:01:49Z monthly 0.7 https://www.moreblossom.com/papers/neural-and-subjective-effects-of-inhaled-nn-dimethyltryptamine-in-natural-settin 2026-04-16T10:28:37Z monthly 0.7 https://www.moreblossom.com/papers/neural-complexity-eeg-biomarkers-of-rapid-and-post-rapid-ketamine-effects-in-lat 2026-05-19T16:47:08Z monthly 0.7 https://www.moreblossom.com/papers/neural-complexity-is-increased-after-low-doses-of-lsd-but-not-moderate-to-high-d 2026-04-16T10:53:33Z monthly 0.7 https://www.moreblossom.com/papers/neural-correlates-of-change-in-major-depressive-disorder-anhedonia-following-ope 2026-05-18T16:11:28Z monthly 0.7 https://www.moreblossom.com/papers/neural-correlates-of-the-dmt-experience-as-assessed-via-multivariate-eeg 2026-04-16T10:53:35Z monthly 0.7 https://www.moreblossom.com/papers/neural-correlates-of-the-lsd-experience-revealed-by-multimodal-neuroimaging 2026-04-16T10:28:45Z monthly 0.7 https://www.moreblossom.com/papers/neural-correlates-of-the-psychedelic-state-as-determined-by-fmri-studies-with-ps 2026-04-16T10:28:47Z monthly 0.7 https://www.moreblossom.com/papers/neural-correlates-of-the-shamanic-state-of-consciousness 2026-05-05T14:59:50Z monthly 0.7 https://www.moreblossom.com/papers/neural-mechanisms-and-psychology-of-psychedelic-ego-dissolution 2026-03-25T05:33:52Z monthly 0.7 https://www.moreblossom.com/papers/neural-mechanisms-of-imagery-under-psilocybin 2026-04-27T12:09:14Z monthly 0.7 https://www.moreblossom.com/papers/neural-plasticity-in-the-ventral-tegmental-area-aversive-motivation-during-drug- 2026-03-24T15:13:11Z monthly 0.7 https://www.moreblossom.com/papers/neuregulin-signaling-mediates-the-acute-and-sustained-antidepressant-effects-of- 2026-04-05T19:19:15Z monthly 0.7 https://www.moreblossom.com/papers/neurochemical-models-of-near-death-experiences-a-large-scale-study-based-on-the- 2026-04-13T18:55:43Z monthly 0.7 https://www.moreblossom.com/papers/neurocognitive-aspects-of-ketamine-and-esketamine-on-subjects-with-treatment-res 2026-05-13T14:27:42Z monthly 0.7 https://www.moreblossom.com/papers/neurocognitive-effects-of-ketamine-and-association-with-antidepressant-response- 2026-05-19T10:29:47Z monthly 0.7 https://www.moreblossom.com/papers/neurocognitive-effects-of-repeated-ketamine-infusions-in-comorbid-posttraumatic- 2026-05-11T17:08:40Z monthly 0.7 https://www.moreblossom.com/papers/neurocognitive-effects-of-six-ketamine-infusions-and-the-association-with-antide 2026-05-19T10:29:47Z monthly 0.7 https://www.moreblossom.com/papers/neurocognitive-effects-of-subanesthetic-serial-ketamine-infusions-in-treatment-r 2026-05-19T11:48:13Z monthly 0.7 https://www.moreblossom.com/papers/neuroendocrine-associations-underlying-the-persistent-therapeutic-effects-of-cla 2026-03-25T06:14:19Z monthly 0.7 https://www.moreblossom.com/papers/neuroimaging-correlates-and-predictors-of-response-to-repeated-dose-intravenous- 2026-05-19T17:04:10Z monthly 0.7 https://www.moreblossom.com/papers/neuroimaging-in-moderate-mdma-use-a-systematic-review 2026-03-25T05:53:49Z monthly 0.7 https://www.moreblossom.com/papers/neuroimaging-in-psychedelic-drug-development-past-present-and-future 2026-03-24T15:13:29Z monthly 0.7 https://www.moreblossom.com/papers/neuroimaging-of-chronic-mdma-ecstasy-effects-a-meta-analysis 2026-04-05T19:19:25Z monthly 0.7 https://www.moreblossom.com/papers/neurological-and-cognitive-alterations-induced-by-mdma-in-humans 2026-03-24T15:58:03Z monthly 0.7 https://www.moreblossom.com/papers/neurometabolic-effects-of-psilocybin-mde-and-d-methamphetamine-in-healthy-volunt 2026-04-16T10:53:42Z monthly 0.7 https://www.moreblossom.com/papers/neuropharmacological-modulation-of-the-aberrant-bodily-self-through-psychedelics 2026-03-30T09:03:36Z monthly 0.7 https://www.moreblossom.com/papers/neuroplasticity-and-psychedelics-a-comprehensive-examination-of-classic-and-non- 2026-03-25T05:43:14Z monthly 0.7 https://www.moreblossom.com/papers/neuroplasticity-the-continuum-of-change 2026-03-23T22:17:10Z monthly 0.7 https://www.moreblossom.com/papers/neuropsychological-functioning-in-users-of-serotonergic-psychedelics-a-systemati 2026-04-05T19:19:26Z monthly 0.7 https://www.moreblossom.com/papers/neuroticism-is-associated-with-challenging-experiences-with-psilocybin-mushrooms 2026-04-16T10:29:04Z monthly 0.7 https://www.moreblossom.com/papers/neurotoxicity-and-lsd-treatment-a-follow-up-study-of-151-patients-in-denmark 2026-04-13T18:56:16Z monthly 0.7 https://www.moreblossom.com/papers/never-drop-without-your-significant-other-cause-that-way-lies-ruin-the-boundary- 2026-04-16T10:29:06Z monthly 0.7 https://www.moreblossom.com/papers/new-insights-into-the-chemical-composition-of-ayahuasca 2026-04-16T10:29:08Z monthly 0.7 https://www.moreblossom.com/papers/new-insights-into-the-clinical-and-nonclinical-effects-of-psychedelic-substances 2026-03-25T05:31:14Z monthly 0.7 https://www.moreblossom.com/papers/new-treatment-strategies-of-depression-based-on-mechanisms-related-to-neuroplast 2026-03-24T15:13:35Z monthly 0.7 https://www.moreblossom.com/papers/new-world-tryptamine-hallucinogens-and-the-neuroscience-of-ayahuasca 2026-04-16T10:53:43Z monthly 0.7 https://www.moreblossom.com/papers/nitrous-oxide-an-emerging-novel-treatment-for-treatment-resistant-depression 2026-03-24T15:13:41Z monthly 0.7 https://www.moreblossom.com/papers/nitrous-oxide-as-an-adjunctive-therapy-in-major-depressive-disorder-a-randomized 2026-04-27T12:15:30Z monthly 0.7 https://www.moreblossom.com/papers/nitrous-oxide-for-treatment-resistant-major-depression-a-proof-of-concept-trial 2026-04-27T12:15:33Z monthly 0.7 https://www.moreblossom.com/papers/nmdar-inhibition-independent-antidepressant-actions-of-ketamine-metabolites 2026-04-05T19:19:32Z monthly 0.7 https://www.moreblossom.com/papers/nn-dimethyltryptamine-affects-eeg-response-in-a-concentration-dependent-manner-a 2026-04-16T10:29:11Z monthly 0.7 https://www.moreblossom.com/papers/nn-dimethyltryptamine-and-the-pineal-gland-separating-fact-from-myth 2026-03-30T09:03:36Z monthly 0.7 https://www.moreblossom.com/papers/nn-dimethyltryptamine-attenuates-spreading-depolarization-and-restrains-neurodeg 2026-04-16T10:53:46Z monthly 0.7 https://www.moreblossom.com/papers/nn-dimethyltryptamine-effects-on-connectome-harmonics-subjective-experience-and- 2026-04-13T18:59:21Z monthly 0.7 https://www.moreblossom.com/papers/no-evidence-that-lsd-microdosing-affects-recall-or-the-balance-between-distracte 2026-04-16T10:29:13Z monthly 0.7 https://www.moreblossom.com/papers/nonanesthetic-effects-of-ketamine-a-review-article 2026-04-05T19:19:38Z monthly 0.7 https://www.moreblossom.com/papers/nootropic-effects-of-lsd-behavioral-molecular-and-computational-evidence 2026-04-16T10:29:15Z monthly 0.7 https://www.moreblossom.com/papers/noribogaine-is-a-g-protein-biased-k-opioid-receptor-agonist 2026-04-13T18:56:01Z monthly 0.7 https://www.moreblossom.com/papers/nourishing-the-spirit-exploratory-research-on-ayahuasca-experiences-along-the-co 2026-04-13T18:49:37Z monthly 0.7 https://www.moreblossom.com/papers/novel-benzofuran-derivatives-induce-monoamine-release-and-substitute-for-the-dis 2026-05-05T13:31:09Z monthly 0.7 https://www.moreblossom.com/papers/novel-class-of-psychedelic-iboga-alkaloids-disrupts-opioid-addiction-states 2026-04-05T19:19:39Z monthly 0.7 https://www.moreblossom.com/papers/novel-extended-release-transdermal-formulations-of-the-psychedelic-nn-dimethyltr 2026-04-16T10:53:47Z monthly 0.7 https://www.moreblossom.com/papers/novel-pharmacological-targets-in-drug-development-for-the-treatment-of-anxiety-a 2026-03-24T15:13:47Z monthly 0.7 https://www.moreblossom.com/papers/novel-psychopharmacological-therapies-for-psychiatric-disorders-psilocybin-and-m 2026-03-30T09:03:36Z monthly 0.7 https://www.moreblossom.com/papers/novel-treatment-approaches-for-substance-use-disorders-therapeutic-use-of-psyche 2026-03-30T09:03:36Z monthly 0.7 https://www.moreblossom.com/papers/of-roots-and-fruits-a-comparison-of-psychedelic-and-nonpsychedelic-mystical-expe 2026-04-16T10:29:16Z monthly 0.7 https://www.moreblossom.com/papers/older-adults-in-psychedelic-assisted-therapy-trials-a-systematic-review 2026-04-05T19:19:40Z monthly 0.7 https://www.moreblossom.com/papers/on-minimizing-risk-and-harm-in-the-use-of-psychedelic 2026-05-05T15:00:22Z monthly 0.7 https://www.moreblossom.com/papers/on-perception-and-consciousness-in-hppd-a-systematic-review 2026-03-24T15:13:52Z monthly 0.7 https://www.moreblossom.com/papers/on-revelations-and-revolutions-drinking-ayahuasca-among-palestinians-under-israe 2026-04-13T18:49:38Z monthly 0.7 https://www.moreblossom.com/papers/on-the-need-for-metaphysics-in-psychedelic-therapy-and-research 2026-03-24T15:13:52Z monthly 0.7 https://www.moreblossom.com/papers/on-the-relationship-between-classic-psychedelics-and-suicidality-a-systematic-re 2026-04-16T10:29:19Z monthly 0.7 https://www.moreblossom.com/papers/on-the-varieties-of-conscious-experiences-altered-beliefs-under-psychedelics-alb 2026-03-30T09:03:36Z monthly 0.7 https://www.moreblossom.com/papers/one-year-outcomes-following-intravenous-ketamine-plus-digital-training-among-pat 2026-05-19T16:29:31Z monthly 0.7 https://www.moreblossom.com/papers/open-label-study-of-consecutive-ibogaine-and-5-meo-dmt-assisted-therapy-for-trau 2026-04-16T10:29:22Z monthly 0.7 https://www.moreblossom.com/papers/opening-to-awe-psychedelic-assisted-self-transcendence-and-positive-adult-develo 2026-04-16T10:53:49Z monthly 0.7 https://www.moreblossom.com/papers/opposite-alterations-of-5ht2a-receptor-brain-density-in-subjects-with-schizophre 2026-04-13T18:56:18Z monthly 0.7 https://www.moreblossom.com/papers/optimal-dosing-for-psilocybin-pharmacotherapy-considering-weight-adjusted-and-fi 2026-04-16T10:29:26Z monthly 0.7 https://www.moreblossom.com/papers/optimized-infusion-rates-for-nn-dimethyltryptamine-to-achieve-a-target-psychedel 2026-03-25T06:16:16Z monthly 0.7 https://www.moreblossom.com/papers/optimizing-outcomes-in-psilocybin-therapy-considerations-in-participant-evaluati 2026-05-05T13:27:58Z monthly 0.7 https://www.moreblossom.com/papers/optimizing-real-world-benefit-and-risk-of-new-psychedelic-medications-the-need-f 2026-03-24T15:13:58Z monthly 0.7 https://www.moreblossom.com/papers/oral-esketamine-for-patients-with-severe-treatment-resistant-depression-effectiv 2026-05-19T09:31:45Z monthly 0.7 https://www.moreblossom.com/papers/oral-esketamine-in-patients-with-treatment-resistant-depression-a-double-blind-r 2026-05-11T19:32:00Z monthly 0.7 https://www.moreblossom.com/papers/oral-ketamine-for-depression-an-updated-systematic-review 2026-04-05T19:19:48Z monthly 0.7 https://www.moreblossom.com/papers/oral-ketamine-for-the-treatment-of-pain-and-treatment-resistant-depression 2026-04-05T19:19:49Z monthly 0.7 https://www.moreblossom.com/papers/oral-ketamine-reduces-the-experience-of-stress-in-people-with-chronic-suicidalit 2026-05-19T10:29:47Z monthly 0.7 https://www.moreblossom.com/papers/oral-noribogaine-shows-high-brain-uptake-and-anti-withdrawal-effects-not-associa 2026-04-05T19:19:52Z monthly 0.7 https://www.moreblossom.com/papers/oral-prolonged-release-ketamine-in-treatment-resistant-depression-a-double-blind 2026-05-12T15:28:33Z monthly 0.7 https://www.moreblossom.com/papers/out-of-the-box-a-psychedelic-model-to-study-the-creative-mind 2026-03-30T09:03:36Z monthly 0.7 https://www.moreblossom.com/papers/outcomes-and-physiologic-responses-associated-with-ketamine-administration-after 2026-04-16T10:29:36Z monthly 0.7 https://www.moreblossom.com/papers/overcoming-blinding-confounds-in-psychedelic-randomized-controlled-trials-using- 2026-03-30T09:03:36Z monthly 0.7 https://www.moreblossom.com/papers/overcoming-epistemic-injustices-in-the-biomedical-study-of-ayahuasca-towards-eth 2026-03-25T04:49:25Z monthly 0.7 https://www.moreblossom.com/papers/overcoming-the-clinical-challenges-of-traditional-ayahuasca-a-first-in-human-tri 2026-04-13T18:39:12Z monthly 0.7 https://www.moreblossom.com/papers/oxytocin-and-the-role-of-fluid-restriction-in-mdma-induced-hyponatremia-a-second 2026-04-16T10:29:37Z monthly 0.7 https://www.moreblossom.com/papers/oxytocin-dependent-reopening-of-a-social-reward-learning-critical-period-with-md 2026-03-24T15:58:22Z monthly 0.7 https://www.moreblossom.com/papers/oxytocin-in-response-to-mdma-provocation-test-in-patients-with-arginine-vasopres 2026-05-18T14:36:49Z monthly 0.7 https://www.moreblossom.com/papers/oxytocin-receptor-gene-variation-predicts-subjective-responses-to-mdma 2026-04-16T10:29:41Z monthly 0.7 https://www.moreblossom.com/papers/oxytocin-receptor-gene-variations-and-socio-emotional-effects-of-mdma-a-pooled-a 2026-04-16T10:29:43Z monthly 0.7 https://www.moreblossom.com/papers/p300-mediated-modulations-in-self-other-processing-under-psychedelic-psilocybin- 2026-04-16T10:29:45Z monthly 0.7 https://www.moreblossom.com/papers/pahnkes-good-friday-experiment-a-long-term-follow-up-and-methodological-critique 2026-04-13T18:57:36Z monthly 0.7 https://www.moreblossom.com/papers/pain-mediates-the-improvement-of-social-functions-of-repeated-intravenous-ketami 2026-05-19T10:29:48Z monthly 0.7 https://www.moreblossom.com/papers/palliative-care-provider-attitudes-toward-existential-distress-and-treatment-wit 2026-04-16T10:53:53Z monthly 0.7 https://www.moreblossom.com/papers/paradoxical-wakefulness-induced-by-psychedelic-5-methoxy-nn-dimethyltryptamine-i 2026-03-24T15:45:01Z monthly 0.7 https://www.moreblossom.com/papers/parental-attitudes-toward-use-of-ketamine-in-adolescent-mood-disorders-and-suici 2026-04-16T10:29:51Z monthly 0.7 https://www.moreblossom.com/papers/participant-experiences-of-therapeutic-touch-in-psilocybin-assisted-therapy 2026-05-11T17:06:29Z monthly 0.7 https://www.moreblossom.com/papers/participant-reports-of-mindfulness-posttraumatic-growth-and-social-connectedness 2026-04-27T12:11:53Z monthly 0.7 https://www.moreblossom.com/papers/participation-in-an-indigenous-amazonian-led-ayahuasca-retreat-associated-with-i 2026-04-13T18:49:39Z monthly 0.7 https://www.moreblossom.com/papers/past-year-hallucinogen-use-in-relation-to-psychological-distress-depression-and- 2026-04-16T10:29:54Z monthly 0.7 https://www.moreblossom.com/papers/patents-on-psychedelics-the-next-legal-battlefront-of-drug-development 2026-04-16T10:29:56Z monthly 0.7 https://www.moreblossom.com/papers/patient-experiences-of-psilocybin-assisted-psychotherapy-an-interpretative-pheno 2026-05-11T17:06:04Z monthly 0.7 https://www.moreblossom.com/papers/patient-perspectives-and-experiences-with-psilocybin-treatment-for-treatment-res 2026-05-13T05:11:11Z monthly 0.7 https://www.moreblossom.com/papers/patients-accounts-of-increased-connectedness-and-acceptance-after-psilocybin-for 2026-05-11T17:06:04Z monthly 0.7 https://www.moreblossom.com/papers/patients-recovery-and-non-recovery-narratives-after-intravenous-ketamine-for-tre 2026-05-11T17:08:43Z monthly 0.7 https://www.moreblossom.com/papers/pattern-breaking-a-complex-systems-approach-to-psychedelic-medicine 2026-03-24T15:58:27Z monthly 0.7 https://www.moreblossom.com/papers/peak-experiences-and-the-afterglow-phenomenon-when-and-how-do-therapeutic-effect 2026-03-25T05:25:46Z monthly 0.7 https://www.moreblossom.com/papers/peak-experiences-of-psilocybin-users-and-non-users 2026-04-16T10:30:04Z monthly 0.7 https://www.moreblossom.com/papers/people-of-color-in-north-america-report-improvements-in-racial-trauma-and-mental 2026-04-16T10:30:06Z monthly 0.7 https://www.moreblossom.com/papers/perceived-attachment-history-predicts-psychedelic-experiences-a-naturalistic-stu 2026-04-16T10:30:07Z monthly 0.7 https://www.moreblossom.com/papers/perceived-benefits-of-mdma-assisted-psychotherapy-beyond-symptom-reduction-quali 2026-04-16T10:30:09Z monthly 0.7 https://www.moreblossom.com/papers/perceived-changes-in-mental-health-and-social-engagement-attributed-to-a-single- 2026-04-16T10:53:55Z monthly 0.7 https://www.moreblossom.com/papers/perceived-key-change-phenomena-of-mdma-assisted-psychotherapy-for-the-treatment- 2026-05-13T13:53:57Z monthly 0.7 https://www.moreblossom.com/papers/perceived-outcomes-of-psychedelic-microdosing-as-self-managed-therapies-for-ment 2026-04-16T10:53:57Z monthly 0.7 https://www.moreblossom.com/papers/percentage-of-heavy-drinking-days-following-psilocybin-assisted-psychotherapy-vs 2026-05-13T04:47:30Z monthly 0.7 https://www.moreblossom.com/papers/perception-is-in-the-details-a-predictive-coding-account-of-the-psychedelic-phen 2026-04-13T18:58:47Z monthly 0.7 https://www.moreblossom.com/papers/perceptions-of-psychedelic-personality-change-determinants-of-use-setting-and-dr 2026-04-16T10:30:23Z monthly 0.7 https://www.moreblossom.com/papers/perceptions-of-safety-subjective-effects-and-beliefs-about-the-clinical-utility- 2026-04-16T10:30:24Z monthly 0.7 https://www.moreblossom.com/papers/peri-traumatic-consumption-of-classic-psychedelics-is-associated-with-lower-anxi 2026-04-13T18:53:28Z monthly 0.7 https://www.moreblossom.com/papers/persisting-effects-of-ayahuasca-on-empathy-creative-thinking-decentering-persona 2026-04-16T10:30:26Z monthly 0.7 https://www.moreblossom.com/papers/persisting-reductions-in-cannabis-opioid-and-stimulant-misuse-after-naturalistic 2026-04-16T10:30:30Z monthly 0.7 https://www.moreblossom.com/papers/personal-psychedelic-use-is-common-among-a-sample-of-psychedelic-therapists-impl 2026-04-16T10:30:31Z monthly 0.7 https://www.moreblossom.com/papers/personality-change-in-a-trial-of-psilocybin-therapy-v-escitalopram-treatment-for 2026-05-19T10:29:48Z monthly 0.7 https://www.moreblossom.com/papers/personality-explains-the-relationship-between-psychedelic-use-and-depression-a-c 2026-04-16T10:53:58Z monthly 0.7 https://www.moreblossom.com/papers/personality-psychopathology-life-attitudes-and-neuropsychological-performance-am 2026-04-16T10:30:38Z monthly 0.7 https://www.moreblossom.com/papers/persons-with-spinal-cord-injury-report-peripherally-dominant-serotonin-like-synd 2026-03-24T15:14:58Z monthly 0.7 https://www.moreblossom.com/papers/perspectives-on-psychedelic-treatment-and-research-in-eating-disorders-a-web-bas 2026-04-16T10:30:40Z monthly 0.7 https://www.moreblossom.com/papers/perspectives-on-the-therapeutic-potential-of-mdma-a-nation-wide-exploratory-surv 2026-04-16T10:30:43Z monthly 0.7 https://www.moreblossom.com/papers/perturbing-whole-brain-models-of-brain-hierarchy-an-application-for-depression-f 2026-05-11T17:06:31Z monthly 0.7 https://www.moreblossom.com/papers/pharmacodynamic-interactions-between-ketamine-and-psychiatric-medications-used-i 2026-04-05T19:20:34Z monthly 0.7 https://www.moreblossom.com/papers/pharmacogenetics-of-ecstasy-cyp1a2-cyp2c19-and-cyp2b6-polymorphisms-moderate-pha 2026-03-24T15:58:33Z monthly 0.7 https://www.moreblossom.com/papers/pharmacogenomics-of-ketamine-a-systematic-review 2026-03-30T09:03:36Z monthly 0.7 https://www.moreblossom.com/papers/pharmacokinetics-and-concentration-effect-relationship-of-oral-lsd-in-humans 2026-04-16T10:30:46Z monthly 0.7 https://www.moreblossom.com/papers/pharmacokinetics-and-pharmacodynamics-of-an-innovative-psychedelic-nn-dimethyltr 2026-04-27T12:06:56Z monthly 0.7 https://www.moreblossom.com/papers/pharmacokinetics-and-pharmacodynamics-of-lysergic-acid-diethylamide-in-healthy-s 2026-04-16T10:54:00Z monthly 0.7 https://www.moreblossom.com/papers/pharmacokinetics-and-pharmacodynamics-of-lysergic-acid-diethylamide-microdoses-i 2026-04-16T10:30:49Z monthly 0.7 https://www.moreblossom.com/papers/pharmacokinetics-and-pharmacodynamics-of-oral-psilocybin-administration-in-healt 2026-04-27T12:05:20Z monthly 0.7 https://www.moreblossom.com/papers/pharmacokinetics-and-pharmacodynamics-of-sublingual-microdosed-lysergic-acid-die 2026-04-27T12:05:33Z monthly 0.7 https://www.moreblossom.com/papers/pharmacokinetics-and-subjective-effects-of-a-novel-oral-lsd-formulation-in-healt 2026-04-16T10:30:52Z monthly 0.7 https://www.moreblossom.com/papers/pharmacokinetics-of-escalating-doses-of-oral-psilocybin-in-healthy-adults 2026-04-16T10:54:01Z monthly 0.7 https://www.moreblossom.com/papers/pharmacokinetics-of-hoasca-alkaloids-in-healthy-humans 2026-04-16T10:30:57Z monthly 0.7 https://www.moreblossom.com/papers/pharmacokinetics-of-nn-dimethyltrypatamine-fumarate-in-humans 2026-04-16T10:30:58Z monthly 0.7 https://www.moreblossom.com/papers/pharmacokinetics-pharmacodynamics-and-urinary-recovery-of-oral-lysergic-acid-die 2026-04-27T12:08:11Z monthly 0.7 https://www.moreblossom.com/papers/pharmacokinetics-pharmacodynamics-and-urinary-recovery-of-oral-mescaline-hydroch 2026-04-27T12:04:50Z monthly 0.7 https://www.moreblossom.com/papers/pharmacological-and-non-pharmacological-predictors-of-the-lsd-experience-in-heal 2026-03-25T05:03:56Z monthly 0.7 https://www.moreblossom.com/papers/pharmacological-effects-of-methylone-and-mdma-in-humans 2026-05-05T13:31:11Z monthly 0.7 https://www.moreblossom.com/papers/pharmacological-fmri-effects-of-subanesthetic-ketamine-on-resting-state-function 2026-04-13T18:40:53Z monthly 0.7 https://www.moreblossom.com/papers/pharmacological-mechanism-of-the-non-hallucinogenic-5-ht2a-agonist-ariadne-and-a 2026-04-05T08:20:58Z monthly 0.7 https://www.moreblossom.com/papers/pharmacological-neural-and-psychological-mechanisms-underlying-psychedelics-a-cr 2026-04-16T10:54:03Z monthly 0.7 https://www.moreblossom.com/papers/pharmacology-and-toxicology-of-n-benzylphenethylamine-nbome-hallucinogens 2026-03-25T04:48:12Z monthly 0.7 https://www.moreblossom.com/papers/pharmacology-of-hallucinations-several-mechanisms-for-one-single-symptom 2026-04-05T19:20:53Z monthly 0.7 https://www.moreblossom.com/papers/pharmacology-of-mdma-in-humans 2026-04-16T10:31:06Z monthly 0.7 https://www.moreblossom.com/papers/phase-1-placebo-controlled-single-ascending-dose-trial-to-evaluate-the-safety-ph 2026-03-30T09:04:12Z monthly 0.7 https://www.moreblossom.com/papers/phenomenology-and-content-of-the-inhaled-n-n-dimethyltryptamine-n-n-dmt-experien 2026-04-16T10:31:08Z monthly 0.7 https://www.moreblossom.com/papers/phenomenology-and-therapeutic-potential-of-patient-experiences-during-oral-esket 2026-04-13T18:51:00Z monthly 0.7 https://www.moreblossom.com/papers/phenomenology-structure-and-dynamic-of-psychedelic-states 2026-03-24T15:15:26Z monthly 0.7 https://www.moreblossom.com/papers/phytochemical-analyses-of-banisteriopsis-caapi-and-psychotria-viridis 2026-03-23T22:22:08Z monthly 0.7 https://www.moreblossom.com/papers/pilot-data-on-salivary-oxytocin-as-a-biomarker-of-lsd-response-in-patients-with- 2026-04-27T12:16:12Z monthly 0.7 https://www.moreblossom.com/papers/pilot-study-of-psilocybin-treatment-for-anxiety-in-patients-with-advanced-stage- 2026-05-12T16:34:52Z monthly 0.7 https://www.moreblossom.com/papers/pilot-study-of-single-dose-psilocybin-for-serotonin-reuptake-inhibitor-resistant 2026-05-13T02:47:09Z monthly 0.7 https://www.moreblossom.com/papers/pilot-study-of-the-5-ht2ar-agonist-psilocybin-in-the-treatment-of-tobacco-addict 2026-05-12T16:59:12Z monthly 0.7 https://www.moreblossom.com/papers/pilot-study-suggests-dna-methylation-of-the-glucocorticoid-receptor-gene-nr3c1-i 2026-05-19T17:11:03Z monthly 0.7 https://www.moreblossom.com/papers/pivotal-mental-states 2026-03-24T15:15:32Z monthly 0.7 https://www.moreblossom.com/papers/plasma-bdnf-concentrations-and-the-antidepressant-effects-of-six-ketamine-infusi 2026-05-19T16:37:01Z monthly 0.7 https://www.moreblossom.com/papers/plasma-oxytocin-concentrations-following-mdma-or-intranasal-oxytocin-in-humans 2026-04-16T10:31:20Z monthly 0.7 https://www.moreblossom.com/papers/population-pharmacokinetic-pharmacodynamic-modeling-of-co-administered-nn-dimeth 2026-04-27T12:11:27Z monthly 0.7 https://www.moreblossom.com/papers/population-pharmacokinetic-pharmacodynamic-modelling-of-the-psychedelic-experien 2026-04-16T10:31:23Z monthly 0.7 https://www.moreblossom.com/papers/population-scale-data-reveals-the-antidepressant-effects-of-ketamine-and-other-t 2026-04-13T18:56:03Z monthly 0.7 https://www.moreblossom.com/papers/positive-effects-of-psychedelics-on-depression-and-wellbeing-scores-in-individua 2026-04-16T10:54:05Z monthly 0.7 https://www.moreblossom.com/papers/positive-expectations-predict-improved-mental-health-outcomes-linked-to-psychede 2026-05-05T13:32:08Z monthly 0.7 https://www.moreblossom.com/papers/positive-psychology-in-the-investigation-of-psychedelics-and-entactogens-a-criti 2026-04-05T19:21:07Z monthly 0.7 https://www.moreblossom.com/papers/positron-emission-tomography-and-fluorodeoxyglucose-studies-of-metabolic-hyperfr 2026-04-16T10:54:08Z monthly 0.7 https://www.moreblossom.com/papers/possible-interactions-between-5-ht2a-receptors-and-the-endocannabinoid-system-in 2026-04-16T10:31:31Z monthly 0.7 https://www.moreblossom.com/papers/possible-role-of-biochemiluminescent-photons-for-lysergic-acid-diethylamide-lsd- 2026-03-24T15:15:44Z monthly 0.7 https://www.moreblossom.com/papers/post-acute-psychological-effects-of-classical-serotonergic-psychedelics-a-system 2026-04-05T19:21:08Z monthly 0.7 https://www.moreblossom.com/papers/post-marketing-safety-concerns-with-esketamine-a-disproportionality-analysis-of- 2026-04-13T18:56:19Z monthly 0.7 https://www.moreblossom.com/papers/post-psychedelic-reductions-in-experiential-avoidance-are-associated-with-decrea 2026-04-16T10:31:35Z monthly 0.7 https://www.moreblossom.com/papers/postpartum-depression-a-role-for-psychedelics 2026-04-05T19:21:11Z monthly 0.7 https://www.moreblossom.com/papers/posttraumatic-growth-after-mdma-assisted-psychotherapy-for-posttraumatic-stress- 2026-04-16T10:31:36Z monthly 0.7 https://www.moreblossom.com/papers/posttraumatic-stress-disorder-after-a-psychedelic-experience-a-case-report 2026-04-16T10:31:38Z monthly 0.7 https://www.moreblossom.com/papers/potential-analgesic-effects-of-psychedelics-on-select-chronic-pain-conditions-a- 2026-04-16T10:31:39Z monthly 0.7 https://www.moreblossom.com/papers/potential-applications-for-sigma-receptor-ligands-in-cancer-diagnosis-and-therap 2026-03-24T15:15:49Z monthly 0.7 https://www.moreblossom.com/papers/potential-involvement-of-serotonergic-signaling-in-ketamines-antidepressant-acti 2026-03-24T15:15:49Z monthly 0.7 https://www.moreblossom.com/papers/potential-psychiatric-uses-for-mdma 2026-03-30T09:03:36Z monthly 0.7 https://www.moreblossom.com/papers/potential-safety-benefits-and-influence-of-the-placebo-effect-in-microdosing-psy 2026-03-25T04:46:33Z monthly 0.7 https://www.moreblossom.com/papers/potential-therapeutic-effects-of-an-ayahuasca-inspired-nn-dmt-and-harmine-formul 2026-04-27T12:06:59Z monthly 0.7 https://www.moreblossom.com/papers/potential-therapeutic-effects-of-psilocybin 2026-03-24T15:15:49Z monthly 0.7 https://www.moreblossom.com/papers/potential-use-of-ayahuasca-in-grief-therapy 2026-04-16T10:31:43Z monthly 0.7 https://www.moreblossom.com/papers/powerful-substances-in-tiny-amounts-an-interview-study-of-psychedelic-microdosin 2026-04-16T10:31:45Z monthly 0.7 https://www.moreblossom.com/papers/practical-considerations-in-the-establishment-of-psychedelic-research-programs 2026-04-05T19:21:18Z monthly 0.7 https://www.moreblossom.com/papers/practices-in-search-of-legitimacy-the-contemporary-use-of-ayahuasca-between-reli 2026-03-25T06:12:27Z monthly 0.7 https://www.moreblossom.com/papers/predicting-changes-in-substance-use-following-psychedelic-experiences-natural-la 2026-04-16T10:31:47Z monthly 0.7 https://www.moreblossom.com/papers/predicting-reactions-to-psychedelic-drugs-a-systematic-review-of-states-and-trai 2026-04-16T10:54:09Z monthly 0.7 https://www.moreblossom.com/papers/predicting-responses-to-psychedelics-a-prospective-study 2026-04-16T10:31:49Z monthly 0.7 https://www.moreblossom.com/papers/predicting-the-abuse-liability-of-entactogen-class-new-and-emerging-psychoactive 2026-03-24T15:16:00Z monthly 0.7 https://www.moreblossom.com/papers/predicting-the-intensity-of-psychedelic-induced-mystical-and-challenging-experie 2026-04-16T10:31:50Z monthly 0.7 https://www.moreblossom.com/papers/predicting-the-outcome-of-psilocybin-treatment-for-depression-from-baseline-fmri 2026-05-13T04:21:54Z monthly 0.7 https://www.moreblossom.com/papers/prediction-of-mdma-response-in-healthy-humans-a-pooled-analysis-of-placebo-contr 2026-04-16T10:31:52Z monthly 0.7 https://www.moreblossom.com/papers/prediction-of-psilocybin-response-in-healthy-volunteers 2026-05-12T10:36:11Z monthly 0.7 https://www.moreblossom.com/papers/predictive-feedback-early-sensory-representations-and-fast-responses-to-predicte 2026-04-16T10:31:54Z monthly 0.7 https://www.moreblossom.com/papers/predictive-value-of-heart-rate-in-treatment-of-major-depression-with-ketamine-in 2026-05-12T14:41:21Z monthly 0.7 https://www.moreblossom.com/papers/predictors-and-potentiators-of-psychedelic-occasioned-mystical-experiences 2026-03-24T15:16:06Z monthly 0.7 https://www.moreblossom.com/papers/predictors-of-attitudes-toward-psychedelics-among-psychologists-in-the-usa 2026-04-16T10:31:58Z monthly 0.7 https://www.moreblossom.com/papers/predictors-of-hallucinogen-persisting-perception-disorder-symptoms-delusional-id 2026-03-24T15:16:00Z monthly 0.7 https://www.moreblossom.com/papers/predictors-of-psychedelic-treatment-outcomes-among-special-operations-forces-vet 2026-04-27T18:03:24Z monthly 0.7 https://www.moreblossom.com/papers/predictors-of-response-to-ketamine-in-treatment-resistant-major-depressive-disor 2026-04-05T19:21:28Z monthly 0.7 https://www.moreblossom.com/papers/preferences-and-attitudes-toward-music-in-nonclinical-uses-of-psychedelics 2026-04-16T10:31:59Z monthly 0.7 https://www.moreblossom.com/papers/prefrontal-connectivity-and-glutamate-transmission-relevance-to-depression-patho 2026-05-18T16:11:28Z monthly 0.7 https://www.moreblossom.com/papers/prefrontal-contributions-to-the-stability-and-variability-of-thought-and-conscio 2026-03-24T15:16:12Z monthly 0.7 https://www.moreblossom.com/papers/preliminary-analysis-of-positive-and-negative-syndrome-scale-in-ketamine-associa 2026-04-05T19:21:32Z monthly 0.7 https://www.moreblossom.com/papers/preliminary-evidence-for-the-importance-of-therapeutic-alliance-in-mdma-assisted 2026-05-19T10:29:48Z monthly 0.7 https://www.moreblossom.com/papers/preliminary-evidence-of-links-between-ayahuasca-use-and-the-corpus-callosum 2026-04-16T10:32:01Z monthly 0.7 https://www.moreblossom.com/papers/preliminary-report-on-the-effects-of-a-low-dose-of-lsd-on-resting-state-amygdala 2026-04-27T12:05:38Z monthly 0.7 https://www.moreblossom.com/papers/preliminary-safety-and-effectiveness-of-psilocybin-assisted-therapy-in-adults-wi 2026-05-19T09:31:45Z monthly 0.7 https://www.moreblossom.com/papers/presence-trust-and-empathy-preferred-characteristics-of-psychedelic-carers 2026-03-25T05:48:24Z monthly 0.7 https://www.moreblossom.com/papers/prevalence-and-associations-of-challenging-difficult-or-distressing-experiences- 2026-04-16T10:32:05Z monthly 0.7 https://www.moreblossom.com/papers/prevalence-and-therapeutic-impact-of-adverse-life-event-reexperiencing-under-cer 2026-05-05T15:00:46Z monthly 0.7 https://www.moreblossom.com/papers/processing-of-self-related-thoughts-in-experienced-users-of-classic-psychedelics 2026-04-16T10:32:09Z monthly 0.7 https://www.moreblossom.com/papers/production-options-for-psilocybin-making-of-the-magic 2026-03-25T05:53:50Z monthly 0.7 https://www.moreblossom.com/papers/prohibited-or-regulated-lsd-psychotherapy-and-the-united-states-food-and-drug-ad 2026-04-13T18:56:20Z monthly 0.7 https://www.moreblossom.com/papers/prolonged-epigenomic-and-synaptic-plasticity-alterations-following-single-exposu 2026-05-19T11:22:53Z monthly 0.7 https://www.moreblossom.com/papers/prolonged-ketamine-infusion-modulates-limbic-connectivity-and-induces-sustained- 2026-05-19T14:54:55Z monthly 0.7 https://www.moreblossom.com/papers/prophylactic-action-of-ayahuasca-in-a-non-human-primate-model-of-depressive-like 2026-05-05T13:26:58Z monthly 0.7 https://www.moreblossom.com/papers/prophylactic-ketamine-attenuates-learned-fear 2026-04-13T18:56:22Z monthly 0.7 https://www.moreblossom.com/papers/prosocial-effects-of-mdma-a-measure-of-generosity 2026-04-16T10:32:13Z monthly 0.7 https://www.moreblossom.com/papers/prospective-association-of-psychological-pain-and-hopelessness-with-suicidal-tho 2026-04-05T19:21:39Z monthly 0.7 https://www.moreblossom.com/papers/prospective-associations-of-psychedelic-treatment-for-co-occurring-alcohol-misus 2026-04-11T11:03:19Z monthly 0.7 https://www.moreblossom.com/papers/prospective-examination-of-synthetic-5-methoxy-nn-dimethyltryptamine-inhalation- 2026-03-30T08:56:55Z monthly 0.7 https://www.moreblossom.com/papers/prospective-examination-of-the-therapeutic-role-of-psychological-flexibility-and 2026-04-16T10:32:14Z monthly 0.7 https://www.moreblossom.com/papers/protocol-for-outcome-evaluation-of-ayahuasca-assisted-addiction-treatment-the-ca 2026-04-16T10:32:18Z monthly 0.7 https://www.moreblossom.com/papers/psilocin-acutely-disrupts-sleep-and-affects-local-but-not-global-sleep-homeostas 2026-04-05T19:21:42Z monthly 0.7 https://www.moreblossom.com/papers/psilocin-and-ketamine-microdosing-effects-of-subchronic-intermittent-microdoses- 2026-04-05T19:21:43Z monthly 0.7 https://www.moreblossom.com/papers/psilocin-lsd-mescaline-and-dob-all-induce-broadband-desynchronization-of-eeg-and 2026-03-30T09:03:36Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-a-naturally-occurring-indoleamine-compound-could-be-useful-to-prevent 2026-03-24T15:17:34Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-acutely-alters-the-functional-connectivity-of-the-claustrum-with-brai 2026-04-16T10:32:20Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-alters-visual-contextual-computations 2026-04-16T10:32:25Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-and-4-bromo-25-dimethoxyphenethylamine-2c-b-at-encoding-distort-episo 2026-04-27T12:06:24Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-and-lsd-have-no-long-lasting-effects-in-an-animal-model-of-alcohol-re 2026-04-16T10:54:13Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-and-mdma-for-the-treatment-of-trauma-related-psychopathology 2026-03-30T09:03:36Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-and-mdma-reduce-costly-punishment-in-the-ultimatum-game 2026-04-16T10:54:15Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-and-obsessive-compulsive-disorder 2026-04-16T10:32:32Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-as-a-new-approach-to-treat-depression-and-anxiety-in-the-context-of-l 2026-03-24T15:16:47Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-as-a-novel-pharmacotherapy-for-treatment-refractory-anorexia-nervosa 2026-03-30T09:04:12Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-compassion-focused-therapy-for-depression 2026-03-24T15:17:34Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-group-psychotherapy-mindfulness-based-stress-reduction-mbsr- 2026-05-13T04:04:57Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-group-therapy-and-attachment-observed-reduction-in-attachmen 2026-05-13T03:53:59Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-group-therapy-for-demoralized-older-long-term-aids-survivor- 2026-05-19T09:31:46Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-group-therapy-in-patients-with-cancer-diagnosed-with-a-major 2026-05-19T17:29:00Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-mindfulness-training-modulates-self-consciousness-and-brain- 2026-04-16T10:32:41Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-neurofeedback-for-the-improvement-of-executive-functions-a-r 2026-03-24T15:17:46Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-neurofeedback-for-the-improvement-of-executive-functions-a-s 2026-04-16T10:32:43Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-psychotherapy-for-depression-and-anxiety-associated-with-lif 2026-05-19T09:31:46Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-psychotherapy-for-methamphetamine-use-disorder-a-pilot-open- 2026-05-13T06:26:07Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-psychotherapy-for-treatment-resistant-depression-a-randomize 2026-05-13T08:10:03Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-psychotherapy-for-treatment-resistant-depression-in-bipolar- 2026-05-19T10:29:49Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-psychotherapy-improves-psychiatric-symptoms-across-multiple- 2026-04-27T12:04:27Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-therapy-a-review-of-a-novel-treatment-for-psychiatric-disord 2026-03-25T06:04:43Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-therapy-and-hiv-related-shame 2026-05-13T04:56:07Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-therapy-for-demoralisation-in-hospice-patients-feasibility-s 2026-05-13T06:08:00Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-therapy-for-depression-a-systematic-review-and-dose-response 2026-04-16T10:54:17Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-therapy-for-depression-a-systematic-review-and-meta-analysis 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-therapy-for-major-depressive-disorder-an-exploratory-placebo 2026-05-12T22:18:43Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-therapy-for-relapse-prevention-in-alcohol-use-disorder-a-pha 2026-05-19T11:23:41Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-therapy-for-the-treatment-of-resistant-major-depressive-diso 2026-05-11T17:06:11Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-therapy-for-treatment-resistant-depression-in-the-us-a-model 2026-03-25T05:17:16Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-therapy-mediates-psycho-social-spiritual-change-in-cancer-pa 2026-05-12T21:27:16Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-therapy-of-major-depressive-disorder-using-acceptance-and-co 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-assisted-treatment-for-alcohol-dependence-a-proof-of-concept-study 2026-05-19T12:23:50Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-biases-facial-recognition-goal-directed-behavior-and-mood-state-towar 2026-04-16T10:33:01Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-can-occasion-mystical-type-experiences-having-substantial-and-sustain 2026-04-05T19:22:05Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-combines-rapid-synaptogenic-and-anti-inflammatory-effects-in-vitro 2026-04-16T10:33:03Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-crystal-structure-solutions-enable-phase-analysis-of-prior-art-and-re 2026-04-16T10:33:05Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-desynchronizes-brain-networks 2026-04-27T12:17:02Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-disrupts-sensory-and-higher-order-cognitive-processing-but-not-pre-at 2026-04-27T11:57:44Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-dose-dependently-causes-delayed-transient-headaches-in-healthy-volunt 2026-04-16T10:33:15Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-enhances-insightfulness-in-meditation-a-perspective-on-the-global-top 2026-04-27T12:42:07Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-for-end-of-life-anxiety-symptoms-a-systematic-review-and-meta-analysi 2026-04-05T19:22:13Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-for-opioid-use-disorder-in-two-adults-stabilized-on-buprenorphine-a-t 2026-05-12T23:18:32Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-for-treating-substance-use-disorders 2026-03-25T06:12:57Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-for-treatment-resistant-depression-fmri-measured-brain-mechanisms 2026-05-12T18:38:16Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-for-treatment-resistant-depression-in-patients-taking-a-concomitant-s 2026-05-19T14:06:19Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-from-ancient-magic-to-modern-medicine 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-in-alcohol-use-disorder-and-comorbid-depressive-symptoms-results-from 2026-05-13T04:17:02Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-in-end-of-life-care-implications-for-further-research 2026-03-24T15:16:59Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-in-long-term-meditators-effects-on-default-mode-network-functional-co 2026-04-16T10:33:21Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-in-the-treatment-of-anorexia-nervosa-the-english-transition-of-a-fren 2026-04-16T10:33:23Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-increases-emotional-empathy-in-patients-with-major-depression 2026-05-12T22:29:24Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-induced-changes-in-brain-network-integrity-and-segregation-correlate- 2026-04-27T12:15:11Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-induced-changes-in-cerebral-blood-flow-are-associated-with-acute-and- 2026-04-16T10:54:26Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-induced-changes-in-neural-reactivity-to-alcohol-and-emotional-cues-in 2026-05-19T10:29:50Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-induced-decrease-in-amygdala-reactivity-correlates-with-enhanced-posi 2026-04-16T10:33:33Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-induced-deficits-in-automatic-and-controlled-inhibition-are-attenuate 2026-04-16T10:54:29Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-induced-mystical-type-experiences-are-related-to-persisting-positive- 2026-04-27T12:15:14Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-induced-reduction-in-chronic-cluster-headache-attack-frequency-correl 2026-05-12T23:28:56Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-induced-spiritual-experiences-and-insightfulness-are-associated-with- 2026-04-16T10:54:30Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-induces-aberrant-prediction-error-processing-of-tactile-mismatch-resp 2026-04-27T12:09:20Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-induces-acute-and-persisting-alterations-in-immune-status-and-the-str 2026-04-27T12:14:24Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-induces-rapid-and-persistent-growth-of-dendritic-spines-in-frontal-co 2026-03-25T05:46:42Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-induces-schizophrenia-like-psychosis-in-humans-via-a-serotonin-2-agon 2026-04-16T10:33:47Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-induces-spatially-constrained-alterations-in-thalamic-functional-orga 2026-04-16T10:33:49Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-induces-time-dependent-changes-in-global-functional-connectivity-psi- 2026-04-27T12:09:22Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-intoxication-did-not-affect-daytime-or-sleep-related-declarative-memo 2026-04-16T10:33:53Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-lacks-antidepressant-like-effect-in-the-flinders-sensitive-line-rat 2026-04-16T10:33:55Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-links-binocular-rivalry-switch-rate-to-attention-and-subjective-arous 2026-05-05T15:00:47Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-microdosers-demonstrate-greater-observed-improvements-in-mood-and-men 2026-04-16T10:54:33Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-microdosing-does-not-affect-emotion-related-symptoms-and-processing-a 2026-04-16T10:34:04Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-mitigates-the-cognitive-deficits-observed-in-a-rat-model-of-fragile-x 2026-04-05T19:22:38Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-modulates-functional-connectivity-of-the-amygdala-during-emotional-fa 2026-04-16T10:34:06Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-modulation-of-time-varying-functional-connectivity-is-associated-with 2026-04-16T10:34:08Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-occasioned-mystical-experiences-in-the-treatment-of-tobacco-addiction 2026-05-12T16:49:40Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-occasioned-mystical-type-experience-in-combination-with-meditation-an 2026-04-27T12:17:24Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-occasioned-mystical-type-experiences-immediate-and-persisting-dose-re 2026-04-16T10:54:34Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-produces-substantial-and-sustained-decreases-in-depression-and-anxiet 2026-05-13T03:40:49Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-psychological-distress-and-suicidality 2026-04-16T10:34:15Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-pulse-regimen-reduces-cluster-headache-attack-frequency-in-the-blinde 2026-05-13T06:58:54Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-sex-dependently-reduces-alcohol-consumption-in-c57bl-6j-mice 2026-03-24T15:17:22Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-summary-of-knowledge-and-new-perspectives 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-targets-a-common-molecular-mechanism-for-cognitive-impairment-and-inc 2026-03-24T15:17:22Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-therapy-for-clinicians-with-symptoms-of-depression-from-frontline-car 2026-05-19T09:31:47Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-therapy-for-females-with-anorexia-nervosa-a-phase-1-open-label-feasib 2026-05-19T12:33:45Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-therapy-for-mood-dysfunction-in-parkinsons-disease-an-open-label-pilo 2026-05-13T04:33:16Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-therapy-for-treatment-resistant-depression-prediction-of-clinical-out 2026-05-13T05:28:12Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-therapy-increases-cognitive-and-neural-flexibility-in-patients-with-m 2026-05-13T07:08:59Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-therapy-of-psychiatric-disorders-is-not-hampered-by-herg-potassium-ch 2026-04-16T10:34:28Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-treatment-extends-cellular-lifespan-and-improves-survival-of-aged-mic 2026-03-24T15:17:28Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-use-is-associated-with-lowered-odds-of-crime-arrests-in-us-adults-a-r 2026-04-16T10:34:29Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-with-psychological-support-for-treatment-resistant-depression-an-open 2026-05-19T12:52:30Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-with-psychological-support-for-treatment-resistant-depression-six-mon 2026-05-19T12:48:33Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-with-psychological-support-improves-emotional-face-recognition-in-tre 2026-05-12T18:18:34Z monthly 0.7 https://www.moreblossom.com/papers/psilocybin-with-psychotherapeutic-support-for-treatment-resistant-depression-a-p 2026-05-12T20:28:45Z monthly 0.7 https://www.moreblossom.com/papers/psilocybins-acute-and-persistent-brain-effects-a-precision-imaging-drug-trial 2026-04-27T12:17:05Z monthly 0.7 https://www.moreblossom.com/papers/psilocybins-effect-on-human-brain-synaptic-plasticity 2026-04-27T12:15:17Z monthly 0.7 https://www.moreblossom.com/papers/psilocybins-effects-on-cognition-and-creativity-a-scoping-review 2026-04-05T19:23:04Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-5-methoxy-nn-dimethyltryptamine-metabolism-pharmacokinetics-drug-int 2026-03-24T15:18:15Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-agents-in-creative-problem-solving-a-pilot-study 2026-04-16T10:34:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-assisted-group-therapy-a-systematic-review 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-assisted-psychotherapy-a-paradigm-shift-in-psychiatric-research-and- 2026-03-25T04:49:26Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-assisted-psychotherapy-a-systematic-review-of-associated-psychologic 2026-03-24T15:19:03Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-assisted-psychotherapy-where-is-the-psychotherapy-research 2026-04-05T19:23:05Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-assisted-therapy-for-people-with-eating-disorders 2026-03-25T05:00:48Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-assisted-therapy-for-substance-use-disorders-and-potential-mechanism 2026-05-19T11:23:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-cognition-the-unreached-frontier-of-psychedelic-science 2026-03-24T15:18:15Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-communitas-intersubjective-experience-during-psychedelic-group-sessi 2026-04-16T10:34:46Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-drug-abuse-potential-assessment-research-for-new-drug-applications-a 2026-04-16T10:54:46Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-drug-assisted-psychotherapy-in-patients-with-terminal-cancer 2026-05-19T11:24:29Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-drug-use-and-schizotypy-in-young-adults 2026-04-16T10:54:47Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-drug-use-in-healthy-individuals-a-review-of-benefits-costs-and-impli 2026-03-24T15:18:40Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-drugs-a-new-era-in-psychiatry 2026-03-24T15:59:46Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-drugs-and-creativity 2026-03-24T15:18:15Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-drugs-and-perception-a-narrative-review-of-the-first-era-of-research 2026-03-25T05:22:44Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-drugs-in-biomedicine 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-drugs-neurobiology-and-potential-for-treatment-of-psychiatric-disord 2026-03-24T15:18:46Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-effects-of-ketamine-in-healthy-volunteers-relationship-to-steady-sta 2026-04-16T10:34:51Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-effects-of-psilocybin-correlate-with-serotonin-2a-receptor-occupancy 2026-04-16T10:54:49Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-experience-dose-dependently-modulated-by-cannabis-results-of-a-prosp 2026-04-16T10:54:50Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-experiences-after-bereavement-improve-symptoms-of-grief-the-influenc 2026-04-16T10:34:57Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-experiences-and-mindfulness-are-associated-with-improved-wellbeing 2026-04-16T10:34:59Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-group-therapy 2026-03-24T15:18:21Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-harm-reduction-and-integration-a-transtheoretical-model-for-clinical 2026-05-05T14:59:23Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-identity-shift-a-critical-approach-to-set-and-setting 2026-04-16T10:35:03Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-induced-mystical-experiences-an-interdisciplinary-discussion-and-cri 2026-03-25T04:57:06Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-injustice-should-bioethics-tune-in-to-the-voices-of-psychedelic-usin 2026-04-16T10:35:05Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-inspired-approaches-for-treating-neurodegenerative-disorders 2026-04-16T10:35:06Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-inspired-drug-discovery-using-an-engineered-biosensor 2026-05-05T14:59:34Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-integration-challenges-participant-experiences-after-a-psilocybin-tr 2026-04-16T10:35:10Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-intimacy-altered-states-of-consciousness-in-romantic-relationships 2026-04-16T10:35:12Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-knowledge-and-opinions-in-psychiatrists-at-two-professional-conferen 2026-04-16T10:35:14Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-medicalization-public-discourse-and-the-morality-of-ego-dissolution 2026-03-25T05:20:05Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-medicine-a-re-emerging-therapeutic-paradigm 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-medicine-the-biology-underlying-the-persisting-psychedelic-effects 2026-04-16T10:35:16Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-medicines-in-major-depression-progress-and-future-challenges 2026-03-25T04:46:35Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-microdosing-benefits-and-challenges-an-empirical-codebook 2026-04-16T10:54:52Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-microdosing-mindfulness-and-anxiety-a-cross-sectional-mediation-stud 2026-04-16T10:35:19Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-mushrooms-in-the-usa-knowledge-patterns-of-use-and-association-with- 2026-04-16T10:35:21Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-nn-dimethyltryptamine-and-5-methoxy-nn-dimethyltryptamine-modulate-i 2026-04-13T18:55:45Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-perceptions-mental-health-service-user-attitudes-to-psilocybin-thera 2026-04-16T10:54:53Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-pleasures-an-affective-understanding-of-the-joys-of-tripping 2026-04-13T18:55:46Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-psychiatrys-brave-new-world 2026-04-16T10:54:54Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-psychotherapy-insights-from-25-years-of-research 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-replications-in-virtual-reality-and-their-therapeutic-effects-on-dep 2026-04-27T13:25:31Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-resting-state-neuroimaging-a-review-and-perspective-on-balancing-rep 2026-04-16T10:54:56Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-science-in-post-covid-19-psychiatry 2026-03-25T06:17:28Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-supportive-psychotherapy-a-psychotherapeutic-model-for-before-and-be 2026-04-16T10:35:24Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-therapies-at-the-crossroads-of-trauma-and-substance-use-historical-p 2026-03-24T15:18:34Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-therapy-for-body-dysmorphic-disorder 2026-03-25T06:13:29Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-therapy-for-depressive-symptoms-a-systematic-review-and-meta-analysi 2026-04-05T19:23:26Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-therapy-for-smoking-cessation-qualitative-analysis-of-participant-ac 2026-05-19T15:19:10Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-therapy-in-the-treatment-of-addiction-the-past-present-and-future 2026-03-25T05:42:59Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-therapys-transdiagnostic-effects-a-research-domain-criteria-rdoc-per 2026-03-25T06:17:29Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-treatment-for-co-occurring-alcohol-misuse-and-post-traumatic-stress- 2026-04-16T10:35:28Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-treatment-for-trauma-related-psychological-and-cognitive-impairment- 2026-04-16T10:35:29Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-treatment-of-functional-neurological-disorder-a-systematic-review 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-treatments-for-psychiatric-disorders-a-systematic-review-and-themati 2026-04-05T19:23:31Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-use-among-psychiatric-medication-prescribers-effects-on-well-being-d 2026-04-27T12:17:44Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-use-and-intimate-partner-violence 2026-04-16T10:35:31Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-use-and-psychiatric-risks 2026-04-16T10:54:57Z monthly 0.7 https://www.moreblossom.com/papers/psychedelic-use-is-associated-with-reduced-daily-opioid-use-among-people-who-use 2026-04-16T10:35:35Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-align-brain-activity-with-context 2026-05-06T13:00:59Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-alter-metaphysical-beliefs 2026-04-16T10:35:38Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-cognitive-liberty-reimagining-drug-policy-through-the-prism-of- 2026-04-16T10:35:40Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-connectedness 2026-03-24T15:19:21Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-consciousness-distinctions-demarcations-and-opportunities 2026-03-23T22:31:32Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-creativity-a-review-of-the-quantitative-literature 2026-03-25T05:26:01Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-dying-care-a-historical-look-at-the-relationship-between-psyche 2026-03-25T06:11:57Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-health-behaviour-change 2026-03-24T15:19:21Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-holistic-thinking-a-tool-for-science 2026-04-16T10:54:59Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-hypnosis-commonalities-and-therapeutic-implications 2026-04-16T10:55:00Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-immunomodulation-novel-approaches-and-therapeutic-opportunities 2026-03-25T04:50:22Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-mental-health-a-population-study 2026-04-16T10:35:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-mindfulness-a-systematic-review-and-meta-analysis 2026-04-05T19:23:40Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-music-neuroscience-and-therapeutic-implications 2026-03-24T16:00:10Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-psychedelic-assisted-psychotherapy 2026-04-16T10:55:01Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-psychological-strengths 2026-04-16T10:35:46Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-psychotherapy 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-psychotherapy-cognitive-behavioral-approaches-as-default 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-psychotherapy-in-canada-humphry-osmond-and-aldous-huxley 2026-04-16T10:35:47Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-reconsolidation-of-traumatic-and-appetitive-maladaptive-memorie 2026-04-05T19:23:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-schizophrenia 2026-03-24T15:19:27Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-schizophrenia-distinct-alterations-to-bayesian-inference 2026-04-16T10:35:49Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-sexual-functioning-a-mixed-methods-study 2026-04-27T12:29:01Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-the-essential-importance-of-context 2026-03-24T15:19:33Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-the-human-receptorome 2026-04-16T10:35:56Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-the-inner-healer-myth-or-mechanism 2026-05-13T05:53:33Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-the-neurobiology-of-meaningfulness 2026-04-16T10:35:59Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-the-science-of-self-experience 2026-03-25T05:37:59Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-and-virtual-reality-parallels-and-applications 2026-03-25T05:22:45Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-as-a-novel-approach-to-treating-autoimmune-conditions 2026-03-25T04:50:23Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-as-a-training-experience-for-psychedelic-therapists-drawing-on-hist 2026-03-25T05:07:15Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-as-a-treatment-for-disorders-of-consciousness 2026-04-16T10:36:01Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-as-an-emerging-novel-intervention-in-the-treatment-of-substance-use 2026-03-24T15:19:45Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-as-anti-inflammatory-agents 2026-03-25T04:47:08Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-as-medicines-an-emerging-new-paradigm 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-as-medicines-for-substance-abuse-rehabilitation-evaluating-treatmen 2026-03-25T05:13:31Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-as-novel-therapeutics-in-alzheimers-disease-rationale-and-potential 2026-04-16T10:55:04Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-as-potent-anti-inflammatory-therapeutics 2026-04-16T10:55:06Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-as-potential-catalysts-of-scientific-creativity-and-insight 2026-03-25T05:41:52Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-as-tools-for-belief-transmission-set-setting-suggestibility-and-per 2026-04-16T10:36:06Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-assisted-psychotherapy-experiences-with-the-limited-medical-use-of- 2026-04-16T10:55:07Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-for-acquired-brain-injury-a-review-of-molecular-mechanisms-and-ther 2026-03-24T15:19:45Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-in-psychiatry-neuroplastic-immunomodulatory-and-neurotransmitter-me 2026-03-25T06:11:40Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-in-the-treatment-of-unipolar-mood-disorders-a-systematic-review 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-meditation-and-self-consciousness 2026-03-24T15:19:57Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-mystical-experience-and-therapeutic-efficacy-a-systematic-review 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-not-linked-to-mental-health-problems-or-suicidal-behavior-a-populat 2026-04-16T10:36:09Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-personality-and-political-perspectives 2026-04-16T10:36:11Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-placebo-effects-and-set-and-setting-insights-from-common-factors-th 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-promote-neuroplasticity-through-the-activation-of-intracellular-5-h 2026-04-16T10:36:12Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-promote-plasticity-by-directly-binding-to-bdnf-receptor-trkb 2026-03-24T15:19:51Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-promote-structural-and-functional-neural-plasticity 2026-05-05T14:59:36Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-reopen-the-social-reward-learning-critical-period 2026-03-24T15:19:51Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-sociality-and-human-evolution 2026-03-25T05:13:32Z monthly 0.7 https://www.moreblossom.com/papers/psychedelics-where-we-are-now-why-we-got-here-what-we-must-do 2026-03-24T15:19:57Z monthly 0.7 https://www.moreblossom.com/papers/psychiatric-risks-for-worsened-mental-health-after-psychedelic-use 2026-04-16T10:36:14Z monthly 0.7 https://www.moreblossom.com/papers/psychiatry-might-need-some-psychedelic-therapy 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psychiatry-the-psychedelic-drugs-past-present-future 2026-03-24T16:00:20Z monthly 0.7 https://www.moreblossom.com/papers/psychiatrys-next-top-model-cause-for-a-re-think-on-drug-models-of-psychosis-and- 2026-04-16T10:36:16Z monthly 0.7 https://www.moreblossom.com/papers/psycho-mycological-studies-of-amanita-from-ancient-sacrament-to-modern-phobia 2026-03-23T22:33:25Z monthly 0.7 https://www.moreblossom.com/papers/psychoactive-substances-as-a-last-resort-a-qualitative-study-of-self-treatment-o 2026-04-16T10:55:08Z monthly 0.7 https://www.moreblossom.com/papers/psychological-and-cardiovascular-effects-and-short-term-sequelae-of-mdma-ecstasy 2026-05-12T10:36:12Z monthly 0.7 https://www.moreblossom.com/papers/psychological-and-cognitive-effects-of-long-term-peyote-use-among-native-america 2026-04-16T10:36:25Z monthly 0.7 https://www.moreblossom.com/papers/psychological-and-neuropsychological-assessment-of-regular-hoasca-users 2026-04-16T10:36:27Z monthly 0.7 https://www.moreblossom.com/papers/psychological-and-physiological-effects-of-extended-dmt 2026-04-13T18:40:13Z monthly 0.7 https://www.moreblossom.com/papers/psychological-effects-of-s-ketamine-and-nn-dimethyltryptamine-dmt-a-double-blind 2026-04-16T10:36:29Z monthly 0.7 https://www.moreblossom.com/papers/psychological-flexibility-as-a-mechanism-of-change-in-psilocybin-assisted-therap 2026-05-19T10:29:50Z monthly 0.7 https://www.moreblossom.com/papers/psychological-flexibility-mediates-the-relations-between-acute-psychedelic-effec 2026-04-16T10:36:33Z monthly 0.7 https://www.moreblossom.com/papers/psychological-variables-implied-in-the-therapeutic-effect-of-ayahuasca-a-context 2026-04-16T10:36:35Z monthly 0.7 https://www.moreblossom.com/papers/psychometric-evaluation-of-the-altered-states-of-consciousness-rating-scale-oav 2026-05-12T10:36:14Z monthly 0.7 https://www.moreblossom.com/papers/psychonauts-psychedelics-a-systematic-multilingual-web-crawling-exercise 2026-04-16T10:36:37Z monthly 0.7 https://www.moreblossom.com/papers/psychopathological-neuroendocrine-and-autonomic-effects-of-34-methylenedioxyethy 2026-04-16T10:55:11Z monthly 0.7 https://www.moreblossom.com/papers/psychopharmacological-agents-and-suicide-risk-reduction-ketamine-and-other-appro 2026-03-30T09:03:43Z monthly 0.7 https://www.moreblossom.com/papers/psychoplastogens-a-promising-class-of-plasticity-promoting-neurotherapeutics 2026-03-24T15:20:21Z monthly 0.7 https://www.moreblossom.com/papers/psychotherapeutic-and-neurobiological-processes-associated-with-ayahuasca-a-prop 2026-03-25T05:20:26Z monthly 0.7 https://www.moreblossom.com/papers/purging-to-cleanse-a-qualitative-study-of-ayahuasca-healing-at-a-drug-treatment- 2026-04-13T18:55:47Z monthly 0.7 https://www.moreblossom.com/papers/pyramidal-cell-types-and-5-ht2a-receptors-are-essential-for-psilocybins-lasting- 2026-03-25T05:46:43Z monthly 0.7 https://www.moreblossom.com/papers/pyretogenic-effect-of-lysergic-acid-diethylamide 2026-03-24T15:20:21Z monthly 0.7 https://www.moreblossom.com/papers/qualitative-and-quantitative-features-of-music-reported-to-support-peak-mystical 2026-04-16T10:36:42Z monthly 0.7 https://www.moreblossom.com/papers/quality-of-acute-psychedelic-experience-predicts-therapeutic-efficacy-of-psilocy 2026-05-12T20:36:30Z monthly 0.7 https://www.moreblossom.com/papers/quality-of-reporting-on-psychological-interventions-in-psychedelic-treatments-a- 2026-03-25T05:00:36Z monthly 0.7 https://www.moreblossom.com/papers/r-ketamine-a-rapid-onset-and-sustained-antidepressant-without-psychotomimetic-si 2026-03-25T05:17:59Z monthly 0.7 https://www.moreblossom.com/papers/r-ketamine-shows-greater-potency-and-longer-lasting-antidepressant-effects-tha 2026-04-05T19:24:02Z monthly 0.7 https://www.moreblossom.com/papers/race-and-ethnicity-moderate-the-associations-between-lifetime-psilocybin-use-and 2026-04-16T10:36:44Z monthly 0.7 https://www.moreblossom.com/papers/race-and-ethnicity-moderate-the-associations-between-lifetime-psychedelic-use-md 2026-04-16T10:55:13Z monthly 0.7 https://www.moreblossom.com/papers/randomized-placebo-controlled-phase-2-study-of-extended-release-ketamine-tablets 2026-05-19T12:16:49Z monthly 0.7 https://www.moreblossom.com/papers/rapid-acting-antidepressant-ketamine-its-metabolites-and-other-candidates-a-hist 2026-03-25T05:18:01Z monthly 0.7 https://www.moreblossom.com/papers/rapid-and-longer-term-antidepressant-effects-of-repeated-dose-intravenous-ketami 2026-05-12T11:42:14Z monthly 0.7 https://www.moreblossom.com/papers/rapid-and-longer-term-antidepressant-effects-of-repeated-ketamine-infusions-in-t 2026-05-11T21:15:16Z monthly 0.7 https://www.moreblossom.com/papers/rapid-and-sustained-antidepressant-effects-of-vaporized-nn-dimethyltryptamine-a- 2026-05-19T12:08:03Z monthly 0.7 https://www.moreblossom.com/papers/rapid-and-sustained-decreases-in-suicidality-following-a-single-dose-of-ayahuasc 2026-04-27T12:06:14Z monthly 0.7 https://www.moreblossom.com/papers/rapid-and-sustained-reduction-of-treatment-resistant-ptsd-symptoms-after-intrave 2026-04-16T10:36:55Z monthly 0.7 https://www.moreblossom.com/papers/rapid-and-sustained-symptom-reduction-following-psilocybin-treatment-for-anxiety 2026-05-12T17:29:24Z monthly 0.7 https://www.moreblossom.com/papers/rapid-antidepressant-effect-of-ketamine-correlates-with-astroglial-plasticity-in 2026-04-13T18:56:23Z monthly 0.7 https://www.moreblossom.com/papers/rapid-antidepressant-effect-of-s-ketamine-in-schizophrenia 2026-04-13T18:51:01Z monthly 0.7 https://www.moreblossom.com/papers/rapid-antidepressant-effects-of-the-psychedelic-ayahuasca-in-treatment-resistant 2026-04-27T11:56:18Z monthly 0.7 https://www.moreblossom.com/papers/rapid-effectiveness-of-intravenous-ketamine-for-ultraresistant-depression-in-a-c 2026-04-16T10:55:18Z monthly 0.7 https://www.moreblossom.com/papers/rapid-effects-of-mdma-administration-on-self-reported-personality-traits-and-aff 2026-04-16T10:37:02Z monthly 0.7 https://www.moreblossom.com/papers/rapid-effects-of-tryptamine-psychedelics-on-perceptual-distortions-and-early-vis 2026-04-16T10:37:04Z monthly 0.7 https://www.moreblossom.com/papers/rapid-infusion-of-esketamine-for-unipolar-and-bipolar-depression-a-retrospective 2026-04-05T19:24:18Z monthly 0.7 https://www.moreblossom.com/papers/rapid-neuroplasticity-changes-and-response-to-intravenous-ketamine-a-randomized- 2026-05-19T16:24:04Z monthly 0.7 https://www.moreblossom.com/papers/rapid-onset-of-intranasal-esketamine-in-patients-with-treatment-resistance-depre 2026-04-05T19:24:21Z monthly 0.7 https://www.moreblossom.com/papers/rapidity-of-symptom-improvement-with-intranasal-esketamine-for-major-depressive- 2026-04-05T19:24:22Z monthly 0.7 https://www.moreblossom.com/papers/reactions-to-psilocybin-administered-in-a-supportive-environment 2026-03-24T15:20:45Z monthly 0.7 https://www.moreblossom.com/papers/reactivations-after-5-methoxy-nn-dimethyltryptamine-use-in-naturalistic-settings 2026-03-30T08:50:29Z monthly 0.7 https://www.moreblossom.com/papers/real-world-effectiveness-of-ketamine-in-treatment-resistant-depression-a-systema 2026-04-16T10:55:21Z monthly 0.7 https://www.moreblossom.com/papers/real-world-effectiveness-of-repeated-intravenous-ketamine-infusions-for-treatmen 2026-04-16T10:37:08Z monthly 0.7 https://www.moreblossom.com/papers/real-world-effectiveness-of-repeated-ketamine-infusions-borderline 2026-05-12T10:28:34Z monthly 0.7 https://www.moreblossom.com/papers/real-world-effectiveness-of-repeated-ketamine-infusions-for-trd 2026-05-12T10:28:32Z monthly 0.7 https://www.moreblossom.com/papers/real-world-effectiveness-of-repeated-ketamine-infusions-trd-covid 2026-04-27T18:03:40Z monthly 0.7 https://www.moreblossom.com/papers/real-world-experience-of-esketamine-use-to-manage-treatment-resistant-depression 2026-04-27T18:03:35Z monthly 0.7 https://www.moreblossom.com/papers/real-world-safety-of-esketamine-nasal-spray-a-comprehensive-analysis-almost-5-ye 2026-04-16T10:37:14Z monthly 0.7 https://www.moreblossom.com/papers/rebus-and-the-anarchic-brain-toward-a-unified-model-of-the-brain-action-of-psych 2026-04-03T18:07:06Z monthly 0.7 https://www.moreblossom.com/papers/recent-advances-in-the-neuropsychopharmacology-of-serotonergic-hallucinogens 2026-03-25T04:48:15Z monthly 0.7 https://www.moreblossom.com/papers/receptor-binding-profile-suggests-multiple-mechanisms-of-action-are-responsible- 2026-04-13T18:56:04Z monthly 0.7 https://www.moreblossom.com/papers/receptor-enriched-analysis-of-functional-connectivity-by-targets-react-a-novel-m 2026-04-16T10:37:17Z monthly 0.7 https://www.moreblossom.com/papers/receptor-informed-network-control-theory-lsd-psilocybin 2026-04-13T18:40:56Z monthly 0.7 https://www.moreblossom.com/papers/receptor-interaction-profiles-of-4-alkoxy-35-dimethoxy-phenethylamines-mescaline 2026-04-16T10:37:19Z monthly 0.7 https://www.moreblossom.com/papers/receptor-interaction-profiles-of-novel-n-2-methoxybenzyl-nbome-derivatives-of-25 2026-03-24T19:10:28Z monthly 0.7 https://www.moreblossom.com/papers/receptor-interaction-profiles-of-novel-psychoactive-tryptamines-compared-with-cl 2026-04-16T10:37:21Z monthly 0.7 https://www.moreblossom.com/papers/reconciling-mystical-experiences-with-naturalistic-psychedelic-science-reply-to- 2026-04-16T10:37:23Z monthly 0.7 https://www.moreblossom.com/papers/reconsidering-dissociation-as-a-predictor-of-antidepressant-efficacy-for-esketam 2026-04-16T10:55:23Z monthly 0.7 https://www.moreblossom.com/papers/reconsidering-evidence-for-psychedelic-induced-psychosis-an-overview-of-reviews- 2026-04-05T19:24:30Z monthly 0.7 https://www.moreblossom.com/papers/recreation-and-realization-reported-motivations-of-use-among-persons-who-consume 2026-04-16T10:37:28Z monthly 0.7 https://www.moreblossom.com/papers/recreational-34-methylenedioxy-n-methylamphetamine-mdma-or-ecstasy-and-self-focu 2026-04-16T10:37:29Z monthly 0.7 https://www.moreblossom.com/papers/recreational-psychedelic-users-frequently-encounter-complete-mystical-experience 2026-04-16T10:37:31Z monthly 0.7 https://www.moreblossom.com/papers/recreational-use-analysis-and-toxicity-of-tryptamines 2026-04-05T19:24:31Z monthly 0.7 https://www.moreblossom.com/papers/recreational-use-of-psychedelics-is-associated-with-elevated-personality-trait-o 2026-04-16T10:37:33Z monthly 0.7 https://www.moreblossom.com/papers/rediscovering-mdma-ecstasy-the-role-of-the-american-chemist-alexander-t-shulgin 2026-04-16T10:37:35Z monthly 0.7 https://www.moreblossom.com/papers/reduced-brain-responsiveness-to-emotional-stimuli-with-escitalopram-but-not-psil 2026-05-05T14:59:41Z monthly 0.7 https://www.moreblossom.com/papers/reduced-death-anxiety-and-obsessive-beliefs-as-mediators-of-the-therapeutic-effe 2026-04-16T10:37:36Z monthly 0.7 https://www.moreblossom.com/papers/reduced-death-anxiety-as-a-mediator-of-the-relationship-between-acute-subjective 2026-04-16T10:37:38Z monthly 0.7 https://www.moreblossom.com/papers/reduced-precision-underwrites-ego-dissolution-and-therapeutic-outcomes-under-psy 2026-03-25T05:22:11Z monthly 0.7 https://www.moreblossom.com/papers/reducing-the-harms-of-nonclinical-psychedelics-use-through-a-peer-support-teleph 2026-04-16T10:37:40Z monthly 0.7 https://www.moreblossom.com/papers/reduction-in-social-anxiety-after-mdma-assisted-psychotherapy-with-autistic-adul 2026-05-19T08:07:32Z monthly 0.7 https://www.moreblossom.com/papers/reduction-of-alcohol-use-and-increase-in-psychological-flexibility-after-a-natur 2026-04-16T10:37:43Z monthly 0.7 https://www.moreblossom.com/papers/reflections-on-the-concord-prison-project-and-the-follow-up-study 2026-03-24T15:21:14Z monthly 0.7 https://www.moreblossom.com/papers/registered-clinical-studies-investigating-psychedelic-drugs-for-psychiatric-diso 2026-04-05T19:24:41Z monthly 0.7 https://www.moreblossom.com/papers/regulation-of-human-research-with-lsd-in-the-united-states-1949-1987 2026-03-24T15:21:20Z monthly 0.7 https://www.moreblossom.com/papers/regulation-of-neural-responses-to-emotion-perception-by-ketamine-in-individuals- 2026-04-16T10:55:25Z monthly 0.7 https://www.moreblossom.com/papers/relational-and-growth-outcomes-following-couples-therapy-with-mdma-for-ptsd 2026-05-05T15:00:07Z monthly 0.7 https://www.moreblossom.com/papers/relational-processes-in-ayahuasca-groups-of-palestinians-and-israelis 2026-04-16T10:37:50Z monthly 0.7 https://www.moreblossom.com/papers/relationship-of-ketamines-antidepressant-and-psychotomimetic-effects-in-unipolar 2026-04-13T10:36:59Z monthly 0.7 https://www.moreblossom.com/papers/relationships-between-reduction-in-symptoms-and-restoration-of-function-and-well 2026-05-19T10:29:51Z monthly 0.7 https://www.moreblossom.com/papers/relief-from-intractable-phantom-pain-by-combining-psilocybin-and-mirror-visual-f 2026-04-16T10:37:54Z monthly 0.7 https://www.moreblossom.com/papers/remembering-molly-immediate-and-delayed-false-memory-formation-after-acute-mdma- 2026-04-27T12:18:07Z monthly 0.7 https://www.moreblossom.com/papers/repeat-dose-ketamine-augmentation-for-treatment-resistant-depression-with-chroni 2026-04-27T12:10:44Z monthly 0.7 https://www.moreblossom.com/papers/repeated-intranasal-ketamine-for-treatment-resistant-depression-the-way-to-go-re 2026-05-19T16:33:14Z monthly 0.7 https://www.moreblossom.com/papers/repeated-ketamine-injections-in-synergy-with-antidepressants-for-treating-refrac 2026-04-13T18:50:45Z monthly 0.7 https://www.moreblossom.com/papers/repeated-low-doses-of-lsd-in-healthy-adults-a-placebo-controlled-dose-response-s 2026-04-16T10:38:01Z monthly 0.7 https://www.moreblossom.com/papers/repeated-low-doses-psilocybin-rats 2026-03-24T15:21:32Z monthly 0.7 https://www.moreblossom.com/papers/repeated-lysergic-acid-diethylamide-in-an-animal-model-of-depression-normalisati 2026-05-05T13:32:09Z monthly 0.7 https://www.moreblossom.com/papers/repeated-lysergic-acid-diethylamide-lsd-reverses-stress-induced-anxiety-like-beh 2026-03-25T06:11:41Z monthly 0.7 https://www.moreblossom.com/papers/replication-and-extension-of-a-model-predicting-response-to-psilocybin 2026-04-16T10:55:27Z monthly 0.7 https://www.moreblossom.com/papers/replication-of-distinct-trajectories-of-antidepressant-response-to-intravenous-k 2026-04-27T18:03:30Z monthly 0.7 https://www.moreblossom.com/papers/replication-of-ketamines-antidepressant-efficacy-in-bipolar-depression-a-randomi 2026-05-18T19:20:15Z monthly 0.7 https://www.moreblossom.com/papers/report-on-psychoactive-drug-use-among-adolescents-using-ayahuasca-within-a-relig 2026-04-16T10:38:08Z monthly 0.7 https://www.moreblossom.com/papers/reported-cases-of-serotonin-syndrome-in-mdma-users-in-faers-database 2026-05-12T10:35:44Z monthly 0.7 https://www.moreblossom.com/papers/reported-effects-of-psychedelic-use-on-those-with-low-well-being-given-various-e 2026-04-16T10:38:13Z monthly 0.7 https://www.moreblossom.com/papers/reporting-of-harms-in-clinical-trials-of-esketamine-in-depression-a-systematic-r 2026-04-16T10:55:28Z monthly 0.7 https://www.moreblossom.com/papers/reports-of-self-compassion-and-affect-regulation-in-psilocybin-assisted-therapy- 2026-04-16T10:38:15Z monthly 0.7 https://www.moreblossom.com/papers/repurposing-ketamine-to-treat-cocaine-use-disorder-integration-of-artificial-int 2026-04-05T19:24:56Z monthly 0.7 https://www.moreblossom.com/papers/research-abuses-against-people-of-colour-and-other-vulnerable-groups-in-early-ps 2026-03-25T06:14:24Z monthly 0.7 https://www.moreblossom.com/papers/residual-neurocognitive-features-of-long-term-ecstasy-users-with-minimal-exposur 2026-04-16T10:38:16Z monthly 0.7 https://www.moreblossom.com/papers/resilience-and-brain-changes-in-long-term-ayahuasca-users-insights-from-psychome 2026-04-16T10:38:18Z monthly 0.7 https://www.moreblossom.com/papers/response-of-cluster-headache-to-psilocybin-and-lsd 2026-04-16T10:38:19Z monthly 0.7 https://www.moreblossom.com/papers/response-to-intravenous-racemic-ketamine-after-switch-from-intranasal-s-ketamine 2026-04-16T10:38:21Z monthly 0.7 https://www.moreblossom.com/papers/restructuring-consciousness-the-psychedelic-state-in-light-of-integrated-informa 2026-03-24T15:21:50Z monthly 0.7 https://www.moreblossom.com/papers/restructuring-insight-an-integrative-review-of-insight-in-problem-solving-medita 2026-03-25T05:57:27Z monthly 0.7 https://www.moreblossom.com/papers/results-from-a-long-term-observational-follow-up-study-of-a-single-dose-of-psilo 2026-04-27T11:56:28Z monthly 0.7 https://www.moreblossom.com/papers/reviewing-the-ketamine-model-for-schizophrenia 2026-04-05T19:25:04Z monthly 0.7 https://www.moreblossom.com/papers/reviewing-the-potential-of-psychedelics-for-the-treatment-of-ptsd 2026-04-13T18:56:59Z monthly 0.7 https://www.moreblossom.com/papers/revisiting-wassons-soma-exploring-the-effects-of-preparation-on-the-chemistry-of 2026-04-05T19:25:06Z monthly 0.7 https://www.moreblossom.com/papers/right-dorsolateral-prefrontal-cortex-volumetric-reduction-is-associated-with-ant 2026-05-19T10:29:51Z monthly 0.7 https://www.moreblossom.com/papers/right-wing-psychedelia-case-studies-in-cultural-plasticity-and-political-pluripo 2026-03-25T05:20:06Z monthly 0.7 https://www.moreblossom.com/papers/risk-assessment-of-ritual-use-of-oral-dimethyltryptamine-dmt-and-harmala-alkaloi 2026-04-05T19:25:08Z monthly 0.7 https://www.moreblossom.com/papers/risks-and-benefits-of-psilocybin-use-in-people-with-bipolar-disorder-an-internat 2026-04-16T10:38:26Z monthly 0.7 https://www.moreblossom.com/papers/risks-associated-with-misuse-of-ketamine-as-a-rapid-acting-antidepressant 2026-03-25T05:18:02Z monthly 0.7 https://www.moreblossom.com/papers/ritualistic-use-of-ayahuasca-enhances-a-shared-functional-connectome-identity-wi 2026-04-16T10:38:28Z monthly 0.7 https://www.moreblossom.com/papers/role-of-5-ht2a-receptors-in-the-effects-of-ayahuasca-on-ethanol-self-administrat 2026-04-05T19:25:11Z monthly 0.7 https://www.moreblossom.com/papers/role-of-serotonin-transporter-and-receptor-gene-variations-in-the-acute-effects- 2026-04-16T10:38:30Z monthly 0.7 https://www.moreblossom.com/papers/role-of-serotoninergic-neurons-and-5-ht-receptors-in-the-action-of-hallucinogens 2026-03-30T09:03:53Z monthly 0.7 https://www.moreblossom.com/papers/role-of-the-5-ht2a-receptor-in-acute-effects-of-lsd-on-empathy-and-circulating-o 2026-04-16T10:38:32Z monthly 0.7 https://www.moreblossom.com/papers/role-of-the-5-ht2a-receptor-in-self-and-other-initiated-social-interaction-in-ly 2026-04-16T10:38:36Z monthly 0.7 https://www.moreblossom.com/papers/rostral-anterior-cingulate-thickness-predicts-the-emotional-psilocybin-experienc 2026-04-16T10:38:37Z monthly 0.7 https://www.moreblossom.com/papers/rs-ketamine-metabolites-rs-norketamine-and-2s6s-hydroxynorketamine-increase-the- 2026-04-13T18:56:26Z monthly 0.7 https://www.moreblossom.com/papers/safer-tripping-serotonergic-psychedelics-and-drug-checking-submission-and-detect 2026-05-05T15:00:23Z monthly 0.7 https://www.moreblossom.com/papers/safety-and-cognitive-pharmacodynamics-following-dose-escalations-with-3-methylme 2026-04-16T10:55:30Z monthly 0.7 https://www.moreblossom.com/papers/safety-and-effectiveness-of-intranasal-esketamine-for-treatment-resistant-depres 2026-04-13T18:54:55Z monthly 0.7 https://www.moreblossom.com/papers/safety-and-efficacy-of-lysergic-acid-diethylamide-assisted-psychotherapy-for-anx 2026-05-19T10:29:52Z monthly 0.7 https://www.moreblossom.com/papers/safety-and-efficacy-of-repeated-low-dose-lsd-for-adhd-treatment-in-adults-a-rand 2026-04-27T12:18:16Z monthly 0.7 https://www.moreblossom.com/papers/safety-and-efficacy-with-esketamine-in-treatment-resistant-depression-long-term- 2026-05-19T15:15:16Z monthly 0.7 https://www.moreblossom.com/papers/safety-and-side-effects-of-ayahuasca-in-humans-an-overview-focusing-on-developme 2026-03-24T15:22:08Z monthly 0.7 https://www.moreblossom.com/papers/safety-and-tolerability-of-inhaled-nn-dimethyltryptamine-bmnd01-candidate-a-phas 2026-04-27T12:18:19Z monthly 0.7 https://www.moreblossom.com/papers/safety-and-tolerability-of-multiple-sublingual-microdoses-of-5-meo-dmt-in-adults 2026-04-27T12:18:22Z monthly 0.7 https://www.moreblossom.com/papers/safety-effectiveness-and-tolerability-of-sublingual-ketamine-in-depression-and-a 2026-04-16T10:38:52Z monthly 0.7 https://www.moreblossom.com/papers/safety-of-ibogaine-administration-in-detoxification-of-opioid-dependent-individu 2026-05-19T15:00:31Z monthly 0.7 https://www.moreblossom.com/papers/safety-pharmacokinetics-and-pharmacodynamics-of-a-6-h-nn-dimethyltryptamine-dmt- 2026-04-27T12:18:32Z monthly 0.7 https://www.moreblossom.com/papers/safety-pharmacology-of-acute-lsd-administration-in-healthy-subjects 2026-04-05T19:25:20Z monthly 0.7 https://www.moreblossom.com/papers/safety-pharmacology-of-acute-mdma-administration-in-healthy-subjects 2026-03-30T09:03:53Z monthly 0.7 https://www.moreblossom.com/papers/safety-pharmacology-of-acute-mescaline-administration-in-healthy-participants 2026-05-05T14:59:27Z monthly 0.7 https://www.moreblossom.com/papers/safety-pharmacology-of-acute-psilocybin-administration-in-healthy-participants 2026-04-16T10:38:55Z monthly 0.7 https://www.moreblossom.com/papers/safety-profile-and-suicidality-associated-with-the-use-of-esketamine-in-the-trea 2026-04-13T18:56:27Z monthly 0.7 https://www.moreblossom.com/papers/safety-tolerability-and-efficacy-of-psilocybin-in-9-patients-with-obsessive-comp 2026-05-12T16:24:07Z monthly 0.7 https://www.moreblossom.com/papers/safety-tolerability-and-subjective-effects-of-vaporized-nn-dimethyltryptamine-a- 2026-04-27T12:18:38Z monthly 0.7 https://www.moreblossom.com/papers/safety-tolerability-pharmacodynamic-and-wellbeing-effects-of-spl026-dimethyltryp 2026-04-27T12:16:03Z monthly 0.7 https://www.moreblossom.com/papers/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-low-dose-lysergic-a 2026-04-27T12:18:41Z monthly 0.7 https://www.moreblossom.com/papers/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-subcutaneous-re104- 2026-04-27T12:18:47Z monthly 0.7 https://www.moreblossom.com/papers/safety-tolerability-pharmacokinetics-and-subjective-effects-of-50-75-and-100-ug 2026-04-27T12:18:50Z monthly 0.7 https://www.moreblossom.com/papers/salience-sensemaking-and-setting-in-psilocybin-microdosing-methodological-lesson 2026-04-16T10:39:05Z monthly 0.7 https://www.moreblossom.com/papers/salvia-divinorum-a-psychopharmacological-riddle-and-a-mind-body-prospect 2026-03-24T15:22:26Z monthly 0.7 https://www.moreblossom.com/papers/salvia-divinorum-from-recreational-hallucinogenic-use-to-analgesic-and-anti-infl 2026-03-24T15:22:26Z monthly 0.7 https://www.moreblossom.com/papers/salvinorin-a-induces-intense-dissociative-effects-blocking-external-sensory-perc 2026-04-16T10:39:06Z monthly 0.7 https://www.moreblossom.com/papers/salvinorin-a-preserves-cerebral-pial-artery-autoregulation-after-forebrain-ische 2026-04-16T10:39:09Z monthly 0.7 https://www.moreblossom.com/papers/scoping-review-of-experiential-measures-from-psychedelic-research-and-clinical-t 2026-03-24T16:01:07Z monthly 0.7 https://www.moreblossom.com/papers/seeing-with-the-eyes-shut-neural-basis-of-enhanced-imagery-following-ayahuasca-i 2026-05-05T13:27:00Z monthly 0.7 https://www.moreblossom.com/papers/self-actualization-and-the-integration-of-psychedelic-experience-the-mediating-r 2026-04-16T10:39:12Z monthly 0.7 https://www.moreblossom.com/papers/self-administration-of-entactogen-psychostimulants-dysregulates-gamma-aminobutyr 2026-04-16T10:55:35Z monthly 0.7 https://www.moreblossom.com/papers/self-blinding-citizen-science-to-explore-psychedelic-microdosing 2026-04-16T10:39:13Z monthly 0.7 https://www.moreblossom.com/papers/self-care-practices-with-psychedelics-a-qualitative-study-of-users-perspectives 2026-04-16T10:39:15Z monthly 0.7 https://www.moreblossom.com/papers/self-compassion-mediates-treatment-effects-in-mdma-assisted-therapy-for-posttrau 2026-05-19T11:51:45Z monthly 0.7 https://www.moreblossom.com/papers/self-entropic-broadening-theory-toward-a-new-understanding-of-self-and-behavior- 2026-03-24T15:22:32Z monthly 0.7 https://www.moreblossom.com/papers/self-experience-in-mdma-assisted-therapy-of-ptsd 2026-05-19T11:23:18Z monthly 0.7 https://www.moreblossom.com/papers/self-experimentations-with-psychedelics-among-mental-health-professionals-lsd-in 2026-04-16T10:39:18Z monthly 0.7 https://www.moreblossom.com/papers/self-experiments-with-psychoactive-substances-a-historical-perspective 2026-03-25T05:55:50Z monthly 0.7 https://www.moreblossom.com/papers/self-medication-for-chronic-pain-using-classic-psychedelics-a-qualitative-invest 2026-04-16T10:39:20Z monthly 0.7 https://www.moreblossom.com/papers/self-rated-effectiveness-of-microdosing-with-psychedelics-for-mental-and-physica 2026-04-16T10:39:22Z monthly 0.7 https://www.moreblossom.com/papers/self-reported-drug-use-and-creativity-reestablishing-layperson-myths 2026-04-16T10:39:24Z monthly 0.7 https://www.moreblossom.com/papers/self-reported-effects-of-classic-psychedelics-on-stuttering 2026-04-16T10:39:26Z monthly 0.7 https://www.moreblossom.com/papers/self-reported-efficacy-of-treatments-in-cluster-headache-a-systematic-review-of- 2026-03-25T05:02:14Z monthly 0.7 https://www.moreblossom.com/papers/self-reported-negative-outcomes-of-psilocybin-users-a-quantitative-textual-analy 2026-04-16T10:39:28Z monthly 0.7 https://www.moreblossom.com/papers/self-reported-ptsd-is-associated-with-increased-use-of-mdma-in-adolescents-with- 2026-04-16T10:39:30Z monthly 0.7 https://www.moreblossom.com/papers/self-transcendent-positive-emotions-as-a-potential-mechanism-underpinning-the-ef 2026-04-16T10:55:37Z monthly 0.7 https://www.moreblossom.com/papers/self-treatment-of-psychosis-and-complex-post-traumatic-stress-disorder-with-lsd- 2026-04-16T10:39:33Z monthly 0.7 https://www.moreblossom.com/papers/self-unbound-ego-dissolution-in-psychedelic-experience 2026-03-25T06:13:31Z monthly 0.7 https://www.moreblossom.com/papers/semantic-activation-in-lsd-evidence-from-picture-naming 2026-04-16T10:39:35Z monthly 0.7 https://www.moreblossom.com/papers/sensitization-to-the-prosocial-effects-of-34-methylenedioxymethamphetamine-mdma 2026-03-25T06:00:49Z monthly 0.7 https://www.moreblossom.com/papers/separating-the-agony-from-ecstasy-r-34-methylenedioxymethamphetamine-has-prosoci 2026-04-05T19:25:45Z monthly 0.7 https://www.moreblossom.com/papers/serotonergic-hallucinogen-induced-visual-perceptual-alterations 2026-03-24T15:22:49Z monthly 0.7 https://www.moreblossom.com/papers/serotonergic-hallucinogens-and-recognition-of-facial-emotion-expressions-a-syste 2026-04-05T19:25:46Z monthly 0.7 https://www.moreblossom.com/papers/serotonergic-hallucinogens-in-the-treatment-of-anxiety-and-depression-in-patient 2026-03-25T05:25:47Z monthly 0.7 https://www.moreblossom.com/papers/serotonergic-hyperactivity-as-a-potential-factor-in-developmental-acquired-and-d 2026-03-24T15:22:55Z monthly 0.7 https://www.moreblossom.com/papers/serotonergic-psychedelic-drugs-lsd-and-psilocybin-reduce-the-hierarchical-differ 2026-04-16T10:39:37Z monthly 0.7 https://www.moreblossom.com/papers/serotonergic-psychedelics-and-personality-a-systematic-review-of-contemporary-re 2026-03-25T04:46:39Z monthly 0.7 https://www.moreblossom.com/papers/serotonergic-psychedelics-in-neural-plasticity 2026-03-23T22:40:29Z monthly 0.7 https://www.moreblossom.com/papers/serotonergic-psychedelics-lsd-psilocybin-increase-the-fractal-dimension-of-corti 2026-04-16T10:39:39Z monthly 0.7 https://www.moreblossom.com/papers/serotonergic-psychedelics-temporarily-modify-information-transfer-in-humans 2026-04-16T10:39:40Z monthly 0.7 https://www.moreblossom.com/papers/serotonin-2-receptor-agonists-produce-anti-inflammatory-effects-through-function 2026-03-25T04:48:16Z monthly 0.7 https://www.moreblossom.com/papers/serotonin-2a-receptor-5-ht2ar-activation-by-25h-nbome-positional-isomers-in-vitr 2026-04-16T10:39:42Z monthly 0.7 https://www.moreblossom.com/papers/serotonin-2a-receptor-signaling-underlies-lsd-induced-alteration-of-the-neural-r 2026-05-19T11:23:44Z monthly 0.7 https://www.moreblossom.com/papers/serotonin-5-ht2-receptor-activation-prevents-allergic-asthma-in-a-mouse-model 2026-03-25T04:47:14Z monthly 0.7 https://www.moreblossom.com/papers/serotonin-and-brain-function-a-tale-of-two-receptors 2026-03-24T15:23:00Z monthly 0.7 https://www.moreblossom.com/papers/serotonin-and-serotonin-receptors-in-hallucinogen-action 2026-03-25T04:48:18Z monthly 0.7 https://www.moreblossom.com/papers/serotonin-antagonists-fail-to-alter-mdma-self-administration-in-rats 2026-04-16T10:39:45Z monthly 0.7 https://www.moreblossom.com/papers/serotonin-psychedelics-and-psychiatry 2026-03-24T15:23:06Z monthly 0.7 https://www.moreblossom.com/papers/serotonin-research-contributions-to-understanding-psychoses 2026-03-24T15:23:00Z monthly 0.7 https://www.moreblossom.com/papers/serotonin-toxicity-of-serotonergic-psychedelics 2026-04-05T19:25:51Z monthly 0.7 https://www.moreblossom.com/papers/serotonin-transporter-ibogaine-complexes-illuminate-mechanisms-of-inhibition-and 2026-04-13T18:56:05Z monthly 0.7 https://www.moreblossom.com/papers/set-and-setting-a-randomized-study-of-different-musical-genres-in-supporting-psy 2026-05-13T05:08:33Z monthly 0.7 https://www.moreblossom.com/papers/set-and-setting-in-psilocybin-assisted-therapy-a-qualitative-study-of-patients-w 2026-05-11T17:06:34Z monthly 0.7 https://www.moreblossom.com/papers/set-and-setting-in-the-santo-daime 2026-04-05T19:25:54Z monthly 0.7 https://www.moreblossom.com/papers/set-and-setting-predict-psychopathology-wellbeing-and-meaningfulness-of-psychede 2026-04-16T10:39:51Z monthly 0.7 https://www.moreblossom.com/papers/set-and-setting-psychedelics-and-the-placebo-response-an-extra-pharmacological-p 2026-03-25T06:07:15Z monthly 0.7 https://www.moreblossom.com/papers/severe-neurological-sequelae-after-a-recreational-dose-of-lsd 2026-04-13T18:56:28Z monthly 0.7 https://www.moreblossom.com/papers/sex-differences-and-serotonergic-mechanisms-in-the-behavioural-effects-of-psiloc 2026-04-16T10:39:53Z monthly 0.7 https://www.moreblossom.com/papers/sex-differences-in-sub-anesthetic-ketamines-antidepressant-effects-and-abuse-lia 2026-03-24T15:23:12Z monthly 0.7 https://www.moreblossom.com/papers/sex-differences-in-the-effects-of-mdma-ecstasy-on-plasma-copeptin-in-healthy-sub 2026-04-27T12:18:53Z monthly 0.7 https://www.moreblossom.com/papers/shame-guilt-and-psychedelic-experience-results-from-a-prospective-longitudinal-s 2026-04-05T19:25:58Z monthly 0.7 https://www.moreblossom.com/papers/shannon-entropy-of-brain-functional-complex-networks-under-the-influence-of-the- 2026-05-05T13:27:01Z monthly 0.7 https://www.moreblossom.com/papers/short-term-changes-in-the-proteome-of-human-cerebral-organoids-induced-by-5-meo- 2026-05-05T13:27:02Z monthly 0.7 https://www.moreblossom.com/papers/short-term-cognitive-effects-of-repeated-dose-esketamine-in-adolescents-with-maj 2026-05-19T14:29:17Z monthly 0.7 https://www.moreblossom.com/papers/side-effects-associated-with-ketamine-use-in-depression-a-systematic-review 2026-04-05T19:26:02Z monthly 0.7 https://www.moreblossom.com/papers/side-effects-of-mdma-assisted-psychotherapy-a-systematic-review-and-meta-analysi 2026-03-25T05:25:26Z monthly 0.7 https://www.moreblossom.com/papers/side-effects-of-microdosing-lysergic-acid-diethylamide-and-psilocybin-a-systemat 2026-04-16T10:55:41Z monthly 0.7 https://www.moreblossom.com/papers/signaling-snapshots-of-a-serotonin-receptor-activated-by-the-prototypical-psyche 2026-03-30T09:03:53Z monthly 0.7 https://www.moreblossom.com/papers/significance-of-mammalian-n-n-dimethyltryptamine-dmt-a-60-year-old-debate 2026-03-25T04:46:40Z monthly 0.7 https://www.moreblossom.com/papers/single-bolus-low-dose-of-ketamine-does-not-prevent-postpartum-depression-a-rando 2026-05-11T22:27:02Z monthly 0.7 https://www.moreblossom.com/papers/single-dose-10-mg-psilocybin-reduces-symptoms-in-adults-with-obsessive-compulsiv 2026-05-13T05:22:41Z monthly 0.7 https://www.moreblossom.com/papers/single-dose-1cp-lsd-administration-for-canine-anxiety-a-pilot-study 2026-03-24T15:23:28Z monthly 0.7 https://www.moreblossom.com/papers/single-dose-infusion-ketamine-and-non-ketamine-n-methyl-d-aspartate-receptor-ant 2026-04-05T19:26:08Z monthly 0.7 https://www.moreblossom.com/papers/single-dose-psilocybin-assisted-therapy-in-major-depressive-disorder-a-placebo-c 2026-05-13T07:55:58Z monthly 0.7 https://www.moreblossom.com/papers/single-dose-psilocybin-for-a-treatment-resistant-episode-of-major-depression 2026-05-19T09:31:49Z monthly 0.7 https://www.moreblossom.com/papers/single-dose-psilocybin-for-a-treatment-resistant-episode-of-major-depression-imp 2026-05-19T09:31:49Z monthly 0.7 https://www.moreblossom.com/papers/single-dose-psilocybin-for-depression-with-severe-treatment-resistance-an-open-l 2026-05-13T08:24:37Z monthly 0.7 https://www.moreblossom.com/papers/single-dose-psilocybin-for-treatment-resistant-obsessive-compulsive-disorder-a-c 2026-04-27T12:02:42Z monthly 0.7 https://www.moreblossom.com/papers/single-dose-psilocybin-for-u-s-military-veterans-with-severe-treatment-resistant 2026-05-19T09:31:49Z monthly 0.7 https://www.moreblossom.com/papers/single-dose-psilocybin-therapy-for-alcohol-use-disorder-pharmacokinetics-feasibi 2026-04-27T12:16:09Z monthly 0.7 https://www.moreblossom.com/papers/single-dose-psilocybin-treatment-for-major-depressive-disorder-a-randomized-clin 2026-05-19T14:10:04Z monthly 0.7 https://www.moreblossom.com/papers/single-dose-synthetic-psilocybin-with-psychotherapy-for-treatment-resistant-bipo 2026-05-13T04:38:42Z monthly 0.7 https://www.moreblossom.com/papers/single-fixed-dose-intranasal-ketamine-for-alleviation-of-acute-suicidal-ideation 2026-05-19T10:29:53Z monthly 0.7 https://www.moreblossom.com/papers/single-ketamine-infusion-and-neurocognitive-performance-in-bipolar-depression 2026-05-11T21:28:52Z monthly 0.7 https://www.moreblossom.com/papers/single-treatment-with-mm120-lysergide-in-generalized-anxiety-disorder-a-randomiz 2026-05-19T10:29:53Z monthly 0.7 https://www.moreblossom.com/papers/single-versus-repeated-sessions-of-ketamine-assisted-psychotherapy-for-people-wi 2026-05-11T21:03:55Z monthly 0.7 https://www.moreblossom.com/papers/sleep-quality-improvements-after-mdma-assisted-psychotherapy-for-the-treatment-o 2026-05-19T16:56:42Z monthly 0.7 https://www.moreblossom.com/papers/slouching-towards-engagement-interactions-between-people-using-psychedelics-natu 2026-04-16T10:40:17Z monthly 0.7 https://www.moreblossom.com/papers/so-how-special-is-special-k-a-systematic-review-and-meta-analysis-of-ketamine-fo 2026-04-05T19:26:25Z monthly 0.7 https://www.moreblossom.com/papers/socio-psychedelic-imaginaries-envisioning-and-building-legal-psychedelic-worlds- 2026-04-16T10:55:44Z monthly 0.7 https://www.moreblossom.com/papers/spatial-correspondence-of-lsd-induced-variations-of-brain-functioning-at-rest-wi 2026-04-16T10:40:22Z monthly 0.7 https://www.moreblossom.com/papers/spatiotemporal-brain-dynamics-of-emotional-face-processing-modulations-induced-b 2026-05-05T15:00:31Z monthly 0.7 https://www.moreblossom.com/papers/special-considerations-for-evaluating-psilocybin-facilitated-psychotherapy-in-vu 2026-04-16T10:55:45Z monthly 0.7 https://www.moreblossom.com/papers/spectral-changes-of-eeg-following-a-6-week-low-dose-oral-ketamine-treatment-in-a 2026-05-11T17:08:44Z monthly 0.7 https://www.moreblossom.com/papers/spectral-signatures-of-serotonergic-psychedelics-and-glutamatergic-dissociatives 2026-04-16T10:40:27Z monthly 0.7 https://www.moreblossom.com/papers/spiritual-experiences-in-psychedelic-assisted-psychotherapy-case-reports-of-comm 2026-05-13T04:52:53Z monthly 0.7 https://www.moreblossom.com/papers/spiritual-health-practitioners-contributions-to-psychedelic-assisted-therapy-a-q 2026-04-16T10:40:31Z monthly 0.7 https://www.moreblossom.com/papers/spiritual-well-being-among-users-and-non-users-of-psychedelics-a-cross-sectional 2026-04-16T10:40:33Z monthly 0.7 https://www.moreblossom.com/papers/spontaneous-and-deliberate-creative-cognition-during-and-after-psilocybin-exposu 2026-05-05T14:59:19Z monthly 0.7 https://www.moreblossom.com/papers/states-and-traits-related-to-the-quality-and-consequences-of-psychedelic-experie 2026-04-16T10:40:36Z monthly 0.7 https://www.moreblossom.com/papers/strategies-for-resolving-challenging-psychedelic-experiences-insights-from-a-mix 2026-04-16T10:55:48Z monthly 0.7 https://www.moreblossom.com/papers/strong-bipartisan-support-for-controlled-psilocybin-use-as-treatment-or-enhancem 2026-04-16T10:40:40Z monthly 0.7 https://www.moreblossom.com/papers/structural-neural-plasticity-evoked-by-rapid-acting-antidepressant-interventions 2026-03-25T05:46:44Z monthly 0.7 https://www.moreblossom.com/papers/structural-pharmacology-and-therapeutic-potential-of-5-methoxytryptamines 2026-03-25T05:50:02Z monthly 0.7 https://www.moreblossom.com/papers/structure-activity-relationship-analysis-of-psychedelics-in-a-rat-model-of-asthm 2026-03-25T04:47:15Z monthly 0.7 https://www.moreblossom.com/papers/structure-activity-relationships-of-serotonergic-5-meo-dmt-derivatives-insights- 2026-03-24T16:01:33Z monthly 0.7 https://www.moreblossom.com/papers/structure-based-discovery-of-nonhallucinogenic-psychedelic-analogs 2026-03-25T05:47:18Z monthly 0.7 https://www.moreblossom.com/papers/structure-of-a-hallucinogen-activated-gq-coupled-5-ht2a-serotonin-receptor 2026-04-16T10:40:42Z monthly 0.7 https://www.moreblossom.com/papers/studying-the-effects-of-classic-hallucinogens-in-the-treatment-of-alcoholism-rat 2026-03-30T09:03:53Z monthly 0.7 https://www.moreblossom.com/papers/sub-acute-and-long-term-effects-of-ayahuasca-on-affect-and-cognitive-thinking-st 2026-05-05T15:00:11Z monthly 0.7 https://www.moreblossom.com/papers/sub-acute-and-long-term-effects-of-ayahuasca-on-mental-health-and-well-being-in- 2026-04-16T10:40:47Z monthly 0.7 https://www.moreblossom.com/papers/sub-acute-effects-of-psilocybin-on-eeg-correlates-of-neural-plasticity-in-major- 2026-05-13T08:03:46Z monthly 0.7 https://www.moreblossom.com/papers/sub-acute-effects-of-psilocybin-on-empathy-creative-thinking-and-subjective-well 2026-04-16T10:40:49Z monthly 0.7 https://www.moreblossom.com/papers/sub-anesthetic-doses-of-ketamine-exert-antidepressant-like-effects-and-upregulat 2026-04-16T10:40:51Z monthly 0.7 https://www.moreblossom.com/papers/subacute-effects-of-a-single-dose-of-psilocybin-on-biomarkers-of-inflammation-in 2026-04-16T10:40:54Z monthly 0.7 https://www.moreblossom.com/papers/subacute-effects-of-the-psychedelic-ayahuasca-on-the-salience-and-default-mode-n 2026-04-16T10:40:56Z monthly 0.7 https://www.moreblossom.com/papers/subjective-effectiveness-of-ibogaine-treatment-for-problematic-opioid-consumptio 2026-04-16T10:40:58Z monthly 0.7 https://www.moreblossom.com/papers/subjective-effects-and-tolerability-of-the-south-american-psychoactive-beverage- 2026-04-16T10:55:51Z monthly 0.7 https://www.moreblossom.com/papers/subjective-effects-of-mdma-ecstasy-on-human-sexual-function 2026-04-16T10:41:02Z monthly 0.7 https://www.moreblossom.com/papers/subjective-features-of-the-psilocybin-experience-that-may-account-for-its-self-a 2026-04-16T10:55:52Z monthly 0.7 https://www.moreblossom.com/papers/subjective-long-term-emotional-and-social-effects-of-recreational-mdma-use-the-r 2026-04-16T10:55:53Z monthly 0.7 https://www.moreblossom.com/papers/subjective-reports-of-the-effects-of-mdma-in-a-clinical-setting 2026-05-19T10:29:54Z monthly 0.7 https://www.moreblossom.com/papers/sublingual-ketamine-for-depression-and-anxiety-a-retrospective-study-of-real-wor 2026-04-13T18:54:57Z monthly 0.7 https://www.moreblossom.com/papers/subtypes-of-the-psychedelic-experience-have-reproducible-and-predictable-effects 2026-04-16T10:41:11Z monthly 0.7 https://www.moreblossom.com/papers/survey-of-entity-encounter-experiences-occasioned-by-inhaled-nn-dimethyltryptami 2026-04-16T10:41:13Z monthly 0.7 https://www.moreblossom.com/papers/survey-of-subjective-god-encounter-experiences-comparisons-among-naturally-occur 2026-04-16T10:41:15Z monthly 0.7 https://www.moreblossom.com/papers/survey-study-of-challenging-experiences-after-ingesting-psilocybin-mushrooms-acu 2026-04-16T10:41:17Z monthly 0.7 https://www.moreblossom.com/papers/sustained-effects-of-single-doses-of-classical-psychedelics-in-humans 2026-03-30T09:03:53Z monthly 0.7 https://www.moreblossom.com/papers/sustained-multifaceted-improvements-in-mental-well-being-following-psychedelic-e 2026-04-16T10:41:19Z monthly 0.7 https://www.moreblossom.com/papers/switch-to-mania-after-ayahuasca-consumption-in-a-man-with-bipolar-disorder-a-cas 2026-04-16T10:55:55Z monthly 0.7 https://www.moreblossom.com/papers/symptom-specificity-of-ayahuascas-effect-on-depressive-symptoms 2026-04-16T10:41:23Z monthly 0.7 https://www.moreblossom.com/papers/synaptic-loss-and-the-pathophysiology-of-ptsd-implications-for-ketamine-as-a-pro 2026-03-30T09:03:53Z monthly 0.7 https://www.moreblossom.com/papers/synergistic-multi-level-understanding-of-psychedelics-three-systematic-reviews-a 2026-03-25T04:53:56Z monthly 0.7 https://www.moreblossom.com/papers/synthesis-and-k-opioid-receptor-activity-of-furan-substituted-salvinorin-a-analo 2026-04-16T10:41:25Z monthly 0.7 https://www.moreblossom.com/papers/synthesizing-the-evidence-for-ketamine-and-esketamine-in-treatment-resistant-dep 2026-03-25T05:56:07Z monthly 0.7 https://www.moreblossom.com/papers/synthetic-surprise-as-the-foundation-of-the-psychedelic-experience 2026-03-23T22:44:17Z monthly 0.7 https://www.moreblossom.com/papers/systematic-review-and-meta-analysis-of-randomized-controlled-trials-of-ketamine- 2026-04-05T19:26:58Z monthly 0.7 https://www.moreblossom.com/papers/systematized-review-of-psychotherapeutic-components-of-psilocybin-assisted-psych 2026-04-05T19:26:59Z monthly 0.7 https://www.moreblossom.com/papers/systemic-enhancement-of-serotonin-signaling-reverses-social-deficits-in-multiple 2026-03-24T15:24:24Z monthly 0.7 https://www.moreblossom.com/papers/taking-psychedelics-seriously 2026-04-05T19:27:00Z monthly 0.7 https://www.moreblossom.com/papers/targeting-glutamate-signalling-in-depression-progress-and-prospects 2026-03-30T09:03:53Z monthly 0.7 https://www.moreblossom.com/papers/targeting-inflammation-in-depression-ketamine-as-an-anti-inflammatory-antidepres 2026-03-24T15:24:24Z monthly 0.7 https://www.moreblossom.com/papers/the-34-methylenedioxymethamphetamine-enhances-early-visual-processing-for-salien 2026-04-16T10:41:26Z monthly 0.7 https://www.moreblossom.com/papers/the-5-ht2a-1a-agonist-psilocybin-disrupts-modal-object-completion-associated-wit 2026-04-16T10:41:28Z monthly 0.7 https://www.moreblossom.com/papers/the-abuse-potential-of-medical-psilocybin-according-to-the-8-factors-of-the-cont 2026-03-24T15:41:12Z monthly 0.7 https://www.moreblossom.com/papers/the-acute-effects-of-psychoactive-drugs-on-emotional-episodic-memory-encoding-co 2026-04-16T10:41:30Z monthly 0.7 https://www.moreblossom.com/papers/the-acute-effects-of-the-atypical-dissociative-hallucinogen-salvinorin-a-on-func 2026-04-16T10:55:56Z monthly 0.7 https://www.moreblossom.com/papers/the-administration-of-psilocybin-to-healthy-hallucinogen-experienced-volunteers- 2026-04-16T10:41:33Z monthly 0.7 https://www.moreblossom.com/papers/the-adverse-events-of-ibogaine-in-humans-an-updated-systematic-review-of-the-lit 2026-04-05T19:27:04Z monthly 0.7 https://www.moreblossom.com/papers/the-alkaloids-of-banisteriopsis-caapi-the-plant-source-of-the-amazonian-hallucin 2026-05-19T11:22:55Z monthly 0.7 https://www.moreblossom.com/papers/the-altered-states-database-psychometric-data-from-a-systematic-literature-revie 2026-03-23T22:44:47Z monthly 0.7 https://www.moreblossom.com/papers/the-anterior-cingulate-cortex-as-a-key-locus-of-ketamines-antidepressant-action 2026-04-16T10:55:58Z monthly 0.7 https://www.moreblossom.com/papers/the-anti-addiction-drug-ibogaine-and-the-heart-a-delicate-relation 2026-03-24T15:24:29Z monthly 0.7 https://www.moreblossom.com/papers/the-antiaddictive-effects-of-ibogaine-a-systematic-literature-review-of-human-st 2026-04-05T19:27:05Z monthly 0.7 https://www.moreblossom.com/papers/the-antidepressant-effects-of-vaporized-nn-dimethyltryptamine-a-preliminary-repo 2026-05-19T14:50:25Z monthly 0.7 https://www.moreblossom.com/papers/the-association-between-naturalistic-use-of-psychedelics-and-co-occurring-substa 2026-04-16T10:41:37Z monthly 0.7 https://www.moreblossom.com/papers/the-association-of-psychedelic-use-and-opioid-use-disorders-among-illicit-users- 2026-04-16T10:41:39Z monthly 0.7 https://www.moreblossom.com/papers/the-associations-of-naturalistic-classic-psychedelic-use-mystical-experience-and 2026-04-16T10:41:41Z monthly 0.7 https://www.moreblossom.com/papers/the-australia-story-current-status-and-future-challenges-for-the-clinical-applic 2026-03-24T15:40:29Z monthly 0.7 https://www.moreblossom.com/papers/the-behavioral-pharmacology-of-hallucinogens 2026-03-24T15:41:24Z monthly 0.7 https://www.moreblossom.com/papers/the-bodily-self-from-psychosis-to-psychedelics 2026-04-16T10:55:59Z monthly 0.7 https://www.moreblossom.com/papers/the-canadian-psychedelic-survey-characteristics-patterns-of-use-and-access-in-a- 2026-04-16T10:41:44Z monthly 0.7 https://www.moreblossom.com/papers/the-challenges-ahead-for-psychedelic-medicine 2026-03-30T09:03:53Z monthly 0.7 https://www.moreblossom.com/papers/the-challenging-experience-questionnaire-characterization-of-challenging-experie 2026-04-16T10:41:46Z monthly 0.7 https://www.moreblossom.com/papers/the-chemical-induction-of-synaesthesia 2026-04-16T10:41:48Z monthly 0.7 https://www.moreblossom.com/papers/the-classic-psychedelic-doi-induces-a-persistent-desynchronized-state-in-medial- 2026-03-24T15:41:25Z monthly 0.7 https://www.moreblossom.com/papers/the-clinical-pharmacology-and-potential-therapeutic-applications-of-5-methoxy-nn 2026-03-30T09:03:53Z monthly 0.7 https://www.moreblossom.com/papers/the-conceptual-framework-for-the-therapeutic-approach-used-in-phase-3-trials-of- 2026-05-05T15:00:08Z monthly 0.7 https://www.moreblossom.com/papers/the-correlation-between-ketamine-and-posttraumatic-stress-disorder-in-burned-ser 2026-04-13T18:54:25Z monthly 0.7 https://www.moreblossom.com/papers/the-correlation-of-esketamine-with-specific-adverse-events-a-deep-dive-into-the- 2026-04-13T18:56:31Z monthly 0.7 https://www.moreblossom.com/papers/the-cost-effectiveness-of-mdma-assisted-psychotherapy-for-the-treatment-of-chron 2026-04-05T19:27:15Z monthly 0.7 https://www.moreblossom.com/papers/the-costs-and-health-benefits-of-expanded-access-to-mdma-assisted-therapy-for-ch 2026-04-05T19:27:16Z monthly 0.7 https://www.moreblossom.com/papers/the-current-state-of-research-on-ayahuasca-a-systematic-review-of-human-studies- 2026-04-05T19:27:17Z monthly 0.7 https://www.moreblossom.com/papers/the-default-mode-ego-functions-and-free-energy-a-neurobiological-account-of-freu 2026-04-16T10:41:51Z monthly 0.7 https://www.moreblossom.com/papers/the-difference-between-placebo-group-and-placebo-control-a-case-study-in-psyched 2026-04-16T10:56:00Z monthly 0.7 https://www.moreblossom.com/papers/the-dmt-and-psilocin-treatment-changes-cd11b-activated-microglia-immunological-p 2026-03-24T15:40:29Z monthly 0.7 https://www.moreblossom.com/papers/the-effect-of-a-single-dose-of-intravenous-ketamine-on-suicidal-ideation-a-syste 2026-05-05T15:01:03Z monthly 0.7 https://www.moreblossom.com/papers/the-effect-of-acutely-administered-mdma-on-subjective-and-bold-fmri-responses-to 2026-05-05T13:31:50Z monthly 0.7 https://www.moreblossom.com/papers/the-effect-of-banisteriopsis-caapi-b-caapi-on-the-motor-deficits-in-the-mptp-tre 2026-04-13T18:55:50Z monthly 0.7 https://www.moreblossom.com/papers/the-effect-of-esketamine-in-patients-with-treatment-resistant-depression-with-an 2026-05-19T10:29:54Z monthly 0.7 https://www.moreblossom.com/papers/the-effect-of-ketamine-on-cognition-anxiety-and-social-functioning-in-adults-wit 2026-04-05T19:27:24Z monthly 0.7 https://www.moreblossom.com/papers/the-effect-of-ketamine-on-preventing-postpartum-depression 2026-05-12T13:57:22Z monthly 0.7 https://www.moreblossom.com/papers/the-effect-of-lysergic-acid-diethylamide-lsd-on-whole-brain-functional-and-effec 2026-04-16T10:42:00Z monthly 0.7 https://www.moreblossom.com/papers/the-effect-of-mdma-on-anterior-pituitary-hormones-a-secondary-analysis-of-a-rand 2026-04-27T12:15:51Z monthly 0.7 https://www.moreblossom.com/papers/the-effect-of-methamphetamine-and-34-methylenedioxymethamphetamine-on-peripheral 2026-04-05T19:27:27Z monthly 0.7 https://www.moreblossom.com/papers/the-effect-of-psychedelics-on-individuals-with-a-personality-disorder-results-fr 2026-04-16T10:42:03Z monthly 0.7 https://www.moreblossom.com/papers/the-effect-of-single-administration-of-intravenous-ketamine-augmentation-on-suic 2026-05-12T09:47:39Z monthly 0.7 https://www.moreblossom.com/papers/the-effectiveness-of-microdosed-psilocybin-in-the-treatment-of-neuropsychiatric- 2026-04-16T10:42:05Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-acutely-administered-3-4-methylenedioxymethamphetamine-on-spontan 2026-05-05T13:31:52Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-daytime-psilocybin-administration-on-sleep-implications-for-antid 2026-04-27T11:57:47Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-drugs-on-behavior-maintained-by-social-contact-role-of-monoamines 2026-03-24T15:40:35Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-ecstasy-on-neurotransmitter-systems-a-review-on-the-findings-of-m 2026-04-05T19:27:30Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-hallucinogens-on-gene-expression 2026-03-25T04:47:17Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-ketamine-and-classic-hallucinogens-on-neurotrophic-and-inflammato 2026-03-24T15:41:42Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-ketamine-on-symptoms-of-depression-and-anxiety-in-real-world-care 2026-04-16T10:42:12Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-low-dose-ketamine-on-the-prefrontal-cortex-and-amygdala-in-treatm 2026-05-11T21:40:50Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-mdma-assisted-therapy-on-alcohol-and-substance-use-in-a-phase-3-t 2026-05-19T08:07:32Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-mdma-on-socio-emotional-processing-does-mdma-differ-from-other-st 2026-03-25T05:26:02Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-microdose-lsd-on-time-perception-a-randomised-double-blind-placeb 2026-04-27T12:18:44Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-psilocybin-and-mdma-on-between-network-resting-state-functional-c 2026-04-16T10:42:18Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-psilocybin-in-adults-with-major-depressive-disorder-and-the-gener 2026-04-16T10:56:07Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-psilocybin-on-cognitive-and-emotional-functions-in-healthy-partic 2026-04-16T10:42:20Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-psilocybin-therapy-versus-escitalopram-on-cognitive-bias-a-second 2026-05-19T16:12:05Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-the-preferential-5-ht2a-agonist-psilocybin-on-prepulse-inhibition 2026-04-16T10:56:08Z monthly 0.7 https://www.moreblossom.com/papers/the-effects-of-tryptamine-psychedelics-in-the-brain-a-meta-analysis-of-functiona 2026-03-24T15:41:54Z monthly 0.7 https://www.moreblossom.com/papers/the-efficacy-of-ketamine-in-the-palliative-care-setting-a-comprehensive-review-o 2026-04-05T19:27:41Z monthly 0.7 https://www.moreblossom.com/papers/the-ego-in-psychedelic-drug-action-ego-defenses-ego-boundaries-and-the-therapeut 2026-05-05T13:32:10Z monthly 0.7 https://www.moreblossom.com/papers/the-emerging-role-of-psilocybin-and-mdma-in-the-treatment-of-mental-illness 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/the-emerging-science-of-microdosing-a-systematic-review-of-research-on-low-dose- 2026-03-25T05:52:29Z monthly 0.7 https://www.moreblossom.com/papers/the-empathogen-34-methylenedioxymethamphetamine-but-not-methamphetamine-increase 2026-04-16T10:42:26Z monthly 0.7 https://www.moreblossom.com/papers/the-endogenous-hallucinogen-and-trace-amine-nn-dimethyltryptamine-dmt-displays-p 2026-04-13T18:55:51Z monthly 0.7 https://www.moreblossom.com/papers/the-entropic-brain-a-theory-of-conscious-states-informed-by-neuroimaging-researc 2026-03-24T15:41:54Z monthly 0.7 https://www.moreblossom.com/papers/the-entropic-brain-revisited 2026-03-24T15:41:54Z monthly 0.7 https://www.moreblossom.com/papers/the-entropic-heart-tracking-the-psychedelic-state-via-heart-rate-dynamics 2026-04-16T10:42:27Z monthly 0.7 https://www.moreblossom.com/papers/the-entropic-tongue-disorganization-of-natural-language-under-lsd 2026-04-16T10:42:29Z monthly 0.7 https://www.moreblossom.com/papers/the-epidemiology-of-5-methoxy-n-n-dimethyltryptamine-5-meo-dmt-use-benefits-cons 2026-04-16T10:42:31Z monthly 0.7 https://www.moreblossom.com/papers/the-epidemiology-of-mescaline-use-pattern-of-use-motivations-for-consumption-and 2026-04-16T10:42:32Z monthly 0.7 https://www.moreblossom.com/papers/the-experience-elicited-by-hallucinogens-presents-the-highest-similarity-to-drea 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/the-experimental-effects-of-psilocybin-on-symptoms-of-anxiety-and-depression-a-m 2026-03-25T06:06:09Z monthly 0.7 https://www.moreblossom.com/papers/the-fabric-of-meaning-and-subjective-effects-in-lsd-induced-states-depend-on-ser 2026-05-19T11:23:46Z monthly 0.7 https://www.moreblossom.com/papers/the-fibrinolytic-system-a-new-target-for-treatment-of-depression-with-psychedeli 2026-03-24T15:42:06Z monthly 0.7 https://www.moreblossom.com/papers/the-forgotten-psychedelic-spatiotemporal-mapping-of-brain-organisation-following 2026-04-27T12:06:27Z monthly 0.7 https://www.moreblossom.com/papers/the-frontiers-of-new-psychedelic-therapies-a-survey-of-sociological-themes-and-i 2026-04-16T10:42:34Z monthly 0.7 https://www.moreblossom.com/papers/the-hallucinogen-d-lysergic-diethylamide-lsd-decreases-dopamine-firing-activity- 2026-03-25T06:11:42Z monthly 0.7 https://www.moreblossom.com/papers/the-hallucinogenic-world-of-tryptamines-an-updated-review 2026-03-24T15:42:06Z monthly 0.7 https://www.moreblossom.com/papers/the-heffter-research-institute-past-and-hopeful-future 2026-04-16T10:42:35Z monthly 0.7 https://www.moreblossom.com/papers/the-hidden-therapist-evidence-for-a-central-role-of-music-in-psychedelic-therapy 2026-05-11T17:06:06Z monthly 0.7 https://www.moreblossom.com/papers/the-history-of-mdma-as-an-underground-drug-in-the-united-states-1960-1979 2026-03-23T22:47:35Z monthly 0.7 https://www.moreblossom.com/papers/the-history-of-psychedelics-in-psychiatry 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/the-iboga-alkaloids 2026-03-24T15:42:06Z monthly 0.7 https://www.moreblossom.com/papers/the-ibogaine-medical-subculture 2026-04-13T18:56:06Z monthly 0.7 https://www.moreblossom.com/papers/the-impact-of-antidepressant-discontinuation-prior-to-treatment-with-psilocybin- 2026-05-19T09:31:50Z monthly 0.7 https://www.moreblossom.com/papers/the-impact-of-ayahuasca-on-suicidality-results-from-a-randomized-controlled-tria 2026-05-05T14:59:32Z monthly 0.7 https://www.moreblossom.com/papers/the-impact-of-childhood-maltreatment-on-intravenous-ketamine-outcomes-for-adult- 2026-04-27T18:03:43Z monthly 0.7 https://www.moreblossom.com/papers/the-impact-of-psychedelics-on-patients-with-alcohol-use-disorder-a-systematic-re 2026-04-05T19:27:49Z monthly 0.7 https://www.moreblossom.com/papers/the-induction-of-synaesthesia-with-chemical-agents-a-systematic-review 2026-04-16T10:56:11Z monthly 0.7 https://www.moreblossom.com/papers/the-influence-of-ceremonial-settings-on-mystical-and-challenging-experiences-occ 2026-04-16T10:42:41Z monthly 0.7 https://www.moreblossom.com/papers/the-influence-of-psilocybin-on-subconscious-and-conscious-emotional-learning 2026-04-27T12:19:27Z monthly 0.7 https://www.moreblossom.com/papers/the-influence-of-therapists-first-hand-experience-with-psychedelics-on-psychedel 2026-04-16T10:42:44Z monthly 0.7 https://www.moreblossom.com/papers/the-integration-of-classic-psychedelics-into-current-substance-use-disorder-trea 2026-03-24T15:40:48Z monthly 0.7 https://www.moreblossom.com/papers/the-kappa-opioid-receptor-and-the-sleep-of-reason-cortico-subcortical-imbalance- 2026-04-16T10:42:46Z monthly 0.7 https://www.moreblossom.com/papers/the-ketamine-analogue-methoxetamine-and-3-and-4-methoxy-analogues-of-phencyclidi 2026-04-13T18:56:32Z monthly 0.7 https://www.moreblossom.com/papers/the-meaning-enhancing-properties-of-psychedelics-and-their-mediator-role-in-psyc 2026-03-25T06:07:16Z monthly 0.7 https://www.moreblossom.com/papers/the-mechanisms-of-psychedelic-visionary-experiences-hypotheses-from-evolutionary 2026-03-25T05:13:33Z monthly 0.7 https://www.moreblossom.com/papers/the-mixed-serotonin-receptor-agonist-psilocybin-reduces-threat-induced-modulatio 2026-04-13T18:45:38Z monthly 0.7 https://www.moreblossom.com/papers/the-moderating-role-of-mystical-type-experiences-on-the-relationship-between-exi 2026-04-16T10:42:48Z monthly 0.7 https://www.moreblossom.com/papers/the-need-for-psychedelic-assisted-therapy-in-the-black-community-and-the-burdens 2026-03-24T15:40:54Z monthly 0.7 https://www.moreblossom.com/papers/the-need-for-publicly-funded-research-on-therapeutic-use-of-psychedelic-drugs 2026-03-24T15:42:18Z monthly 0.7 https://www.moreblossom.com/papers/the-neural-basis-of-psychedelic-action 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/the-neurobiology-of-depression-ketamine-and-rapid-acting-antidepressants-is-it-g 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/the-neurobiology-of-psychedelic-drugs-implications-for-the-treatment-of-mood-dis 2026-03-24T15:42:18Z monthly 0.7 https://www.moreblossom.com/papers/the-nmda-antagonist-ketamine-and-the-5-ht-agonist-psilocybin-produce-dissociable 2026-04-16T10:56:13Z monthly 0.7 https://www.moreblossom.com/papers/the-non-hallucinogen-2-bromo-lysergic-acid-diethylamide-as-preventative-treatmen 2026-04-16T10:42:52Z monthly 0.7 https://www.moreblossom.com/papers/the-non-hallucinogenic-serotonin-1b-receptor-is-necessary-for-the-antidepressant 2026-03-24T15:42:18Z monthly 0.7 https://www.moreblossom.com/papers/the-nucleus-accumbens-and-ketamine-treatment-in-major-depressive-disorder 2026-04-13T10:37:21Z monthly 0.7 https://www.moreblossom.com/papers/the-paradoxical-psychological-effects-of-lysergic-acid-diethylamide-lsd 2026-04-16T10:42:53Z monthly 0.7 https://www.moreblossom.com/papers/the-patients-perspective-on-the-effects-of-intranasal-esketamine-in-treatment-re 2026-04-13T18:55:00Z monthly 0.7 https://www.moreblossom.com/papers/the-peak-experience-variable-in-dpt-assisted-psychotherapy-with-cancer-patients 2026-05-13T10:01:40Z monthly 0.7 https://www.moreblossom.com/papers/the-persistence-of-the-subjective-in-neuropsychopharmacology-observations-of-con 2026-03-24T15:42:24Z monthly 0.7 https://www.moreblossom.com/papers/the-pharmacokinetics-and-pharmacodynamics-of-ibogaine-in-opioid-use-disorder-pat 2026-04-27T12:18:29Z monthly 0.7 https://www.moreblossom.com/papers/the-pharmacology-of-lysergic-acid-diethylamide-a-review 2026-03-24T16:02:12Z monthly 0.7 https://www.moreblossom.com/papers/the-pharmacology-of-psilocybin 2026-03-24T15:42:24Z monthly 0.7 https://www.moreblossom.com/papers/the-phenomenology-and-potential-religious-import-of-states-of-consciousness-faci 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/the-phenomenology-of-psilocybins-experience-mediates-subsequent-persistent-psych 2026-05-05T14:59:49Z monthly 0.7 https://www.moreblossom.com/papers/the-polypharmacology-of-psychedelics-reveals-multiple-targets-for-potential-ther 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/the-potential-dangers-of-using-mdma-for-psychotherapy 2026-04-05T19:27:58Z monthly 0.7 https://www.moreblossom.com/papers/the-potential-economic-and-public-health-impact-of-mdma-assisted-group-therapy-f 2026-04-16T10:42:57Z monthly 0.7 https://www.moreblossom.com/papers/the-potential-of-5-methoxy-nn-dimethyltryptamine-in-the-treatment-of-alcohol-use 2026-03-24T16:02:12Z monthly 0.7 https://www.moreblossom.com/papers/the-potential-of-psychedelics-for-the-treatment-of-alzheimers-disease-and-relate 2026-04-16T10:56:15Z monthly 0.7 https://www.moreblossom.com/papers/the-potential-of-psychedelics-for-the-treatment-of-episodic-migraine 2026-03-25T05:02:15Z monthly 0.7 https://www.moreblossom.com/papers/the-potential-pro-cognitive-effects-with-intravenous-subanesthetic-ketamine-in-a 2026-04-13T10:37:21Z monthly 0.7 https://www.moreblossom.com/papers/the-potential-role-of-psychedelic-drugs-in-mental-health-care-of-the-future 2026-03-25T05:01:12Z monthly 0.7 https://www.moreblossom.com/papers/the-potential-synergistic-effects-between-psychedelic-administration-and-nature- 2026-05-05T14:59:51Z monthly 0.7 https://www.moreblossom.com/papers/the-potential-use-of-n-methyl-34-methylenedioxyamphetamine-mdma-assisted-psychot 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/the-power-of-social-attribution-perspectives-on-the-healing-efficacy-of-ayahuasc 2026-04-16T10:42:59Z monthly 0.7 https://www.moreblossom.com/papers/the-promise-of-psychedelic-science 2026-03-24T15:41:00Z monthly 0.7 https://www.moreblossom.com/papers/the-prosocial-effects-of-3-4-methylenedioxymethamphetamine-mdma-controlled-studi 2026-03-25T05:14:49Z monthly 0.7 https://www.moreblossom.com/papers/the-psychedelic-debriefing-in-alcohol-dependence-treatment-illustrating-key-chan 2026-05-13T05:04:38Z monthly 0.7 https://www.moreblossom.com/papers/the-psychedelic-integration-scales-tools-for-measuring-psychedelic-integration-b 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/the-psychedelic-model-of-schizophrenia-the-case-of-nn-dimethyltryptamine 2026-03-24T15:42:31Z monthly 0.7 https://www.moreblossom.com/papers/the-psychedelic-mystical-experience-in-the-human-encounter-with-death 2026-03-24T16:02:16Z monthly 0.7 https://www.moreblossom.com/papers/the-psychedelic-nn-dipropyltryptamine-prevents-seizures-in-a-mouse-model-of-frag 2026-03-24T15:41:00Z monthly 0.7 https://www.moreblossom.com/papers/the-psychedelic-personality-personality-structure-and-associations-in-a-sample-o 2026-04-16T10:43:04Z monthly 0.7 https://www.moreblossom.com/papers/the-psychedelic-renaissance-in-clinical-research-a-bibliometric-analysis-of-thre 2026-03-24T15:41:00Z monthly 0.7 https://www.moreblossom.com/papers/the-psychedelic-state-induced-by-ayahuasca-modulates-the-activity-and-connectivi 2026-05-05T13:27:04Z monthly 0.7 https://www.moreblossom.com/papers/the-psychological-and-human-brain-effects-of-music-in-combination-with-psychedel 2026-04-13T10:37:21Z monthly 0.7 https://www.moreblossom.com/papers/the-psychological-and-physiological-effects-of-mdma-on-normal-volunteers 2026-04-16T10:43:08Z monthly 0.7 https://www.moreblossom.com/papers/the-psychology-of-philosophy-associating-philosophical-views-with-psychological- 2026-04-16T10:56:17Z monthly 0.7 https://www.moreblossom.com/papers/the-psychopharmacology-of-hallucinogens 2026-03-24T16:02:19Z monthly 0.7 https://www.moreblossom.com/papers/the-psychoplastogen-tabernanthalog-induces-neuroplasticity-without-proximate-imm 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/the-rapid-antidepressant-effectiveness-of-repeated-dose-of-intravenous-ketamine- 2026-04-05T19:28:06Z monthly 0.7 https://www.moreblossom.com/papers/the-readiness-of-psychiatrists-to-implement-psychedelic-assisted-psychotherapy 2026-04-16T10:43:12Z monthly 0.7 https://www.moreblossom.com/papers/the-relation-between-naturalistic-use-of-psychedelics-and-perception-of-emotiona 2026-04-16T10:43:13Z monthly 0.7 https://www.moreblossom.com/papers/the-relationship-between-dissociation-and-antidepressant-effects-of-esketamine-n 2026-04-27T12:10:17Z monthly 0.7 https://www.moreblossom.com/papers/the-relationship-between-naturalistic-psychedelic-use-and-clinical-care-in-canad 2026-04-16T10:43:16Z monthly 0.7 https://www.moreblossom.com/papers/the-relationship-between-subjective-effects-induced-by-a-single-dose-of-ketamine 2026-04-05T19:28:11Z monthly 0.7 https://www.moreblossom.com/papers/the-relationship-between-the-default-mode-network-and-the-theory-of-mind-network 2026-04-16T10:56:19Z monthly 0.7 https://www.moreblossom.com/papers/the-relationships-of-classic-psychedelic-use-with-criminal-behavior-in-the-unite 2026-04-16T10:43:18Z monthly 0.7 https://www.moreblossom.com/papers/the-rise-of-psilocybin-use-in-the-united-states-a-multisource-observational-stud 2026-04-16T10:43:19Z monthly 0.7 https://www.moreblossom.com/papers/the-risk-of-chronic-psychedelic-and-mdma-microdosing-for-valvular-heart-disease 2026-03-24T15:42:50Z monthly 0.7 https://www.moreblossom.com/papers/the-ritual-use-of-ayahuasca-during-treatment-of-severe-physical-illnesses-a-qual 2026-04-16T10:43:21Z monthly 0.7 https://www.moreblossom.com/papers/the-role-of-5-ht2a-5-ht2c-and-mglu2-receptors-in-the-behavioral-effects-of-trypt 2026-04-13T18:55:52Z monthly 0.7 https://www.moreblossom.com/papers/the-role-of-extracellular-serotonin-and-mdma-in-the-sensitizing-effects-of-mdma 2026-04-16T10:43:23Z monthly 0.7 https://www.moreblossom.com/papers/the-role-of-ketamine-in-treatment-resistant-depression-a-systematic-review 2026-04-05T19:28:16Z monthly 0.7 https://www.moreblossom.com/papers/the-role-of-music-in-psychedelic-assisted-therapy-a-comparative-analysis-of-neur 2026-03-24T15:41:06Z monthly 0.7 https://www.moreblossom.com/papers/the-role-of-the-dorsolateral-prefrontal-cortex-in-ego-dissolution-and-emotional- 2026-04-16T10:43:24Z monthly 0.7 https://www.moreblossom.com/papers/the-role-of-the-psychedelic-experience-in-psilocybin-treatment-for-treatment-res 2026-05-19T12:57:45Z monthly 0.7 https://www.moreblossom.com/papers/the-safety-and-efficacy-of-34-methylenedioxymethamphetamine-assisted-psychothera 2026-05-19T10:29:55Z monthly 0.7 https://www.moreblossom.com/papers/the-serotonergic-hallucinogen-5-methoxy-nn-dimethyltryptamine-disrupts-cortical- 2026-04-05T19:28:21Z monthly 0.7 https://www.moreblossom.com/papers/the-serotonin-5-ht2c-receptor-and-the-non-addictive-nature-of-classic-hallucinog 2026-03-24T15:42:56Z monthly 0.7 https://www.moreblossom.com/papers/the-serotonin-hallucinogen-5-meo-dmt-alters-cortico-thalamic-activity-in-freely- 2026-04-16T10:56:20Z monthly 0.7 https://www.moreblossom.com/papers/the-shipibo-ceremonial-use-of-ayahuasca-to-promote-well-being-an-observational-s 2026-04-16T10:43:30Z monthly 0.7 https://www.moreblossom.com/papers/the-socialization-of-hallucinations-cultural-priors-social-interactions-and-cont 2026-04-16T10:43:32Z monthly 0.7 https://www.moreblossom.com/papers/the-structural-diversity-of-psychedelic-drug-actions-revealed 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/the-subjective-effects-of-psychedelics-are-necessary-for-their-enduring-therapeu 2026-03-24T15:41:06Z monthly 0.7 https://www.moreblossom.com/papers/the-subjective-effects-of-psychedelics-may-not-be-necessary-for-their-enduring-t 2026-03-24T15:41:06Z monthly 0.7 https://www.moreblossom.com/papers/the-therapeutic-alliance-between-study-participants-and-intervention-facilitator 2026-05-19T17:08:56Z monthly 0.7 https://www.moreblossom.com/papers/the-therapeutic-alliance-in-psychedelic-assisted-psychotherapy-a-novel-target-fo 2026-03-24T15:41:13Z monthly 0.7 https://www.moreblossom.com/papers/the-therapeutic-potential-of-microdosing-psychedelics-in-depression 2026-04-10T12:33:44Z monthly 0.7 https://www.moreblossom.com/papers/the-therapeutic-potential-of-psychedelic-drugs-past-present-and-future 2026-03-24T16:02:27Z monthly 0.7 https://www.moreblossom.com/papers/the-therapeutic-potential-of-psychedelics-the-european-regulatory-perspective 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/the-therapeutic-potentials-of-ayahuasca-possible-effects-against-various-disease 2026-03-25T05:13:36Z monthly 0.7 https://www.moreblossom.com/papers/the-unique-neural-signature-of-your-trip-functional-connectome-fingerprints-of-s 2026-04-27T12:14:30Z monthly 0.7 https://www.moreblossom.com/papers/the-use-of-illicit-drugs-as-self-medication-in-the-treatment-of-cluster-headache 2026-04-16T10:43:37Z monthly 0.7 https://www.moreblossom.com/papers/the-use-of-ketamine-as-an-antidepressant-a-systematic-review-and-meta-analysis 2026-04-05T19:28:24Z monthly 0.7 https://www.moreblossom.com/papers/the-use-of-psychedelic-agents-with-autistic-schizophrenic-children 2026-03-24T15:43:08Z monthly 0.7 https://www.moreblossom.com/papers/the-use-of-salvia-divinorum-from-a-mazatec-perspective 2026-03-24T15:41:12Z monthly 0.7 https://www.moreblossom.com/papers/the-use-of-the-psychological-flexibility-model-to-support-psychedelic-assisted-t 2026-04-16T10:43:39Z monthly 0.7 https://www.moreblossom.com/papers/the-varieties-of-the-psychedelic-experience-a-preliminary-study-of-the-associati 2026-04-05T19:28:26Z monthly 0.7 https://www.moreblossom.com/papers/the-viability-of-microdosing-psychedelics-as-a-strategy-to-enhance-cognition-and 2026-03-24T15:41:12Z monthly 0.7 https://www.moreblossom.com/papers/the-watts-connectedness-scale-a-new-scale-for-measuring-a-sense-of-connectedness 2026-04-16T10:56:21Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-alliance-and-rapport-modulate-responses-to-psilocybin-assisted-thera 2026-05-13T07:37:59Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-effect-of-an-ayahuasca-analogue-in-clinically-depressed-patients-a-l 2026-04-16T10:56:23Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-effect-of-increased-openness-investigating-mechanism-of-action-in-md 2026-05-19T10:29:55Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-effect-of-psilocybin-in-addiction-a-systematic-review 2026-04-05T19:28:31Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-effects-of-classic-serotonergic-psychedelics-a-systematic-review-of- 2026-04-05T19:28:33Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-effects-of-ritual-ayahuasca-use-in-the-treatment-of-substance-depend 2026-04-16T10:43:49Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-emergence-of-dissociated-traumatic-memories-during-psilocybin-treatm 2026-05-12T20:07:43Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-infusions-of-ketamine-do-the-psychoactive-effects-matter 2026-05-19T10:29:56Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-mechanisms-of-classic-hallucinogens-in-the-treatment-of-addictions-f 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-mechanisms-of-psilocybin-changes-in-amygdala-and-prefrontal-function 2026-05-13T05:46:40Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-mechanisms-of-psychedelics-and-entactogens 2026-03-24T15:43:20Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-potential-ascribed-to-ayahuasca-by-users-in-the-czech-republic 2026-04-16T10:43:52Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-potential-of-ketamine-for-alcohol-use-disorder 2026-03-24T15:43:20Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-potential-of-psilocybin-for-treating-psychological-distress-among-su 2026-04-16T10:43:54Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-potentials-of-ketamine-and-esketamine-in-ocd-sud-ed 2026-03-25T06:13:16Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-substance-current-practice-and-therapeutic-conduct-in-preparatory-se 2026-04-05T19:28:39Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-use-of-classic-psychedelics-to-treat-cancer-related-psychiatric-dist 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-use-of-lsd-in-psychiatry-a-systematic-review-of-randomized-controlle 2026-04-16T10:56:26Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-use-of-psilocybin-practical-considerations-for-dosing-and-administra 2026-03-24T16:02:37Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-use-of-serotoninergic-hallucinogens-a-review-of-the-evidence-and-of- 2026-03-24T15:43:20Z monthly 0.7 https://www.moreblossom.com/papers/therapeutic-uses-of-psychedelics-for-eating-disorders-and-body-dysmorphic-disord 2026-04-05T19:28:41Z monthly 0.7 https://www.moreblossom.com/papers/this-is-something-that-changed-my-life-a-qualitative-study-of-patients-experienc 2026-05-11T17:08:36Z monthly 0.7 https://www.moreblossom.com/papers/three-cases-of-reported-improvement-in-microsmia-and-anosmia-following-naturalis 2026-04-16T10:43:58Z monthly 0.7 https://www.moreblossom.com/papers/three-decades-of-research-on-the-development-of-ibogaine-treatment-of-substance- 2026-03-24T15:43:26Z monthly 0.7 https://www.moreblossom.com/papers/time-course-of-pharmacokinetic-and-hormonal-effects-of-inhaled-high-dose-salvino 2026-04-16T10:44:00Z monthly 0.7 https://www.moreblossom.com/papers/time-is-of-the-essence-coupling-sleep-wake-and-circadian-neurobiology-to-the-ant 2026-03-24T15:43:26Z monthly 0.7 https://www.moreblossom.com/papers/time-resolved-network-control-analysis-links-reduced-control-energy-under-dmt-wi 2026-04-13T18:40:21Z monthly 0.7 https://www.moreblossom.com/papers/time-resolved-neural-and-experience-dynamics-of-medium-and-high-dose-dmt 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/tms-eeg-and-resting-state-eeg-applied-to-altered-states-of-consciousness-oscilla 2026-04-16T10:44:02Z monthly 0.7 https://www.moreblossom.com/papers/topographic-pharmaco-eeg-mapping-of-the-effects-of-the-south-american-psychoacti 2026-04-16T10:44:04Z monthly 0.7 https://www.moreblossom.com/papers/toward-a-contextual-psychedelic-assisted-therapy-perspectives-from-acceptance-an 2026-04-16T10:44:06Z monthly 0.7 https://www.moreblossom.com/papers/toward-a-positive-psychology-of-psychoactive-drug-use 2026-03-24T15:43:32Z monthly 0.7 https://www.moreblossom.com/papers/towards-an-understanding-of-psychedelic-induced-neuroplasticity 2026-03-25T06:10:39Z monthly 0.7 https://www.moreblossom.com/papers/towards-new-mechanisms-an-update-on-therapeutics-for-treatment-resistant-major-d 2026-03-25T05:23:04Z monthly 0.7 https://www.moreblossom.com/papers/towards-psychedelic-apprenticeship-developing-a-gentle-touch-for-the-mediation-a 2026-04-16T10:44:07Z monthly 0.7 https://www.moreblossom.com/papers/toxicities-associated-with-nbome-ingestion-a-novel-class-of-potent-hallucinogens 2026-04-05T19:28:45Z monthly 0.7 https://www.moreblossom.com/papers/traditional-amazonian-medicine-in-addiction-treatment-qualitative-results 2026-04-16T10:56:27Z monthly 0.7 https://www.moreblossom.com/papers/trait-mindfulness-and-personality-characteristics-in-a-microdosing-adhd-sample-a 2026-04-16T10:44:10Z monthly 0.7 https://www.moreblossom.com/papers/trait-openness-and-serotonin-2a-receptors-in-healthy-volunteers-a-positron-emiss 2026-04-16T10:44:11Z monthly 0.7 https://www.moreblossom.com/papers/trajectory-of-antidepressant-effects-after-single-or-two-dose-administration-of- 2026-03-24T15:43:39Z monthly 0.7 https://www.moreblossom.com/papers/transcriptomics-informed-large-scale-cortical-model-captures-topography-of-pharm 2026-04-13T18:57:08Z monthly 0.7 https://www.moreblossom.com/papers/transformative-experience-and-social-connectedness-mediate-the-mood-enhancing-ef 2026-04-16T10:44:13Z monthly 0.7 https://www.moreblossom.com/papers/transient-memory-impairment-after-acute-dose-of-75mg-3-4-methylene-dioxymethamph 2026-04-27T12:05:00Z monthly 0.7 https://www.moreblossom.com/papers/transient-stimulation-with-psychoplastogens-is-sufficient-to-initiate-neuronal-g 2026-04-13T18:56:33Z monthly 0.7 https://www.moreblossom.com/papers/translating-psychedelic-therapies-from-clinical-trials-to-community-clinics-buil 2026-04-16T10:44:17Z monthly 0.7 https://www.moreblossom.com/papers/transpersonal-ecodelia-surveying-psychedelically-induced-biophilia 2026-04-16T10:44:19Z monthly 0.7 https://www.moreblossom.com/papers/trauma-interventions-using-mindfulness-based-extinction-and-reconsolidation-timb 2026-05-19T09:31:50Z monthly 0.7 https://www.moreblossom.com/papers/trauma-under-psychedelics-mdma-shows-protective-effects-during-the-peritraumatic 2026-04-16T10:44:21Z monthly 0.7 https://www.moreblossom.com/papers/treating-addiction-perspectives-from-eeg-and-imaging-studies-on-psychedelics 2026-05-05T13:27:05Z monthly 0.7 https://www.moreblossom.com/papers/treating-bipolar-depression-with-esketamine-safety-and-effectiveness-data-from-a 2026-04-14T20:57:41Z monthly 0.7 https://www.moreblossom.com/papers/treating-drug-dependence-with-the-aid-of-ibogaine-a-qualitative-study 2026-04-13T18:50:48Z monthly 0.7 https://www.moreblossom.com/papers/treating-drug-dependence-with-the-aid-of-ibogaine-a-retrospective-study 2026-04-13T18:54:26Z monthly 0.7 https://www.moreblossom.com/papers/treating-posttraumatic-stress-disorder-with-mdma-assisted-psychotherapy-a-prelim 2026-04-05T19:28:55Z monthly 0.7 https://www.moreblossom.com/papers/treatment-approaches-and-efficacy-in-psychedelic-induced-psychosis-a-systematic- 2026-03-30T09:04:00Z monthly 0.7 https://www.moreblossom.com/papers/treatment-of-a-complex-personality-disorder-using-repeated-doses-of-lsd-a-case-r 2026-05-05T14:59:20Z monthly 0.7 https://www.moreblossom.com/papers/treatment-of-acute-opioid-withdrawal-with-ibogaine 2026-04-16T10:44:22Z monthly 0.7 https://www.moreblossom.com/papers/treatment-of-alcoholism-using-psychedelic-drugs-a-review-of-the-program-of-resea 2026-03-24T16:02:49Z monthly 0.7 https://www.moreblossom.com/papers/treatment-of-opioid-use-disorder-with-ibogaine-detoxification-and-drug-use-outco 2026-04-16T10:44:24Z monthly 0.7 https://www.moreblossom.com/papers/treatment-patterns-healthcare-utilization-and-costs-of-patients-with-treatment-r 2026-04-16T10:44:25Z monthly 0.7 https://www.moreblossom.com/papers/treatment-response-with-esketamine-nasal-spray-plus-an-oral-antidepressant-in-pa 2026-04-27T12:10:20Z monthly 0.7 https://www.moreblossom.com/papers/treatment-with-psychedelics-is-psychotherapy-beyond-reductionism 2026-04-16T10:44:27Z monthly 0.7 https://www.moreblossom.com/papers/trends-in-the-top-cited-articles-on-classic-psychedelics 2026-03-24T15:43:57Z monthly 0.7 https://www.moreblossom.com/papers/trial-of-ketamine-masked-by-surgical-anesthesia-in-depressed-patients 2026-05-19T11:44:10Z monthly 0.7 https://www.moreblossom.com/papers/trial-of-psilocybin-versus-escitalopram-for-depression 2026-05-19T15:10:25Z monthly 0.7 https://www.moreblossom.com/papers/tripping-on-nothing-placebo-psychedelics-and-contextual-factors 2026-04-16T10:56:30Z monthly 0.7 https://www.moreblossom.com/papers/tripping-up-addiction-the-use-of-psychedelic-drugs-in-the-treatment-of-problemat 2026-03-25T05:30:14Z monthly 0.7 https://www.moreblossom.com/papers/trips-and-neurotransmitters-discovering-principled-patterns-across-6850-hallucin 2026-04-16T10:44:35Z monthly 0.7 https://www.moreblossom.com/papers/turn-on-tune-in-and-drop-out-predictors-of-attrition-in-a-prospective-observatio 2026-04-16T10:44:37Z monthly 0.7 https://www.moreblossom.com/papers/turn-on-tune-in-drop-in-psychedelics-creativity-and-entrepreneurship 2026-03-24T15:44:09Z monthly 0.7 https://www.moreblossom.com/papers/twenty-percent-better-with-20-micrograms-a-qualitative-study-of-psychedelic-micr 2026-04-16T10:56:31Z monthly 0.7 https://www.moreblossom.com/papers/two-dose-investigation-of-the-5-ht-agonist-psilocybin-on-relative-and-global-cer 2026-04-16T10:44:41Z monthly 0.7 https://www.moreblossom.com/papers/two-models-of-legalization-of-psychedelic-substances-reasons-for-concern 2026-04-13T18:56:08Z monthly 0.7 https://www.moreblossom.com/papers/unauthorized-research-on-cluster-headache 2026-03-25T05:08:17Z monthly 0.7 https://www.moreblossom.com/papers/underground-ibogaine-use-for-the-treatment-of-substance-use-disorders-a-qualitat 2026-04-13T18:50:51Z monthly 0.7 https://www.moreblossom.com/papers/underground-mdma-lsd-and-2-cb-assisted-individual-and-group-psychotherapy-in-zur 2026-04-16T10:44:44Z monthly 0.7 https://www.moreblossom.com/papers/unifying-theories-of-psychedelic-drug-effects 2026-03-24T15:44:15Z monthly 0.7 https://www.moreblossom.com/papers/unique-effects-of-sedatives-dissociatives-psychedelics-stimulants-and-cannabinoi 2026-03-25T04:48:43Z monthly 0.7 https://www.moreblossom.com/papers/unique-psychological-mechanisms-underlying-psilocybin-therapy-versus-escitalopra 2026-05-19T16:20:05Z monthly 0.7 https://www.moreblossom.com/papers/unlocking-the-self-can-microdosing-psychedelics-make-one-feel-more-authentic 2026-04-16T10:44:49Z monthly 0.7 https://www.moreblossom.com/papers/updated-cost-effectiveness-of-mdma-assisted-therapy-for-the-treatment-of-posttra 2026-04-16T10:44:52Z monthly 0.7 https://www.moreblossom.com/papers/updating-the-dynamic-framework-of-thought-creativity-and-psychedelics 2026-03-25T04:57:09Z monthly 0.7 https://www.moreblossom.com/papers/use-of-benefit-enhancement-strategies-among-5-methoxy-nn-dimethyltryptamine-5-me 2026-03-30T09:04:12Z monthly 0.7 https://www.moreblossom.com/papers/use-of-ketamine-and-esketamine-for-depression-an-overview-of-systematic-reviews- 2026-04-05T19:29:14Z monthly 0.7 https://www.moreblossom.com/papers/use-of-psilocybin-mushrooms-among-us-adults-2015-2018 2026-04-16T10:44:54Z monthly 0.7 https://www.moreblossom.com/papers/use-of-repeated-intravenous-ketamine-therapy-in-treatment-resistant-bipolar-depr 2026-04-13T18:50:52Z monthly 0.7 https://www.moreblossom.com/papers/use-of-the-classic-hallucinogen-psilocybin-for-treatment-of-existential-distress 2026-03-24T16:02:59Z monthly 0.7 https://www.moreblossom.com/papers/user-perceptions-of-the-benefits-and-harms-of-hallucinogenic-drug-use-a-web-base 2026-04-16T10:44:55Z monthly 0.7 https://www.moreblossom.com/papers/using-a-mdma-and-lsd-group-therapy-model-in-clinical-practice-in-switzerland-and 2026-04-16T10:44:57Z monthly 0.7 https://www.moreblossom.com/papers/using-psilocybin-to-investigate-the-relationship-between-attention-working-memor 2026-04-05T19:29:18Z monthly 0.7 https://www.moreblossom.com/papers/using-psychedelics-with-therapeutic-intent-is-associated-with-lower-shame-and-co 2026-04-16T10:44:59Z monthly 0.7 https://www.moreblossom.com/papers/using-the-theory-of-planned-behavior-to-predict-implementation-of-harm-reduction 2026-04-16T10:45:00Z monthly 0.7 https://www.moreblossom.com/papers/validation-of-the-psychological-insight-scale-a-new-scale-to-assess-psychologica 2026-04-16T10:45:02Z monthly 0.7 https://www.moreblossom.com/papers/validation-of-the-revised-mystical-experience-questionnaire-in-experimental-sess 2026-03-23T22:54:40Z monthly 0.7 https://www.moreblossom.com/papers/verbal-memory-impairment-in-polydrug-ecstasy-users-a-clinical-perspective 2026-04-05T19:29:22Z monthly 0.7 https://www.moreblossom.com/papers/view-meditation-action-a-tibetan-framework-to-inform-psychedelic-assisted-therap 2026-03-24T15:44:33Z monthly 0.7 https://www.moreblossom.com/papers/views-on-using-psychoactive-substances-to-self-manage-functional-neurological-di 2026-04-16T10:45:04Z monthly 0.7 https://www.moreblossom.com/papers/virtual-reality-and-psychedelics-for-the-treatment-of-psychiatric-disease-a-syst 2026-04-05T19:29:24Z monthly 0.7 https://www.moreblossom.com/papers/virtual-reality-as-a-moderator-of-psychedelic-assisted-psychotherapy 2026-04-16T10:45:06Z monthly 0.7 https://www.moreblossom.com/papers/visitors-of-the-dutch-drug-checking-services-profile-and-drug-use-experience 2026-04-16T10:45:08Z monthly 0.7 https://www.moreblossom.com/papers/visual-hallucinations-originating-in-the-retinofugal-pathway-under-clinical-and- 2026-04-16T10:56:34Z monthly 0.7 https://www.moreblossom.com/papers/wassons-alternative-candidates-for-soma 2026-04-16T10:45:09Z monthly 0.7 https://www.moreblossom.com/papers/well-being-problematic-alcohol-consumption-and-acute-subjective-drug-effects-in- 2026-04-16T10:56:36Z monthly 0.7 https://www.moreblossom.com/papers/what-predicts-beneficial-outcomes-in-psychedelic-use-a-quantitative-content-anal 2026-04-16T10:45:13Z monthly 0.7 https://www.moreblossom.com/papers/when-the-endogenous-hallucinogenic-trace-amine-n-n-dimethyltryptamine-meets-the- 2026-03-25T05:14:32Z monthly 0.7 https://www.moreblossom.com/papers/when-the-trial-ends-the-case-for-post-trial-provisions-in-clinical-psychedelic-r 2026-03-25T05:41:53Z monthly 0.7 https://www.moreblossom.com/papers/who-are-you-after-psychedelics-a-systematic-review-and-a-meta-analysis-of-the-ma 2026-04-16T10:56:37Z monthly 0.7 https://www.moreblossom.com/papers/whole-brain-mapping-reveals-the-divergent-impact-of-ketamine-on-the-dopamine-sys 2026-03-24T15:44:45Z monthly 0.7 https://www.moreblossom.com/papers/whole-brain-multimodal-neuroimaging-model-using-serotonin-receptor-maps-explains 2026-04-13T18:40:59Z monthly 0.7 https://www.moreblossom.com/papers/why-mdma-therapy-for-alcohol-use-disorder-and-why-now 2026-03-24T15:44:45Z monthly 0.7 https://www.moreblossom.com/papers/why-psychiatry-needs-psychedelics-and-psychedelics-need-psychiatry 2026-03-24T15:44:45Z monthly 0.7 https://www.moreblossom.com/papers/why-was-early-therapeutic-research-on-psychedelic-drugs-abandoned 2026-04-05T19:29:29Z monthly 0.7 https://www.moreblossom.com/papers/within-treatment-changes-in-a-novel-addiction-treatment-program-using-traditiona 2026-04-11T11:18:39Z monthly 0.7 https://www.moreblossom.com/papers/working-with-weirdness-a-response-to-moving-past-mysticism-in-psychedelic-scienc 2026-03-25T04:59:23Z monthly 0.7 https://www.moreblossom.com/papers/zalsupindole-is-a-nondissociative-nonhallucinogenic-neuroplastogen-with-therapeu 2026-03-30T09:04:00Z monthly 0.7